Child health nursing Important topics according to inc for exam point of view

Reading File
Searching the Web

INC India nursing exam important topics child health nursing pediatric nursing

Finding Sources
Reading Web Page

https://www.indiannursingcouncil.org/uploads/pdf/17296837541…

Finding Sources
Searching the Web

INC BSc nursing exam child health nursing important topics growth development IMNCI immunization

Finding Sources
Reading Web Page

https://www.scribd.com/document/476738288/Child-Health-Nsg-I…

Based on my research from the INC syllabus, standard pediatric nursing resources (Harriet Lane Handbook and Red Book available in the library), web searches, and exam question patterns, here is a comprehensive guide:

Child Health Nursing - Important Topics (INC Exam)


UNIT 1: Growth & Development (HIGH PRIORITY - Always Asked)

Essay/Long Answer Topics

  • Define growth and development. Discuss the principles and factors affecting growth and development
  • Milestones of development - motor, language, social, cognitive (age-wise: 3m, 6m, 9m, 1yr, 18m, 2yr, 5yr)
  • Theories of development - Piaget (cognitive), Erikson (psychosocial), Freud (psychosexual), Kohlberg (moral)
  • Anthropometric measurements in children - weight, height, head circumference, chest circumference
  • Growth charts and their significance (WHO/IAP growth charts)

Short Notes

  • Denver Developmental Screening Test (DDST)
  • Primitive reflexes (Moro, rooting, Babinski, sucking, palmar grasp)
  • Fontanelles - anterior and posterior
  • Teething/dentition
  • Role of play in child development - types of play

UNIT 2: Neonatal Nursing (VERY HIGH PRIORITY)

Essay/Long Answer Topics

  • Normal newborn assessment - physical characteristics, Apgar scoring
  • Care of the newborn at birth - immediate care
  • Low Birth Weight (LBW) / Preterm baby - classification, problems, nursing management
  • Neonatal sepsis - causes, signs, management
  • Hyperbilirubinemia (Neonatal jaundice) - types, management, phototherapy, exchange transfusion
  • Birth asphyxia - Apgar score, resuscitation (NRP - Neonatal Resuscitation Protocol)
  • Respiratory Distress Syndrome (RDS/HMD) - causes, clinical features, nursing care

Short Notes

  • Kangaroo Mother Care (KMC)
  • SNCU / NICU care
  • Apgar scoring (components and interpretation)
  • Thermoregulation in newborns
  • Meconium aspiration syndrome
  • Hypoglycemia in newborns
  • Neonatal tetanus
  • Surfactant therapy

UNIT 3: IMNCI (HIGH PRIORITY)

Essay/Long Answer Topics

  • IMNCI - Introduction, components, classification and management of sick child
  • Classification of illness under IMNCI (very severe disease, severe pneumonia, etc.)
  • Assessment and classification of:
    • Cough/Breathing difficulty
    • Diarrhea
    • Fever
    • Ear problems
    • Malnutrition/Anemia

Short Notes

  • Danger signs in a sick child (IMNCI)
  • Oral rehydration therapy (ORS) - preparation and administration
  • Zinc supplementation in diarrhea
  • Home management under IMNCI

UNIT 4: Immunization (HIGH PRIORITY)

Essay/Long Answer Topics

  • National Immunization Schedule (NIS) - complete schedule with vaccines, doses, routes, and age
  • Cold chain - components, maintenance, importance
  • Types of vaccines - live attenuated, killed, toxoid, recombinant
  • Adverse reactions to vaccines and management

Short Notes

  • BCG vaccine - dose, site, BCG scar
  • OPV vs IPV
  • Pentavalent vaccine
  • Rotavirus vaccine
  • MR/MMR vaccine
  • Mission Indradhanush
  • Herd immunity

UNIT 5: Nutritional Disorders (FREQUENTLY ASKED)

Essay/Long Answer Topics

  • Protein Energy Malnutrition (PEM) - Kwashiorkor vs Marasmus - differences, clinical features, management
  • Breastfeeding - importance, advantages, technique, WHO recommendations, complications
  • Complementary feeding - introduction, schedule
  • Vitamin A deficiency - Bitot's spots, xerophthalmia, management, Vitamin A supplementation program

Short Notes

  • Vitamin D deficiency - Rickets (clinical features, investigations)
  • Iron deficiency anemia in children
  • Scurvy
  • Iodine deficiency disorders
  • Mid-upper arm circumference (MUAC)
  • Grading of malnutrition (Gomez classification, Waterlow classification)

UNIT 6: Respiratory Disorders

Essay/Long Answer Topics

  • Pneumonia in children - classification (WHO), clinical features, management, nursing care
  • Bronchial Asthma - pathophysiology, clinical features, management, nursing care
  • Bronchiolitis - clinical features, management
  • Croup (Laryngotracheobronchitis) - types, management

Short Notes

  • Tachypnea (age-specific respiratory rates)
  • Pulse oximetry
  • Nebulization
  • Chest physiotherapy
  • ARDS in children

UNIT 7: Gastrointestinal Disorders

Essay/Long Answer Topics

  • Diarrheal diseases - acute, persistent, dysentery; ORT, Plan A/B/C management
  • Intussusception - clinical features (red currant jelly stool), diagnosis, management
  • Hirschsprung's disease - pathophysiology, clinical features, nursing management
  • Cleft lip and palate - nursing management pre- and post-operative

Short Notes

  • Appendicitis in children
  • Celiac disease
  • Pyloric stenosis
  • Worm infestations (Ascariasis)
  • Hepatitis in children

UNIT 8: Cardiovascular Disorders

Essay/Long Answer Topics

  • Congenital Heart Diseases (CHD) - classification (acyanotic vs cyanotic), clinical features, surgical management
    • Acyanotic: VSD, ASD, PDA, COA
    • Cyanotic: TOF (Tetralogy of Fallot), TGA
  • Rheumatic fever - Jones criteria, clinical features, nursing management, prophylaxis

Short Notes

  • Infective endocarditis
  • Heart failure in children
  • Clubbing and cyanosis
  • Tet spell management

UNIT 9: Renal Disorders

Essay/Long Answer Topics

  • Nephrotic Syndrome - clinical features (massive proteinuria, hypoalbuminemia, edema, hyperlipidemia), management, nursing care
  • Nephritic Syndrome (Acute Glomerulonephritis) - APSGN, clinical features, management

Short Notes

  • Urinary Tract Infection (UTI) in children
  • Vesicoureteral reflux
  • Hemolytic Uremic Syndrome (HUS)
  • Wilms' tumor (Nephroblastoma)

UNIT 10: Neurological Disorders

Essay/Long Answer Topics

  • Meningitis - bacterial vs viral, clinical features, LP findings, nursing management
  • Febrile seizures - definition, types, management
  • Cerebral Palsy - types, clinical features, rehabilitation, nursing care
  • Hydrocephalus - types, clinical features, VP shunt - nursing care

Short Notes

  • Neural tube defects (Spina bifida, myelomeningocele)
  • Encephalitis
  • Reye's syndrome
  • Cerebral edema management
  • Signs of meningeal irritation (Kernig's, Brudzinski's)

UNIT 11: Hematological Disorders

Essay/Long Answer Topics

  • Thalassemia - types, clinical features, management, nursing care, chelation therapy
  • Hemophilia - types (A vs B), management, nursing care
  • Sickle Cell Anemia - pathophysiology, clinical features, crisis management
  • Iron Deficiency Anemia - assessment, management

Short Notes

  • Blood transfusion reactions
  • DIC in children
  • Leukemia in children (ALL - most common)
  • Thrombocytopenic purpura (ITP)

UNIT 12: Infectious Diseases of Childhood

Essay/Long Answer Topics

  • Measles - clinical features, complications, Koplik's spots, nursing management
  • Dengue fever - classification (WHO), warning signs, NS1 antigen, management
  • Typhoid - Widal test, Rose spots, management
  • Tuberculosis in children - diagnosis, Mantoux test, RNTCP/NTEP

Short Notes

  • Chickenpox (Varicella)
  • Mumps
  • Pertussis (Whooping cough)
  • Diphtheria
  • Malaria in children

UNIT 13: Surgical/Congenital Conditions

Short Notes (Very Frequently Asked)

  • Hypospadias and Epispadias
  • Undescended testis (Cryptorchidism)
  • Inguinal hernia in children
  • Congenital hip dysplasia (DDH)
  • Club foot (CTEV) - Ponseti method
  • Congenital hypothyroidism - neonatal screening

UNIT 14: Pediatric Emergency & Critical Care

Essay/Long Answer Topics

  • Pediatric Basic Life Support (PBLS) - steps, ratios, compression depth
  • Shock in children - types, fluid resuscitation, nursing management
  • Burns in children - TBSA estimation (Lund and Browder chart), fluid resuscitation (Parkland formula)
  • Poisoning in children - management (organophosphate, kerosene)

Short Notes

  • PALS (Pediatric Advanced Life Support)
  • Fluid and electrolyte balance in children
  • Maintenance fluid calculation (Holliday-Segar formula)
  • Intussusception emergency

UNIT 15: Child Mental Health & Special Topics

Short Notes

  • Mental Retardation / Intellectual Disability - classification (IQ levels), management
  • Autism Spectrum Disorder (ASD) - characteristics
  • ADHD - features, management
  • Down Syndrome (Trisomy 21) - features, nursing care
  • Failure to Thrive (FTT)
  • Child abuse - types, indicators, nurse's role, reporting

UNIT 16: Legal/Policy Framework (INC-Specific Focus)

  • Child Rights - UNCRC, CRC articles
  • POCSO Act
  • Integrated Child Development Services (ICDS)
  • National Child Health Program / RBSK
  • IMNCI vs IMCI - differences
  • Rashtriya Bal Swasthya Karyakram (RBSK)
  • IMR, NMR, U5MR - definitions and current Indian statistics

Top 10 Most Repeated Essay Topics (INC Exam Pattern)

RankTopic
1Growth & Development milestones
2National Immunization Schedule
3Nursing management of preterm/LBW baby
4IMNCI - assessment and classification
5Protein Energy Malnutrition (Kwashiorkor & Marasmus)
6Nephrotic Syndrome
7Tetralogy of Fallot (TOF)
8Meningitis - nursing management
9Thalassemia
10Neonatal jaundice / Hyperbilirubinemia

Quick Revision: Always-Tested Short Notes

  • Apgar scoring
  • Kangaroo Mother Care
  • Fontanelles
  • Cold chain maintenance
  • ORS preparation
  • Koplik's spots (Measles)
  • Jones criteria (Rheumatic fever)
  • Waterlow/Gomez classification
  • Denver Developmental Test
  • Types of play
  • BCG scar
  • Breastfeeding technique & positions
  • MUAC (Mid Upper Arm Circumference)

Study Tip: The INC exam (for BSc Nursing final year) heavily tests application-based nursing care plans, so for every major disease, practice writing: assessment findings, nursing diagnoses, interventions, and health education. Topics from IMNCI, immunization, and neonatal care appear in almost every exam paper.

Explain each one of them in extreme details according to 50 marks

Asking for Preferences

There are 16 units with dozens of topics — explaining ALL of them at 50-mark depth would be extremely long (500+ pages). Which would you like? · What format do you want the output in?

Asking for Preferences

Which topic do you want to start with?

Great choice! Let me pull from the medical library and compile a complete 50-mark answer on Growth & Development.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have rich textbook content. Let me compile the complete 50-mark answer.

GROWTH AND DEVELOPMENT IN CHILDREN

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Growth and development are fundamental concepts in pediatric nursing. Growth refers to the increase in the physical size of the body - measurable, quantitative changes such as weight, height, and head circumference. Development refers to the progressive increase in skills and functions - qualitative changes in the child's abilities, emotions, and intellect.
Growth and development are inseparable - the child grows and develops as a whole. They include physical, intellectual, emotional, and social aspects. Normal growth and development require optimal nutrition, freedom from recurrent infections, and freedom from adverse genetic and environmental influences.
(Park's Textbook of Preventive and Social Medicine, p. 631)

SECTION 1: PRINCIPLES OF GROWTH AND DEVELOPMENT

  1. Cephalocaudal direction - development proceeds from head downward (a baby controls head before trunk before legs)
  2. Proximodistal direction - development proceeds from center outward (trunk control before arm before finger control)
  3. Simple to complex - a child crawls before walking, babbles before speaking
  4. General to specific - gross motor before fine motor
  5. Continuous but uneven - growth is a continuous process but the rate varies; fastest in fetal life, first year, and puberty
  6. Sequential and predictable - milestones follow a fixed sequence; a child never skips stages
  7. Individual variation - each child has their own pace; milestones are averages not rigid rules
  8. Interrelated aspects - physical, mental, social, and emotional development influence each other

SECTION 2: DETERMINANTS (FACTORS AFFECTING GROWTH & DEVELOPMENT)

A. Biological/Internal Factors

FactorEffect
Genetic inheritanceDetermines height, weight, mental capacity, and personality
AgeGrowth rate is maximum during fetal life, first year, and puberty
SexGirls have growth spurt at 10-11 years; boys at 12-13 years
Birth weightLow birth weight affects subsequent development
HormonesGrowth hormone, thyroid hormone, insulin, sex hormones

B. Environmental/External Factors

FactorEffect
NutritionMost important modifiable factor; malnutrition causes growth retardation
InfectionsRepeated infections (diarrhea, measles) slow growth; maternal infections (rubella, syphilis) affect fetal growth
Parasitic infestationsRoundworms compete for nutrients and hamper growth
Physical surroundingsSunshine, ventilation, good housing promote growth
Psychological factorsLove, secure attachment, parent-child relationship promote emotional and intellectual development
Economic factorsHigher socioeconomic status = better nutrition and living conditions = better growth
Education of parentsEducated parents provide better child-rearing practices
Birth order and spacingClosely spaced births with poor spacing can impair individual child's nutrition
(Park's Textbook of Preventive and Social Medicine, p. 631-632)

SECTION 3: PHYSICAL GROWTH PARAMETERS

A. Weight

  • Birth weight: 2.5 - 3.5 kg (average 3 kg)
  • Formula for expected weight:
    • Up to 6 months: Birth weight + (Age in months × 600 g)
    • 6-12 months: Birth weight + (Age in months × 500 g)
    • 1-6 years: Age (years) × 2 + 8 kg
    • 7-12 years: Age (years) × 7 - 5 / 2
Weight gain pattern:
AgeWeekly Gain
0-3 months200 g/week
4-6 months150 g/week
7-9 months100 g/week
10-12 months50-75 g/week
1-2 years2.5 kg/year
3-5 years2.0 kg/year
Key milestones:
  • Birth weight doubles by 5 months
  • Birth weight triples by 1 year
  • Birth weight quadruples by 2 years

B. Height (Length)

  • Birth length: ~50 cm
  • Increases by 25 cm in 1st year
  • Increases by 12 cm in 2nd year, then 9, 7, 6 cm each year up to 5 years
  • Formula: Height = Age (years) × 6 + 77 cm (for 2-12 years)
  • Adult height: Boys reach 98% adult height by 17.75 years; Girls by 16.5 years

C. Head Circumference

  • Birth: 33-35 cm (average 34 cm)
  • 6 months: 43 cm
  • 1 year: 46-47 cm
  • 2 years: 48 cm
  • Adult: 55-58 cm
  • Head circumference > chest circumference up to 1 year; they equalize at 1 year; after that chest > head

D. Chest Circumference

  • Birth: 30-33 cm (about 2 cm less than head circumference)
  • Equals head circumference at 1 year
  • Exceeds head circumference after 1 year

E. Anterior Fontanelle

  • Diamond-shaped, at junction of coronal and sagittal sutures
  • Size at birth: 2-3 cm
  • Closes at 12-18 months (up to 2 years is acceptable)
  • Bulging = raised ICP (meningitis, hydrocephalus)
  • Sunken = dehydration

F. Posterior Fontanelle

  • Triangular-shaped
  • Closes at 6-8 weeks (2 months)

SECTION 4: DEVELOPMENTAL MILESTONES (Age-Wise - Most Exam-Tested)

FOUR AREAS OF DEVELOPMENT (Gesell's 4 Streams):

  1. Gross motor - posture, locomotion
  2. Fine motor / Adaptive - hand-eye coordination, manipulation
  3. Language - communication
  4. Personal-social - interaction, self-care

MILESTONE TABLE

AgeGross MotorFine Motor / AdaptiveLanguagePersonal-Social
NewbornFlexed posture, turns head to sideGrasp reflex presentCriesRegards face
6-8 weeksRaises head briefly prone--Social smile (most imp!)
3 monthsHolds head erect; raises chestHands open at restCoos, vocalizesRecognizes mother
4-5 monthsRolls over (prone to supine)Reaches for objectsLaughs aloudRecognizes mother clearly
6 monthsSits with support; rolls both waysTransfers objects hand to handBabbles (ma-ma, da-da - non-specific)Enjoys peek-a-boo/hide and seek
9 monthsSits without support; crawlsPincer grasp (crude)"mama/dada" non-specific; understands "no"Stranger anxiety (suspicious of strangers)
10-11 monthsStands with support; cruisesNeat pincer graspFirst words with meaningWaves bye-bye
12 monthsWalks with one hand held; stands aloneReleases objects voluntarily1-2 meaningful wordsComes when called
15 monthsWalks independently (wide base)Tower of 2 cubes4-6 wordsUses cup/spoon
18 monthsRuns (narrow base beginning); walks up stairs with supportTower of 3-4 cubes; scribbles8-10 words; points to body partsFeeds self with spoon; dry by day
2 yearsRuns well; up/down stairs both feetTower of 6-7 cubes; copies vertical line2-3 word sentences; 50 wordsParallel play; dry by day
3 yearsRides tricycle; jumpsTower of 9 cubes; copies circleFull sentences; asks questionsDresses/undresses with help; associative play
4 yearsHops on one foot; skipsCopies cross (+)Tells storiesCooperative play; follows rules
5 yearsSkips alternating feetCopies triangle2000 words vocabulary; names 4 colorsDresses independently
6 yearsRides bicycleCopies diamondReads; writes namePlays competitive games
(Park's Textbook of Preventive and Social Medicine, Table 10, p. 635)

SECTION 5: PRIMITIVE REFLEXES

ReflexHow to ElicitResponseDisappears By
Moro (Startle)Sudden movement/noiseArms abduct, extend then flex (embracing)3-4 months
RootingStroke corner of mouthTurns head toward stimulus3-4 months
SuckingTouch lips/palateSucking movements4 months (awake); persists during sleep
Palmar graspPlace finger in palmFingers flex and grip3-4 months
Plantar graspPress sole below toesToes flex and curl9-12 months
BabinskiStroke lateral soleDorsiflexion of big toe, fanning of others12-18 months
Stepping/WalkingHold upright, touch sole to surfaceStepping movements2 months
Tonic Neck Reflex (TNR)Turn head to one sideSame side arm extends, opposite arm flexes (fencing)4-6 months
Parachute reflexHold prone, lower toward surfaceArms extend outwardAppears at 8-9 months; persists lifelong
Nursing significance: Persistence of primitive reflexes beyond expected age suggests neurological impairment (e.g., cerebral palsy).

SECTION 6: THEORIES OF DEVELOPMENT

A. Sigmund Freud - Psychosexual Theory

StageAgeFocusFixation leads to
Oral0-1 yearMouth (feeding, sucking)Dependency, smoking
Anal1-3 yearsAnus (bowel control)Rigidity or messiness
Phallic3-6 yearsGenitals (Oedipus/Electra complex)Guilt, authority issues
Latency6-12 yearsSchool, peers-
Genital12+ yearsSexual maturity-

B. Erik Erikson - Psychosocial Theory (Most Important for Nursing)

StageAgeCrisisHealthy Resolution
Infancy0-2 yearsTrust vs. MistrustConsistent nurturing builds trust
Toddler2-4 yearsAutonomy vs. Shame & DoubtAllow safe exploration
Preschool5-7 yearsInitiative vs. GuiltSet limits for protection, not condemnation
School age8-12 yearsIndustry vs. InferiorityEncourage achievement and competence
Adolescence13-17 yearsIdentity vs. Role ConfusionSupport career goals and independence
(Textbook of Family Medicine 9e, Table 22-10, p. 566)

C. Jean Piaget - Cognitive Development Theory

StageAgeKey FeatureCharacteristics
Sensorimotor0-2 yearsObject permanence (8-9 months)Learning through senses and movement
Pre-operational2-7 yearsEgocentrism, magical thinkingCannot understand conservation; animism
Concrete operational7-11 yearsLogical reasoning about concrete thingsConservation, classification, seriation
Formal operational12+ yearsAbstract reasoningHypothetical thinking

D. Lawrence Kohlberg - Moral Development Theory

LevelAgeStageDescription
Pre-conventional2-7 yearsPunishment & Obedience; Self-interestRules followed to avoid punishment
Conventional7-11 yearsGood boy/girl; Law & OrderRules followed to please others
Post-conventional12+ yearsSocial contract; Universal principlesRules based on ethical principles

E. Gesell's Normative/Maturation Theory

  • Development depends on neurological and physical maturation
  • Universal, sequential progression of milestones
  • Minimal role of environment
  • Basis for developmental milestone charts used clinically (Textbook of Family Medicine 9e, Table 22-9)

SECTION 7: DENTITION

Primary (Deciduous) Teeth - 20 total

TeethEruption AgeShedding Age
Lower central incisors6-8 months6-7 years
Upper central incisors8-10 months7-8 years
Lateral incisors10-12 months7-9 years
First molars12-16 months9-11 years
Canines16-20 months10-12 years
Second molars20-30 months11-13 years
Formula: Age in months - 6 = number of teeth (up to 30 months)

Permanent Teeth - 32 total

  • First permanent molar: 6 years (6-year molar)
  • All permanent teeth by 21 years

SECTION 8: DENVER DEVELOPMENTAL SCREENING TEST (DDST)

  • Developed by Frankenburg and Dodds (1967), revised as Denver II (1992)
  • Used to screen children 0-6 years for developmental delays
  • Tests 4 domains: personal-social, fine motor-adaptive, language, gross motor
  • Each item: tested by observation, parent report, or direct elicitation
  • Each item represented as a bar spanning the age range when 25%, 50%, 75%, and 90% of children pass
  • Interpretation:
    • Normal: No delays, at most one caution
    • Suspect: Two or more cautions or one delay
    • Untestable: Refusal to perform key items
  • Nursing use: Screening tool only - not diagnostic; abnormal result requires full evaluation

SECTION 9: GROWTH CHARTS

  • Road-to-health chart (Morley): Monitors weight gain over time
  • India adopted WHO Child Growth Standards (2006) in February 2009
  • Used in ICDS and National Rural Health Mission
  • Three growth curves: General body growth, brain/head growth (rapid in preschool years), reproductive system growth (rapid at puberty)

Nutritional Classification Using Anthropometry

ClassificationIndicatorMeaning
UnderweightWeight-for-age < -2 SDCurrent or past malnutrition
StuntingHeight-for-age < -2 SDChronic/past malnutrition
WastingWeight-for-height < -2 SDAcute/current malnutrition
MUAC < 12.5 cmMid-upper arm circumferenceSevere acute malnutrition

SECTION 10: PLAY AND ITS IMPORTANCE IN DEVELOPMENT

Play is the primary medium through which children learn and develop.

Types of Play (Parten's Classification)

TypeAgeDescription
Solitary play< 2 yearsPlays alone without regard for others
Parallel play2-3 yearsPlays alongside others, not with them
Associative play3-4 yearsInteracts with others but no organized goal
Cooperative play4+ yearsOrganized, goal-directed group play
Onlooker playAnyObserves others without participating

Other Classifications

  • Dramatic/Symbolic play - pretend play (preschool)
  • Constructive play - building, creating
  • Games with rules - school age

Therapeutic Benefits of Play

  • Physical: develops motor skills and coordination
  • Cognitive: encourages problem-solving and creativity
  • Emotional: outlets for fear, anxiety, and tension
  • Social: teaches sharing, cooperation, and empathy
  • Therapeutic play in hospitals reduces fear and facilitates cooperation

SECTION 11: NURSING IMPLICATIONS

  1. Assessment: Use age-appropriate developmental screening tools (DDST) in all routine child visits
  2. Health promotion: Educate parents on expected milestones at each age; avoid comparing children
  3. Anticipatory guidance: Prepare parents for upcoming developmental stages and safety concerns (e.g., childproofing at crawling stage)
  4. Hospitalized children: Maintain developmental routines; provide age-appropriate play; minimize separation anxiety (most intense at 6 months - 3 years)
  5. Stimulation: Educate parents on importance of talking, reading, and playing with children to promote development
  6. Red flags: Refer for evaluation if a child loses previously gained milestones or significantly lags behind (e.g., not walking by 18 months, no words by 15 months)
  7. Growth monitoring: Plot on WHO growth chart at every visit; three consecutive downward crossings of growth percentile lines is significant

SECTION 12: DEVELOPMENTAL RED FLAGS (Danger Signs)

AgeRed Flag
2 monthsNo social smile
4 monthsNo head control; hands still fisted
6 monthsCannot sit with support; no babbling
9 monthsNo stranger anxiety; no pincer grasp developing
12 monthsNo single meaningful word; not standing with support
18 monthsNot walking independently; fewer than 5-6 words
2 yearsNo two-word phrases; not running
3 yearsCannot climb stairs; speech not understood by strangers
Any ageLoss of previously acquired milestones (most serious)

CONCLUSION

Growth and development represent the most fundamental aspect of child health nursing. A thorough understanding of normal milestones, developmental theories, and growth parameters enables nurses to monitor child health, detect problems early, guide parents effectively, and deliver developmentally appropriate care. The nurse plays a pivotal role in developmental surveillance, health promotion, and early intervention to ensure every child reaches their full potential.

Exam tip: For 50-mark answers, always include: definition, principles, factors, physical parameters with formulas, milestone table (4 streams), primitive reflexes, developmental theories (Erikson + Piaget are most important), DDST, growth chart, play types, nursing implications, and red flags. Each section alone can carry 5-8 marks.

Just say the next topic you want covered (e.g., National Immunization Schedule, LBW/Preterm Baby, IMNCI, etc.) and I will give you the same depth.

Next

Finding Sources
Finding Sources
Searching the Web

India national immunization schedule 2024 2025 UIP vaccines list updated

Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
I now have all the content needed from Park's textbook (the gold standard for INC). Here is the complete 50-mark answer:

NATIONAL IMMUNIZATION SCHEDULE (NIS)

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Immunization is one of the most cost-effective public health interventions for reducing child morbidity and mortality. It is defined as the process by which an individual is made immune or resistant to an infectious disease, typically by administering a vaccine. India's Universal Immunization Programme (UIP) is one of the largest public health programs in the world, targeting approximately 27 million newborns and 30 million pregnant women annually.
The National Immunization Schedule (NIS) outlines the vaccines to be given, the age at which they must be given, the dose, route, and site of administration.

SECTION 1: HISTORICAL MILESTONES OF IMMUNIZATION IN INDIA

YearMilestone
1978Expanded Programme of Immunization (EPI) launched - BCG, DPT, OPV, Typhoid (urban areas)
1983TT vaccine for pregnant women introduced
1985Universal Immunization Programme (UIP) launched
1990UIP expanded nationally; Vitamin A supplementation added
1992Integrated with Child Survival and Safe Motherhood (CSSM)
1997Reproductive and Child Health (RCH) programme
2005National Rural Health Mission (NRHM) launched
2006Hepatitis B vaccine included in NIS
2011Pentavalent vaccine replaced DPT + Hep B + Hib separately
2014Mission Indradhanush launched
2016IPV (Inactivated Polio Vaccine), Rotavirus vaccine, Adult JE vaccine added
2017MR (Measles-Rubella) vaccine replaced Measles vaccine
2017PCV (Pneumococcal Conjugate Vaccine) added (select states)
(Park's Textbook of Preventive and Social Medicine, Table 8)

SECTION 2: NATIONAL IMMUNIZATION SCHEDULE (NIS) - INDIA 2020

A. FOR PREGNANT WOMEN

VaccineWhen to GiveDoseRouteSite
TT/Td - 1Early in pregnancy0.5 mlIntramuscularUpper arm
TT/Td - 24 weeks after TT-10.5 mlIntramuscularUpper arm
TT/Td - BoosterIf received 2 TT doses in a pregnancy within last 3 years0.5 mlIntramuscularUpper arm

B. FOR INFANTS (Birth to 12 Months)

VaccineWhen to GiveDoseRouteSite
BCGAt birth (or as early as possible till 1 year)0.1 ml (0.05 ml until 1 month)IntradermalLeft upper arm
Hepatitis B (Birth dose)At birth, within 24 hours0.5 mlIntramuscularAntero-lateral mid-thigh
OPV-0At birth, within first 15 days2 dropsOralOral
OPV 1, 2, 36 weeks, 10 weeks, 14 weeks2 dropsOralOral
Pentavalent 1, 2, 36 weeks, 10 weeks, 14 weeks0.5 mlIntramuscularAntero-lateral mid-thigh
PCV (Pneumococcal Conjugate)6 weeks & 14 weeks (primary); booster at 9-12 months0.5 mlIntramuscularAntero-lateral mid-thigh
Rotavirus (RVV)6 weeks, 10 weeks, 14 weeks3 dropsOralOral
IPV (Inactivated Polio)6 weeks and 14 weeks (fractional doses)0.1 mlIntradermalRight upper arm
MR 1st dose9-12 completed months0.5 mlSubcutaneousRight upper arm
JE-1 (endemic districts)9-12 completed months0.5 mlSubcutaneousLeft upper arm
Vitamin A (1st dose)At 9 completed months (with MR vaccine)1 ml (1 lakh IU)OralOral

C. FOR CHILDREN (12 Months to 5 Years)

VaccineWhen to GiveDoseRouteSite
MR 2nd dose16-24 months0.5 mlSubcutaneousRight upper arm
DPT Booster-116-24 months0.5 mlIntramuscularAntero-lateral mid-thigh
OPV Booster16-24 months2 dropsOralOral
JE-2 (endemic districts)16-24 months0.5 mlSubcutaneousLeft upper arm
Vitamin A (2nd to 9th dose)16 months, then every 6 months till 5 years2 ml (2 lakh IU)OralOral
DPT Booster-25-6 years0.5 mlIntramuscularUpper arm
OPV (5 years)5 years2 dropsOralOral

D. FOR SCHOOL-AGE CHILDREN

VaccineWhen to GiveDoseRouteSite
TT10 years and 16 years0.5 mlIntramuscularUpper arm
(Park's Textbook of Preventive and Social Medicine, Table 43 - NIS India 2020)

SECTION 3: PENTAVALENT VACCINE (High-Yield)

  • Contains 5 antigens in a single injection:
    1. Diphtheria toxoid
    2. Pertussis (whole cell)
    3. Tetanus toxoid
    4. Hepatitis B surface antigen
    5. Hib (Haemophilus influenzae type b) conjugate
  • Replaces: Separate DPT + Hepatitis B + Hib vaccines
  • Schedule: 6, 10, and 14 weeks
  • Route: Intramuscular, antero-lateral mid-thigh
  • Significance: Reduces the number of injections from 6 to 3 for the same protection

SECTION 4: INDIVIDUAL VACCINE DETAILS

1. BCG (Bacillus Calmette-Guérin)

  • Type: Live attenuated (Mycobacterium bovis)
  • Protects against: Tuberculosis (especially miliary TB and tuberculous meningitis in children)
  • Dose: 0.1 ml (0.05 ml for neonates up to 1 month)
  • Route: Intradermal
  • Site: Left upper arm (over deltoid insertion)
  • BCG scar: Appears at 2-4 weeks as a papule, ulcerates, heals with scar by 6-12 weeks
  • No scar: Does NOT mean vaccine failure; do not repeat if properly administered
  • Contraindication: Immunocompromised children (HIV positive with symptoms), generalized eczema

2. Oral Polio Vaccine (OPV)

  • Type: Live attenuated (Sabin) - trivalent (types 1, 2, 3)
  • Dose: 2 drops orally
  • Schedule: Birth (OPV-0), 6/10/14 weeks (OPV 1,2,3), 16-24 months (booster), 5 years
  • Advantages: Easy to administer, produces intestinal immunity, herd immunity
  • Disadvantage: Vaccine-Associated Paralytic Polio (VAPP) - 1 in 2.7 million doses
  • Heat sensitive - must be stored at -15 to -25°C; sensitive to light

3. IPV (Inactivated Polio Vaccine - Salk)

  • Type: Killed (inactivated) virus
  • Dose: 0.1 ml intradermal (fractional IPV/fIPV - used in India)
  • Schedule: 6 weeks and 14 weeks
  • Advantage: No risk of VAPP
  • Disadvantage: Does not produce intestinal immunity
  • India uses both OPV + IPV for better protection (sequential schedule)

4. Hepatitis B Vaccine

  • Type: Recombinant (HBsAg)
  • Schedule: Birth (within 24 hours), 6 weeks (via pentavalent), 14 weeks (via pentavalent)
  • Important: Birth dose within 24 hours prevents perinatal transmission (most important dose)
  • Sensitive to freezing - should never be frozen; store at +2°C to +8°C

5. DPT (Diphtheria, Pertussis, Tetanus)

  • Diphtheria: Toxoid (formaldehyde-inactivated toxin)
  • Pertussis: Killed whole cells of Bordetella pertussis
  • Tetanus: Toxoid
  • Now given as part of Pentavalent at 6, 10, 14 weeks
  • DPT Booster 1: 16-24 months; Booster 2: 5-6 years
  • Adverse reactions: Fever, local swelling, irritability; rarely febrile convulsions

6. MR Vaccine (Measles-Rubella)

  • Type: Live attenuated
  • Replaced: Measles vaccine
  • 1st dose: 9-12 months; 2nd dose: 16-24 months
  • Route: Subcutaneous, right upper arm
  • Contraindication: Pregnancy, immunocompromised state, active febrile illness
  • Do not give within 3 months of blood/immunoglobulin transfusion (inhibits immune response)

7. Rotavirus Vaccine (RVV)

  • Type: Live oral vaccine
  • Protects against: Severe rotavirus gastroenteritis
  • Schedule: 3 drops orally at 6, 10, 14 weeks
  • India uses: Rotavac (indigenous vaccine developed by Bharat Biotech)
  • Important: Must complete by 1 year of age

8. Vitamin A Supplementation

  • 1st dose: 1 lakh IU (1 ml) at 9 months (with MR vaccine)
  • 2nd dose onwards: 2 lakh IU (2 ml) every 6 months from 16 months to 5 years (total 9 doses)
  • Prevents: Night blindness, xerophthalmia, reduces child mortality
  • Route: Oral

9. TT (Tetanus Toxoid) for Pregnant Women

  • TT-1: Early in pregnancy
  • TT-2: 4 weeks after TT-1 (provides 80% protection for 3 years)
  • Booster: If previously received 2 doses within last 3 years
  • Purpose: Prevents maternal and neonatal tetanus
  • Protect until: TT-2 given at least 4 weeks before delivery provides protection to newborn

10. JE (Japanese Encephalitis) Vaccine

  • Given only in endemic districts of India
  • Live attenuated SA-14-14-2 strain (Jeev vac) - 2 doses: 9-12 months and 16-24 months

SECTION 5: TYPES OF VACCINES

TypeExamplesKey Feature
Live attenuatedBCG, OPV, MR, RVV, Yellow FeverWeakened pathogen; stronger immunity; contraindicated in immunocompromised
Killed/InactivatedIPV, Hepatitis A, Influenza, Pertussis (whole cell)Heat-killed; safer; needs boosters
ToxoidTT, DiphtheriaInactivated toxin; protects against toxin action
Subunit/RecombinantHepatitis B, HPV, PCVContains specific antigens; very safe
ConjugateHib, PCV, MeningococcalPolysaccharide linked to protein carrier; works in infants < 2 years

SECTION 6: COLD CHAIN

Definition

The cold chain is a system of storage and transport of vaccines at low temperature from the manufacturer to the actual vaccination site. It ensures vaccine potency is maintained throughout the supply chain.
The 6 Rights of cold chain: Right vaccine | Right quantity | Right place | Right time | Right condition | Right cost
(Park's Textbook of Preventive and Social Medicine, p. 493)

Temperature Requirements

VaccineStorage Temperature
OPV-15°C to -25°C (frozen)
BCG, MR, MMR, Varicella+2°C to +8°C
DPT, TT, DT, Hepatitis B, Pentavalent, IPV, PCV+2°C to +8°C (must NOT be frozen - freeze-sensitive)

Freeze-Sensitive Vaccines (Must NOT be frozen)

  • Hepatitis B, DPT, TT, DT, Td
  • Pentavalent, IPV, PCV, HPV, Influenza

Cold Chain Equipment (Level-wise)

LevelEquipmentTemperature
National/StateWalk-In Freezer (WIF)-15°C to -25°C
National/State/RegionalWalk-In Cooler (WIC)+2°C to +8°C
District/PHCDeep Freezer (DF)-15°C to -25°C (for OPV)
PHC/SubcentreIce-Lined Refrigerator (ILR)+2°C to +8°C
Field/session siteVaccine carrier with ice packs+2°C to +8°C
TransportCold boxes+2°C to +8°C

Key Cold Chain Points

  • ILR (Ice-Lined Refrigerator): Most important at PHC level; maintains temperature even during power cuts for 6-8 hours due to ice lining
  • Deep Freezer: Top-opening lid (prevents cold air loss); used for OPV and freezing ice packs
  • WIF provides 72 hours of holdover time after power failure
  • Vaccine Vial Monitor (VVM): Heat-sensitive label on vials; inner square darker than outer circle = vaccine unusable

SECTION 7: VACCINE STORAGE - KEY RULES

  1. Store vaccines at the back of the refrigerator (not the door - temperature fluctuates)
  2. Never store vaccines at the bottom of the refrigerator (risk of freezing)
  3. Always store diluents with the vaccine (they must be reconstituted at the same temperature)
  4. OPV at the top; freeze-sensitive vaccines in the middle
  5. Keep vaccines away from the freezer compartment
  6. Monitor temperature twice daily; record in temperature monitoring chart
  7. Never use a domestic refrigerator for vaccine storage

SECTION 8: OPEN VIAL POLICY

Multi-dose vials opened at session sites can be used in subsequent sessions for up to 4 weeks provided:
  • Expiry date has not passed
  • Vaccines are stored at appropriate temperature
  • Vaccine vial monitor has not crossed the discard point
  • No contamination of needle or vial cap
  • Exception: BCG, measles/MR, and any reconstituted vaccine must be discarded at end of session (within 4 hours of reconstitution)

SECTION 9: ADVERSE EVENTS FOLLOWING IMMUNIZATION (AEFI)

Definition

Any untoward medical occurrence following immunization which may or may not have a causal relationship with the vaccine.

Classification of AEFI

TypeDescriptionExamples
Vaccine product-relatedDue to inherent property of vaccineBCG lymphadenitis, Rotavirus intussusception
Vaccine quality defect-relatedDue to manufacturing defectContaminated vaccine
Immunization error-relatedDue to improper preparation/handlingWrong dose, wrong route, contaminated syringe
Immunization anxiety-relatedDue to anxiety, fear of injectionVasovagal syncope
CoincidentalUnrelated to vaccine - temporal association onlyFever due to unrelated infection

Common AEFI by Vaccine

VaccineCommon AEFISerious AEFI
BCGLocal induration, ulcer, scarBCG-itis, disseminated BCG disease
DPT/PentavalentLocal pain, swelling, feverFebrile convulsions, hypotonic-hyporesponsive episode (HHE)
OPVNone usuallyVaccine-associated paralytic polio (VAPP)
MR/MeaslesMild rash, fever after 5-10 daysAnaphylaxis (rare)
Hepatitis BLocal painAnaphylaxis (very rare)

Management of AEFI

  1. Assess severity
  2. Immediate treatment (e.g., adrenaline for anaphylaxis)
  3. Report to district/state AEFI committee within 24 hours
  4. Investigate using standard checklist
  5. Document and submit report

SECTION 10: MISSION INDRADHANUSH

  • Launched: December 25, 2014 by Government of India
  • Goal: Fully immunize all children (0-2 years) and pregnant women who are left out or dropped out from routine immunization
  • Targets: Districts with low immunization coverage (< 50%)
  • Intensified Mission Indradhanush (IMI): Launched 2017, targets to reach 90% full immunization coverage
  • SAANS Campaign and Har Ghar Dastak campaigns supplemented it

SECTION 11: HERD IMMUNITY

  • Definition: Indirect protection to unimmunized individuals in a population when a sufficient proportion is immunized
  • Herd immunity threshold: Varies by disease (measles ~95%, polio ~80-85%)
  • Importance: Protects those who cannot be vaccinated (newborns, immunocompromised)
  • Achieved when reproductive number (R0) falls below 1

SECTION 12: NURSING RESPONSIBILITIES IN IMMUNIZATION

Before Vaccination

  1. Assess contraindications - high fever, severe allergic reaction to previous dose, immunocompromised state
  2. Review immunization history and fill due vaccines
  3. Check vaccine vial - VVM, expiry date, appearance
  4. Prepare correct dose and diluent at room temperature (for live vaccines - reconstitute immediately before use)
  5. Inform parent about the vaccine, its purpose, and possible side effects

During Vaccination

  1. Confirm identity and age
  2. Use correct site, route, dose, and technique
  3. Use separate syringe and needle for each vaccine
  4. Never mix vaccines in same syringe (unless licensed combination)
  5. Record in immunization card and register

After Vaccination

  1. Observe child for 30 minutes for immediate reactions
  2. Advise parent on management of common side effects (paracetamol for fever and pain)
  3. Tell parent the date of next vaccine
  4. Update immunization card and give to parent
  5. Report and document any AEFI

SECTION 13: IMMUNIZATION COVERAGE INDICATORS

IndicatorDefinition
Full immunizationChild receives BCG + 3 OPV + 3 Pentavalent + MR before 1 year
Partial immunizationReceived some but not all vaccines
UnimmunizedNo vaccine received
DPT3 coveragePercentage receiving 3 doses of DPT - best indicator of programme performance
IMRNumber of infant deaths per 1000 live births

CONCLUSION

The National Immunization Schedule is the backbone of preventive child health care in India. As frontline healthcare providers, nurses play the most critical role in ensuring vaccines reach every child safely and on time. Maintaining the cold chain, correctly administering vaccines, counseling parents, managing AEFI, and maintaining accurate records are the core nursing responsibilities that directly determine the success of the immunization programme and ultimately reduce vaccine-preventable child deaths in India.

Exam tip for 50 marks: Always include Introduction + Historical milestones + Full NIS table (most marks here) + Cold chain with equipment and temperatures + Individual vaccine details (BCG scar, OPV vs IPV, pentavalent components) + AEFI classification and management + Nursing responsibilities. These sections together will easily cover a full 50-mark answer.

Ready for the next topic? Just say "Next" and I'll move to Nursing Management of Preterm/LBW Baby (Topic #3).

Next

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I have sufficient content from the textbooks. Here is the complete 50-mark answer:

NURSING MANAGEMENT OF PRETERM / LOW BIRTH WEIGHT (LBW) BABY

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

A preterm baby is one born before 37 completed weeks of gestation, regardless of birth weight. A Low Birth Weight (LBW) baby is one with a birth weight of less than 2500 g, regardless of gestational age. These two conditions frequently overlap - prematurity is the most common cause of LBW. LBW is the single most important determinant of neonatal mortality and morbidity worldwide. In India, approximately 18-20% of all births are LBW babies.

SECTION 1: DEFINITIONS AND CLASSIFICATION

A. Classification by Birth Weight

CategoryBirth Weight
Normal birth weight≥ 2500 g
Low Birth Weight (LBW)< 2500 g
Very Low Birth Weight (VLBW)< 1500 g
Extremely Low Birth Weight (ELBW)< 1000 g

B. Classification by Gestational Age

CategoryGestational Age
Late preterm34 0/7 to 36 6/7 weeks
Moderate preterm32 0/7 to 33 6/7 weeks
Very preterm (VP)28 0/7 to 31 6/7 weeks
Extremely preterm (EP)< 28 0/7 weeks
Term37 to 41 6/7 weeks
Post-term≥ 42 weeks
(Kaplan & Sadock's Comprehensive Textbook of Psychiatry, Table 2.13-4)

C. Classification by Intrauterine Growth

TypeDefinition
Appropriate for Gestational Age (AGA)Birth weight between 10th-90th percentile
Small for Gestational Age (SGA)Birth weight < 10th percentile (Intrauterine Growth Restriction - IUGR)
Large for Gestational Age (LGA)Birth weight > 90th percentile

D. Types of LBW

  1. Preterm AGA - born early but weight appropriate for gestational age (prematurity is the cause)
  2. Term SGA (IUGR) - born at term but small due to placental insufficiency or other causes
  3. Preterm SGA - both premature and growth restricted (worst prognosis)

SECTION 2: CAUSES / ETIOLOGY

A. Causes of Preterm Birth

Maternal causes:
  • Preeclampsia and eclampsia
  • Infections (UTI, chorioamnionitis, TORCH infections)
  • Cervical incompetence
  • Uterine abnormalities (bicornuate uterus)
  • Previous preterm delivery
  • Multiple pregnancy (twins, triplets)
  • Polyhydramnios
  • Antepartum hemorrhage (placenta previa, abruption)
  • Anaemia, malnutrition
  • Age extremes (< 18 years or > 35 years)
Fetal causes:
  • Congenital anomalies
  • Multiple gestation
  • IUGR
Socioeconomic causes:
  • Poverty, malnutrition
  • Inadequate antenatal care
  • Hard physical labor
  • Smoking, alcohol, drug abuse

B. Causes of IUGR/SGA

  • Placental insufficiency (most common)
  • Maternal hypertension, preeclampsia
  • TORCH infections
  • Chromosomal abnormalities
  • Maternal smoking, alcohol, substance abuse
  • Multiple pregnancy

SECTION 3: PHYSICAL CHARACTERISTICS OF A PRETERM BABY

SystemCharacteristics
General appearanceSmall, thin, scrawny appearance; head appears large relative to body
SkinThin, translucent, red/pink; veins visible; abundant lanugo hair; little subcutaneous fat; wrinkled
SkullSoft, wide sutures and fontanelles; skull bones soft and pliable
EarsSoft, pliable cartilage; ears fold easily and slowly return
EyesFused eyelids (< 26 weeks); poorly reactive pupils
Breast tissueNo breast nodule (< 34 weeks)
GenitaliaMale: undescended testes, scrotum smooth; Female: prominent labia minora, clitoris
Plantar creasesAbsent or only in anterior 1/3 (< 36 weeks); full foot creases at term
Muscle toneHypotonic; frog-leg posture
ReflexesWeak or absent sucking and swallowing reflexes (mature at 32-34 weeks)
NailsSoft, not reaching fingertips
Ballard Score / New Ballard Score: Used to assess gestational age of the neonate based on neuromuscular and physical maturity (0 to 4 scoring on 6 physical + 6 neuromuscular criteria). More reliable than dates alone.

SECTION 4: PROBLEMS OF PRETERM / LBW BABY

A. Thermoregulation Problems

  • Thin skin with poor insulating subcutaneous fat
  • Large body surface area relative to body weight (rapid heat loss)
  • Immature hypothalamic thermoregulation center
  • Poor flexion posture (more body surface exposed)
  • Absent/minimal brown adipose tissue (main source of non-shivering thermogenesis)
  • Result: Hypothermia - most common and dangerous problem

B. Respiratory Problems

  • Respiratory Distress Syndrome (RDS / Hyaline Membrane Disease): Deficiency of surfactant (produced by Type II pneumocytes, matures after 35 weeks); leads to alveolar collapse, progressive atelectasis
  • Apnea of prematurity: Cessation of breathing > 20 seconds or < 20 seconds with bradycardia/cyanosis - due to immature respiratory center
  • Weak respiratory muscles, poor chest wall compliance

C. Feeding / Nutritional Problems

  • Absent or poor sucking and swallowing reflex (matures at 32-34 weeks)
  • Small stomach capacity
  • Poor gut motility; immature enzyme systems
  • Gastroesophageal reflux
  • Risk of Necrotizing Enterocolitis (NEC) - ischemic, inflammatory bowel necrosis; hallmark: pneumatosis intestinalis on X-ray

D. Neurological Problems

  • Intraventricular Hemorrhage (IVH): Bleeding into germinal matrix → ventricles; most common in < 32 weeks; leads to hydrocephalus, cerebral palsy
  • Periventricular Leukomalacia (PVL): White matter injury; major cause of cerebral palsy
  • Hypoxic-Ischemic Encephalopathy (HIE)
  • Seizures
  • Long-term: cognitive delay, learning disabilities, behavioral problems

E. Metabolic Problems

  • Hypoglycemia: Most common metabolic problem; blood glucose < 45 mg/dL (or < 40 mg/dL in neonates per some guidelines); due to low glycogen stores and hyperinsulinism
  • Hypocalcemia: Serum calcium < 7 mg/dL; causes jitteriness, seizures
  • Hyponatremia, Hypokalemia
  • Metabolic acidosis

F. Hematological Problems

  • Anemia of prematurity: Low erythropoietin production; iatrogenic blood loss from sampling
  • Hyperbilirubinemia (Jaundice): Immature liver; inadequate conjugation; exaggerated physiological jaundice - risk of kernicterus
  • Disseminated Intravascular Coagulation (DIC)

G. Infection / Sepsis

  • Immature immune system (low IgG, poor phagocytosis, skin barrier immature)
  • Neonatal sepsis: Most common organisms - Group B Streptococcus (early onset), Staphylococcus, E. coli (late onset)
  • Risk of fungal infections (Candida)

H. Cardiovascular Problems

  • Patent Ductus Arteriosus (PDA): Failure of ductus to close; causes left-to-right shunt, pulmonary edema; treated with indomethacin (prostaglandin inhibitor) or surgical ligation

I. Ophthalmic Problems

  • Retinopathy of Prematurity (ROP): Abnormal vascularization of retina due to oxygen toxicity; leading cause of preventable blindness in preterm infants; screen all infants < 32 weeks or < 1500 g

J. Renal Problems

  • Immature kidneys; cannot concentrate or dilute urine effectively
  • Risk of fluid and electrolyte imbalance

SECTION 5: ASSESSMENT OF THE PRETERM / LBW BABY - APGAR SCORE

ParameterScore 0Score 1Score 2
Appearance (Color)Blue/pale all overBlue extremities, pink bodyPink all over
Pulse (Heart Rate)Absent< 100 bpm≥ 100 bpm
Grimace (Reflex irritability)No responseGrimace/weak cryCough, sneeze, cry
Activity (Muscle tone)LimpSome flexionActive flexion
RespirationAbsentWeak, irregularStrong cry
Interpretation:
  • 7-10: Normal
  • 4-6: Moderate depression - requires stimulation and oxygen
  • 0-3: Severe depression - requires immediate resuscitation
Timing: Assessed at 1 minute (reflects intrauterine condition) and 5 minutes (reflects response to resuscitation). If still < 7 at 5 min, repeat every 5 min up to 20 min.

SECTION 6: NURSING MANAGEMENT

A. IMMEDIATE CARE AT BIRTH (The 6 Warmth Steps + ABCD)

  1. Warm - Pre-warm radiant warmer to 35-36°C before delivery; place baby under radiant warmer immediately
  2. Dry - Dry immediately and thoroughly with warm towel; remove wet linen
  3. Stimulate - Rub back and soles of feet
  4. Position - Sniffing position (neck slightly extended)
  5. Clear airway - Suction if meconium or secretions present (mouth before nose)
  6. Assess - Breathing, heart rate, color at 1 minute (Apgar)

B. THERMOREGULATION (MOST IMPORTANT)

Neutral Thermal Environment (NTE): Temperature at which metabolic rate and oxygen consumption are lowest while maintaining normal body temperature. Target axillary temperature: 36.5°C - 37.5°C
Methods to maintain warmth:
  1. Radiant warmer (open care system): For sick/very preterm infants; allows easy access; set servo-control to maintain skin temperature 36.5°C
  2. Incubator/Isolette (closed incubator): For stable preterm babies; maintains warm, humid environment; reduces insensible water loss; temperature set according to weight and age
  3. Kangaroo Mother Care (KMC): Skin-to-skin contact between mother/father and baby; baby placed on parent's bare chest vertically; maintains temperature, promotes bonding, breastfeeding; proven to reduce mortality in LBW
  4. Warm room: Room temperature 25-28°C; avoid drafts
  5. Warm clothing: Cap (prevents 20-25% heat loss from head), socks, double wrapping
4 Mechanisms of Heat Loss (and prevention):
MechanismPrevention
Radiation (to cold surfaces)Keep away from cold walls/windows
Convection (to air currents)Avoid drafts; use warm room
Conduction (to cold surfaces in contact)Warm mattress, warm linen
Evaporation (from wet skin)Dry immediately; warm humidified incubator

C. RESPIRATORY SUPPORT

  1. Position: Head slightly extended (sniffing position); prone position improves oxygenation but requires monitoring
  2. Oxygen therapy: Maintain SpO₂ 91-95% in preterm infants (avoid hyperoxia → ROP; avoid hypoxia → brain damage)
  3. CPAP (Continuous Positive Airway Pressure): First-line for RDS; maintains alveoli open; prevents atelectasis; nasal prongs
  4. Mechanical ventilation: For severe RDS or apnea not responding to CPAP
  5. Surfactant therapy: Exogenous surfactant (Poractant alfa - Curosurf; Beractant - Survanta) administered via endotracheal tube; dramatic improvement in RDS
  6. Antenatal corticosteroids: Betamethasone or dexamethasone given to mother 24-48 hours before preterm delivery to accelerate fetal lung maturation and surfactant production
  7. Apnea management: Caffeine citrate (methylxanthine) stimulates respiratory center; most effective treatment for apnea of prematurity

D. NUTRITION AND FEEDING

Goals: Achieve intrauterine growth rate of 15-20 g/kg/day; caloric requirement 110-130 kcal/kg/day
Feeding methods:
  1. Direct breastfeeding: If > 34 weeks and sucking reflex present; best option
  2. Expressed Breast Milk (EBM) via cup/spoon: For 32-34 weeks
  3. Orogastric / Nasogastric (tube) feeding: For < 32 weeks or sick infants unable to suck; gavage feeding
  4. Total Parenteral Nutrition (TPN): For very sick/very preterm infants who cannot tolerate enteral feeds; via central venous line
Breast milk advantages for preterm:
  • Contains more protein and sodium than term milk
  • Rich in IgA, growth factors, anti-infective factors
  • Reduces risk of NEC by 6-10 times
  • Promotes gut maturation
Feeding schedule for LBW:
  • Start early (within 1-2 hours of birth if stable)
  • Begin with 1-2 ml/kg/feed every 2-3 hours
  • Increase by 10-20 ml/kg/day as tolerated
  • Monitor for feed intolerance (abdominal distension, vomiting, residual)
Supplements for preterm:
  • Iron supplementation from 2 weeks of age (2-3 mg/kg/day)
  • Vitamin D: 400-800 IU/day
  • Calcium and phosphorus supplementation
  • Human milk fortifier (HMF) added to breast milk for VLBW infants

E. PREVENTION AND MANAGEMENT OF INFECTION

  1. Hand hygiene: Most important - wash hands before and after handling baby
  2. Aseptic technique: Sterile gloves for procedures; proper cord care
  3. Minimal handling: Cluster care to reduce disturbance
  4. Restrict visitors and persons with infection
  5. Early signs of sepsis in preterm: Lethargy, poor feeding, temperature instability, apnea, bradycardia, abdominal distension, jaundice
  6. Blood culture before starting antibiotics
  7. Empiric antibiotics: Ampicillin + Gentamicin for early-onset sepsis; Vancomycin + Gentamicin for late-onset
  8. Monitor CBC, CRP for infection markers

F. FLUID AND ELECTROLYTE MANAGEMENT

  • Insensible water loss (IWL) is very high in preterm (thin skin, large surface area, radiant warmers)
  • Fluid requirement: 60-80 ml/kg/day on day 1; increase by 10-20 ml/kg/day; up to 150-180 ml/kg/day by end of first week
  • Monitor urine output (target 1-3 ml/kg/hr); daily weight
  • Monitor electrolytes daily: sodium, potassium, calcium, glucose
  • 10% Dextrose as initial maintenance fluid; add sodium after first 24 hours

G. PREVENTION OF HYPOGLYCEMIA

  • Blood glucose monitoring every 3-6 hours (especially first 24-48 hours)
  • Start early enteral feeds; if not possible, IV dextrose
  • Target blood glucose: 45-120 mg/dL
  • Symptomatic hypoglycemia: IV 10% dextrose bolus 2 ml/kg, then continuous infusion

H. KANGAROO MOTHER CARE (KMC) - HIGH PRIORITY

Definition: A method of care of preterm/LBW infants involving skin-to-skin contact, exclusive breastfeeding, and early discharge with follow-up.
Components (3 components of KMC):
  1. Kangaroo position: Baby placed skin-to-skin vertically on mother's chest between the breasts; baby's head turned to one side, hips and knees flexed (frog position); covered with mother's clothes
  2. Kangaroo nutrition: Exclusive breastfeeding or expressed breast milk
  3. Kangaroo support: Early discharge with follow-up and support
Criteria to start KMC:
  • Haemodynamically stable baby
  • No IV lines or if IV access maintained
  • Baby tolerating enteral feeds
  • Birth weight usually > 1000 g (can start even earlier in centers with expertise)
Benefits of KMC:
  • Maintains temperature as effectively as incubator
  • Promotes breastfeeding and bonding
  • Reduces infection rates
  • Reduces apnea episodes
  • Accelerates neurological development
  • Reduces mortality by 40% (WHO)
  • Reduces length of hospital stay
  • Cost-effective; especially valuable in resource-limited settings
Nursing responsibilities in KMC:
  • Teach mother the correct KMC position
  • Monitor baby's temperature, breathing, feeding
  • Support mother with breastfeeding
  • Advise on hygiene and skin care
  • Empower mother and build confidence

I. MONITORING

Daily monitoring of LBW/preterm baby:
  • Temperature every 3-4 hours (axillary 36.5-37.5°C)
  • Heart rate (normal: 120-160/min)
  • Respiratory rate (normal: 40-60/min)
  • SpO₂ (target 91-95%)
  • Blood glucose (every 3-6 hours initially)
  • Urine output (measure via weighing diapers)
  • Weight (daily - target gain 15-20 g/kg/day after regaining birth weight)
  • Feed tolerance (residual, vomiting, abdominal distension)
  • Signs of jaundice (transcutaneous bilirubinometry or serum bilirubin as needed)
  • Signs of infection

J. RETINOPATHY OF PREMATURITY (ROP) SCREENING

  • All infants < 32 weeks gestation or birth weight < 1500 g must be screened
  • First screening: 4 weeks after birth
  • Ophthalmologist performs indirect ophthalmoscopy
  • Laser photocoagulation for Stage 3+ ROP

SECTION 7: NEONATAL RESUSCITATION (NRP)

Indications for resuscitation: Apnea, heart rate < 100 bpm, persistent central cyanosis
Steps (ABCD approach):
A - Airway
  • Position baby in sniffing position under radiant warmer
  • Clear airway: suction if needed (mouth then nose)
  • Dry and stimulate (rub back/soles)
  • Reposition and reassess in first 30 seconds
B - Breathing
  • If not breathing or heart rate < 100 bpm: Positive pressure ventilation (PPV) with bag and mask
  • Rate: 40-60 breaths/min; use 21% O₂ initially (room air); add oxygen if SpO₂ remains low
  • Reassess after 30 seconds of PPV
C - Circulation
  • If heart rate < 60 bpm despite 30 seconds of adequate PPV: Start chest compressions
  • Thumb technique (preferred): 2 thumbs on lower 1/3 of sternum, hands encircling chest
  • Rate: 3 compressions: 1 breath = 90 compressions + 30 breaths/min
  • Depth: 1/3 of chest AP diameter
D - Drugs
  • If heart rate remains < 60 bpm despite PPV + compressions:
  • Adrenaline (Epinephrine): 0.1-0.3 ml/kg of 1:10,000 solution IV (via umbilical vein catheter)
  • Normal saline (volume expander): 10 ml/kg if blood loss or shock

SECTION 8: COMPLICATIONS (Long-term)

SystemComplication
NeurologicalCerebral palsy, cognitive delay, learning disability, ADHD, autism
PulmonaryChronic Lung Disease (CLD) / Bronchopulmonary Dysplasia (BPD)
VisualRetinopathy of prematurity (ROP), blindness
HearingSensorineural hearing loss
GrowthFailure to thrive, short stature
MetabolicIncreased risk of diabetes, hypertension, cardiovascular disease in adult life (Barker hypothesis)

SECTION 9: PREVENTION OF PRETERM BIRTH AND LBW

  1. Antenatal care: Early booking, regular ANC visits
  2. Nutrition: Adequate protein, iron, folic acid supplementation; prevent anemia
  3. Folic acid: 400 mcg/day periconceptionally to prevent neural tube defects
  4. Treat infections: UTI, TORCH, STIs
  5. Cervical cerclage for cervical incompetence
  6. Progesterone: Vaginal progesterone in women with short cervix or previous preterm birth
  7. Tocolytics: Nifedipine, ritodrine to delay preterm labor (48 hours to allow steroid administration)
  8. Antenatal steroids: Betamethasone 12 mg IM x 2 doses 24 hours apart to mother at 24-34 weeks; accelerates fetal lung maturation (most important antenatal intervention for preterm)
  9. Spacing births: Birth spacing ≥ 2 years
  10. Stop smoking, alcohol

SECTION 10: NURSING DIAGNOSES AND CARE PLAN

Nursing DiagnosisGoalInterventions
Ineffective thermoregulation r/t immature heat productionMaintain temp 36.5-37.5°CRadiant warmer/incubator, KMC, warm clothing, monitor temperature
Ineffective breathing pattern r/t immature lungsMaintain SpO₂ 91-95%CPAP, position, monitor RR and SpO₂
Imbalanced nutrition: less than body requirements r/t weak suckAdequate weight gain 15-20 g/kg/dayTube feeding, EBM, KMC for breastfeeding support
Risk for infection r/t immature immune systemNo signs of sepsisHand hygiene, aseptic technique, minimal handling
Risk for hypoglycemia r/t low glycogen storesBlood glucose 45-120 mg/dLEarly feeds, blood glucose monitoring, IV dextrose
Anxiety of parents r/t premature birthParents verbalize understandingCounseling, teaching, KMC involvement

SECTION 11: DISCHARGE PLANNING AND CRITERIA

Criteria for discharge of LBW baby:
  1. Baby able to maintain temperature in open cot (room temperature 25°C)
  2. Weight ≥ 1800-2000 g and gaining weight consistently
  3. Exclusive breastfeeding established or feeding well
  4. No apnea for at least 5-7 days
  5. No medical problems requiring hospital care
  6. Mother/caregiver trained in KMC, feeding, temperature monitoring
  7. Follow-up appointment arranged
Discharge teaching to parents:
  • KMC technique at home
  • Signs of danger (poor feeding, fever, fast breathing, jaundice, blue color)
  • Immunization schedule (as per corrected age)
  • Exclusive breastfeeding for 6 months
  • Follow-up for ROP, hearing, developmental monitoring

CONCLUSION

Preterm and LBW babies represent a high-risk population requiring specialized, vigilant nursing care. The nurse's role encompasses immediate resuscitation, meticulous thermoregulation, respiratory and nutritional support, infection prevention, parent education, and long-term follow-up coordination. Kangaroo Mother Care, when practiced correctly and consistently, is the single most powerful nursing intervention that reduces mortality, promotes breastfeeding, and accelerates development in LBW babies. Through skilled, evidence-based nursing care, the majority of preterm infants can achieve outcomes approaching those of term infants.

Exam tip for 50 marks: Always include: definitions with weight/gestational age classifications + causes + physical characteristics (Ballard score) + problems table (all systems) + Apgar scoring table + detailed nursing management (Thermoregulation is the MOST marks-bearing section) + KMC components and benefits + NRP steps + nursing care plan + discharge criteria. The examiner expects you to write as if you are managing the baby at the bedside.

Say "Next" for Topic 4: IMNCI - Assessment and Classification.

Next

Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
I have sufficient content from the textbooks. I'll now deliver the complete 50-mark answer from my comprehensive knowledge base and the Park's textbook references.

IMNCI - INTEGRATED MANAGEMENT OF NEONATAL AND CHILDHOOD ILLNESS

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

The Integrated Management of Neonatal and Childhood Illness (IMNCI) is a strategy developed jointly by WHO and UNICEF in the 1990s to reduce childhood morbidity and mortality by improving the management of the most common serious illnesses in children under 5 years of age. The original IMCI (Integrated Management of Childhood Illness) was adapted by India and renamed IMNCI to include the neonatal period (0-7 days).
IMNCI is the central pillar of child health interventions under India's Reproductive and Child Health (RCH-II) programme and the National Rural Health Mission (NRHM).
Rationale: Five conditions account for over 70% of all deaths in children under 5:
  1. Pneumonia (~20%)
  2. Diarrhea (~20%)
  3. Malaria
  4. Measles
  5. Malnutrition (underlying cause in >50% of all under-5 deaths)
(Park's Textbook of Preventive and Social Medicine, p. 516-522)

SECTION 1: OBJECTIVES OF IMNCI

  1. Reduce child mortality and morbidity due to common childhood illnesses
  2. Improve the overall health and development of young children
  3. Ensure that health workers correctly assess, classify, and treat sick children
  4. Teach families when to seek care and how to provide home care
  5. Improve practices in health facilities and within communities

SECTION 2: COMPONENTS / THREE PILLARS OF IMNCI

ComponentDescription
1. Improving case management skills of health workersTraining ANMs, nurses, medical officers to use standard case management guidelines
2. Improving overall health systemEnsuring drug availability, functioning referral systems, and supportive supervision
3. Improving family and community practicesEducating families on home care, danger signs, feeding, immunization

SECTION 3: INDIAN ADAPTATION (IMNCI vs IMCI)

The Indian version differs from global IMCI in the following key ways:
a. Includes 0-7 days of age (global IMCI starts from 2 months) - hence the word "Neonatal"
b. Incorporates national guidelines on:
  • Malaria (based on India's endemic zones)
  • Anaemia
  • Vitamin A supplementation
  • National immunization schedule
c. Training begins with sick young infants (up to 2 months)
d. Training time devoted to sick young infant and sick child is almost equal
e. Skill-based training using case studies and clinical practice
f. Two sets of chart booklets:
  • Chart 1: Children 2 months up to 5 years
  • Chart 2: Children 1 week up to 2 months (sick young infant)
(Park's Textbook of Preventive and Social Medicine, p. 517)

SECTION 4: IMNCI CASE MANAGEMENT PROCESS

The IMNCI approach follows a systematic 4-step process:

ASSESS → CLASSIFY → TREAT → COUNSEL

ASSESS (history + examination using standard guidelines)
    ↓
CLASSIFY (color-coded triage: Red / Yellow / Green)
    ↓
TREAT (according to classification)
    ↓
COUNSEL (follow-up, home care, feeding, immunization)

SECTION 5: ASSESSMENT IN IMNCI (2 months to 5 years)

Step 1: CHECK FOR GENERAL DANGER SIGNS (First - Always)

A child has a danger sign if:
  1. Cannot drink or breastfeed
  2. Vomits everything
  3. Had convulsions during this illness
  4. Lethargic or unconscious
A child with ANY general danger sign = URGENT action/referral
  • Pre-refer treatment must be given before referral

Step 2: ASSESS MAIN SYMPTOMS

A. COUGH OR DIFFICULT BREATHING

Ask: How long? Any chest indrawing? Stridor?
Examine: Count respiratory rate for 1 full minute; check for chest indrawing, stridor
Age-specific fast breathing cut-offs (High-yield):
AgeFast Breathing (Tachypnea)
< 2 months≥ 60 breaths/min
2-12 months≥ 50 breaths/min
12 months - 5 years≥ 40 breaths/min
Classification of Cough/Difficult Breathing:
ClassificationSignsActionColor
Very Severe Disease / Severe PneumoniaAny general danger sign OR chest indrawing OR stridor in calm childURGENT referral; pre-refer: first dose cotrimoxazole/amoxicillin; paracetamol if feverRED
PneumoniaFast breathing (no chest indrawing, no danger signs)Give amoxicillin for 5 days; paracetamol for fever; soothe throat; follow up in 2 daysYELLOW
No Pneumonia: Cough or ColdNo fast breathing, no chest indrawingSoothe throat with safe remedy; advise when to return; follow up in 5 days if not improvingGREEN

B. DIARRHOEA

Ask: How long? Blood in stool? Sunken eyes? Drinking?
Examine: Skin turgor (pinch), sunken eyes, mental state, thirst
Classification of Diarrhoea:
ClassificationSignsTreatmentColor
Severe Dehydration2 or more: lethargic/unconscious; sunken eyes; not able to drink; skin pinch goes back very slowly (≥2 seconds)URGENT referral; IV fluids (Ringer's Lactate); Plan CRED
Some Dehydration2 or more: restless/irritable; sunken eyes; drinks eagerly/thirsty; skin pinch goes back slowlyORS in facility (75 ml/kg over 4 hours); Plan B; continue feedingYELLOW
No DehydrationNot enough signs for some/severe dehydrationHome ORS; Plan A; continue feedingGREEN
Persistent Diarrhoea (≥ 14 days):
  • With dehydration → URGENT referral
  • Without dehydration → Advise feeding; return in 5 days
Dysentery (blood in stool):
  • Give cotrimoxazole for 5 days
  • Follow up in 2 days

C. FEVER

Ask: How long? Malaria risk area? Measles?
Examine: Stiff neck; runny nose; rash; measles signs; check for ear problems
Classification based on malaria risk:
In HIGH malaria risk area:
ClassificationSignsTreatmentColor
Very Severe Febrile Disease / Severe MalariaAny general danger sign OR stiff neck OR petechiaeURGENT referral; quinine/artesunate; paracetamolRED
MalariaFever only (no stiff neck, no danger signs)Antimalarial; paracetamol; return if not improvingYELLOW
Fever - Malaria UnlikelyFever < 7 days; no clear causeParacetamol; treat underlying causeGREEN
MEASLES Classification:
ClassificationSignsTreatmentColor
Severe complicated measlesGeneral danger sign OR cloudy cornea OR deep/extensive mouth ulcersURGENT referral; Vitamin A; antibioticsRED
Measles with eye/mouth complicationsPus from eyes OR mouth ulcersVitamin A; treat eyes; gentian violet for mouthYELLOW
MeaslesRash + fever + cough/runny nose/red eyesVitamin A; follow upGREEN

D. EAR PROBLEMS

Ask: Ear pain? Discharge? How long?
Examine: Pus from ear? Tender mastoid?
ClassificationSignsTreatmentColor
MastoiditisTender swelling behind earURGENT referral; first dose antibioticsRED
Acute ear infectionEar pain or pus < 14 daysAmoxicillin for 5 days; dry ear; paracetamolYELLOW
Chronic ear infectionEar discharge ≥ 14 daysDry ear 3 times daily; no antibiotics unless signs worsenYELLOW
No ear infectionNo ear pain, no discharge-GREEN

E. MALNUTRITION AND ANAEMIA

Examine: Weight-for-age; look for visible severe wasting; bilateral pitting oedema; palmar pallor
ClassificationSignsTreatmentColor
Severe malnutrition / Severe anaemiaSevere visible wasting OR bilateral pitting oedema OR severe palmar pallorURGENT referralRED
Anaemia or Very Low WeightSome palmar pallor OR very low weight-for-ageIron for 14 days; mebendazole; feeding advice; follow upYELLOW
No anaemia; Not very low weightNo palmar pallor; weight in acceptable rangeAdvise on feeding; praiseGREEN

SECTION 6: SICK YOUNG INFANT (1 week to 2 months)

This is a special high-risk category in IMNCI. Neonates and young infants show illness differently from older children.

Check for POSSIBLE SERIOUS BACTERIAL INFECTION

Signs of possible bacterial infection (any ONE is enough to classify as serious):
  1. Stopped feeding well (was feeding well before)
  2. Convulsions
  3. Fast breathing (≥ 60 breaths/min)
  4. Severe chest indrawing
  5. Nasal flaring
  6. Grunting
  7. Bulging fontanelle
  8. Pus draining from ear
  9. Umbilical redness extending to skin
  10. Temperature ≥ 37.5°C (fever) or < 35.5°C (hypothermia)
  11. Many or severe skin pustules
  12. Lethargic or unconscious
ClassificationSignsTreatment
Possible Serious Bacterial InfectionAny of the above signsURGENT referral; pre-refer: Ampicillin + Gentamicin IM
Local bacterial infectionPus from eye OR umbilical redness NOT extending to skin OR < 10 skin pustulesTreat at home; antibiotics; return in 2 days
No infectionNone of the aboveHome care; counsel on feeding

Check JAUNDICE in Young Infants

ClassificationSignsTreatment
Severe jaundiceYellow palms and soles at any age OR jaundice appearing in first 24 hoursURGENT referral; keep warm during transport
JaundiceJaundice appearing after 24 hours with yellow eyes/skin but NOT palms/solesAdvise to return in 1 day; advise on breastfeeding
No jaundiceNo yellow colorationNormal care

SECTION 7: ORS TREATMENT PLANS

PLAN A - No Dehydration (Home Management)

Teach mother the 4 rules of home treatment:
Rule 1: Give more fluids
  • Breastfed child: breastfeed more frequently
  • Non-breastfed: give clean water, ORS, rice water
  • Amount of ORS to give after each stool:
    • Child < 2 years: 50-100 ml
    • Child ≥ 2 years: 100-200 ml
ORS Composition (WHO Reduced-Osmolarity ORS 2002):
  • Sodium: 75 mmol/L
  • Glucose: 75 mmol/L
  • Potassium: 20 mmol/L
  • Chloride: 65 mmol/L
  • Citrate: 10 mmol/L
  • Osmolarity: 245 mOsm/L
Home preparation of ORS: 1 sachet in 1 liter clean water. Home-made: 1 level teaspoon salt + 8 level teaspoons sugar in 1 liter water.
Rule 2: Continue feeding
Rule 3: Zinc supplementation
  • < 6 months: 10 mg/day for 14 days
  • ≥ 6 months: 20 mg/day for 14 days
  • Reduces severity and duration of diarrhea; prevents future episodes
Rule 4: Return if danger signs appear

PLAN B - Some Dehydration (Give ORS in clinic)

  • Give 75 ml/kg of ORS over 4 hours in clinic
  • Reassess every hour
  • If improves → go to Plan A
  • If worsens → go to Plan C

PLAN C - Severe Dehydration (IV fluids urgently)

  • Ringer's Lactate (or Normal Saline):
    • Child < 12 months: 30 ml/kg in 1 hour, then 70 ml/kg in 5 hours
    • Child ≥ 12 months: 30 ml/kg in 30 minutes, then 70 ml/kg in 2.5 hours
  • Reassess every 30 minutes
  • If can drink: start ORS while IV running

SECTION 8: FEEDING ASSESSMENT AND COUNSELING IN IMNCI

IMNCI gives equal importance to nutritional assessment and feeding counseling.

Feeding Problems to Assess:

  • Is the child exclusively breastfed (< 6 months)?
  • Is the child receiving appropriate complementary foods after 6 months?
  • Frequency and amount of food per day
  • Any feeding difficulty?

WHO Recommendations on Feeding:

  • Exclusive breastfeeding for first 6 months
  • Initiation of breastfeeding within 1 hour of birth
  • Complementary foods introduced from 6 months while continuing breastfeeding
  • Breastfeeding continued up to 2 years and beyond
  • Give iron-rich foods (legumes, meat, green leafy vegetables)
Minimum number of meals per day (IMNCI guideline):
AgeBreastfedNon-breastfed
6-8 months2-3 times4-5 times
9-23 months3-4 times4-5 times

SECTION 9: COLOR-CODED CLASSIFICATION SYSTEM (Summary)

ColorMeaningAction
REDUrgent - needs immediate referralUrgent pre-treatment + refer to hospital
YELLOWModerate - needs specific treatmentTreat at home with oral medication; follow-up in 2-5 days
GREENMild / No illnessHome care; advise mother; no medication needed

SECTION 10: FOLLOW-UP VISITS

IllnessFollow-up In
Pneumonia (after antibiotic started)2 days
Diarrhoea with some dehydration (after Plan B)5 days
Dysentery2 days
Fever / Malaria (if not improving)2 days
Measles with complications2 days
Ear infection (acute)5 days
Malnutrition / very low weight30 days
Persistent diarrhea (without dehydration)5 days
Feeding problem5 days

SECTION 11: IMMUNIZATION AND VITAMIN A IN IMNCI

Every IMNCI visit must include:
  1. Check immunization status: Refer to NIS; administer due vaccines
  2. Vitamin A supplementation:
    • 1 lakh IU at 9 months with MR vaccine
    • 2 lakh IU every 6 months from 16 months to 5 years (total 9 doses)
  3. Deworming: Albendazole/Mebendazole 400 mg single dose for all children ≥ 12 months every 6 months

SECTION 12: FACILTY-IMNCI (F-IMNCI)

F-IMNCI is the adaptation of IMNCI for use at first-level health facilities (PHCs, CHCs) rather than only at the community/outpatient level.
Key additional elements:
  • Oxygen therapy
  • IV fluid management
  • Management of severe pneumonia, severe dehydration, severe malnutrition
  • Lumbar puncture for meningitis
  • Blood smear for malaria
  • Laboratory support

SECTION 13: RASHTRIYA BAL SWASTHYA KARYAKRAM (RBSK)

Launched: February 2013 - an initiative linked to IMNCI
4Ds covered under RBSK:
  1. Defects at Birth (neural tube defects, CHD, cleft lip/palate, Down syndrome)
  2. Diseases (childhood illness - pneumonia, diarrhea, malaria)
  3. Deficiency Conditions (anemia, Vitamin A/D deficiency, malnutrition)
  4. Development Delays and Disabilities (cerebral palsy, hearing loss, vision problems, autism)
Coverage: Children 0-18 years (estimated 27 crore children) Screening teams: Mobile Health Teams (MHTs) at block level; 2 AYUSH doctors per team Free treatment at District Early Intervention Centers (DEICs)
(Park's Textbook of Preventive and Social Medicine, p. 517)

SECTION 14: NURSING RESPONSIBILITIES IN IMNCI

At Health Facility (PHC/CHC):

  1. Train in IMNCI charts and use them for every sick child under 5
  2. Systematic assessment - follow the IMNCI sequence (general danger signs first, then specific symptoms)
  3. Correct classification - use color-coded classification accurately
  4. Prescribe and administer pre-referral drugs as per classification
  5. Prepare referral note with classification, treatment given, and reason for referral
  6. Counsel mothers on ORS preparation, feeding, home care, and danger signs
  7. Maintain records and IMNCI tally sheets
  8. Ensure immunizations and Vitamin A are given at every opportunity (catch-up)
  9. Supervise follow-up visits and reassess

At Community Level (ASHA/ANM):

  1. Home visits for all newborns within 24 hours, 3 days, 7 days, 14 days, and 28 days
  2. Identify danger signs and refer promptly
  3. Promote breastfeeding and complementary feeding
  4. Health education - when to seek care, ORS preparation, fever management
  5. Link families to health facilities

SECTION 15: WHEN TO RETURN IMMEDIATELY (Danger Signs - Teach Every Mother)

Teach every mother to return immediately if:
  1. Child cannot drink or is drinking poorly
  2. Child becomes sicker
  3. Child develops fever (if fever was not present)
  4. Child has fast breathing
  5. Child has difficulty breathing
  6. Blood in stool
  7. Child is drinking poorly (in diarrhea)
  8. Convulsions

CONCLUSION

IMNCI represents a paradigm shift in child health care - from disease-specific management to an integrated, systematic approach covering the child as a whole. The color-coded classification system makes it practical for health workers at all levels to assess, classify, and treat sick children consistently. By combining preventive (immunization, nutrition), promotive (counseling, feeding), and curative (case management) strategies, IMNCI directly addresses the major causes of under-5 child mortality in India. Nurses trained in IMNCI are equipped to make life-saving decisions at the frontline of child healthcare.

Exam tip for 50 marks: Examiners expect: Introduction with the 5 killer diseases + Objectives + 3 components + IMNCI vs IMCI differences + Full assessment flow (danger signs, then each condition separately) + Color-coded classification tables for each illness + ORS Plans A/B/C with ORS composition + Feeding counseling + Nursing responsibilities + Follow-up schedule. The classification tables carry the maximum marks.

Say "Next" for Topic 5: Protein Energy Malnutrition - Kwashiorkor and Marasmus.

Next

Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Excellent content from the textbooks. Delivering the complete 50-mark answer now:

PROTEIN ENERGY MALNUTRITION (PEM) - KWASHIORKOR AND MARASMUS

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Protein Energy Malnutrition (PEM) is the most prevalent nutritional deficiency disease worldwide and is the leading cause of child mortality and morbidity in developing countries including India. It results from an inadequate intake of protein and/or energy (calories) to meet the body's requirements for growth and normal functioning.
PEM encompasses a spectrum of conditions ranging from mild growth retardation to life-threatening Severe Acute Malnutrition (SAM). The two major clinical forms of SAM are:
  1. Marasmus - Severe acute malnutrition WITHOUT oedema (wasting)
  2. Kwashiorkor - Severe acute malnutrition WITH oedema
  3. Marasmic Kwashiorkor - Overlapping features of both
PEM is intimately linked with poverty, poor sanitation, recurrent infections, and inadequate childcare practices. It is estimated that malnutrition underlies more than 50% of all under-5 child deaths globally.
(Dermatology 2-Volume Set 5e, p. 974-975)

SECTION 1: DEFINITIONS

TermDefinition
UndernutritionDeficiency of energy, protein, or micronutrients resulting from inadequate intake, poor absorption, or increased requirements
MalnutritionBroader term covering both undernutrition and overnutrition
Severe Acute Malnutrition (SAM)Weight-for-height < -3 SD OR MUAC < 115 mm OR bilateral pitting oedema
Moderate Acute Malnutrition (MAM)Weight-for-height -2 to -3 SD OR MUAC 115-124 mm
MarasmusSevere calorie AND protein deficiency; NO oedema; extreme wasting
KwashiorkorPredominantly protein deficiency with adequate/excess carbohydrate; WITH oedema

SECTION 2: CAUSES / ETIOLOGY

A. Primary Causes (Dietary)

  1. Inadequate dietary intake - insufficient quantity and quality of food
  2. Prolonged exclusive breastfeeding without timely complementary feeding
  3. Weaning practices - abrupt weaning onto high-carbohydrate, low-protein diet (main cause of Kwashiorkor)
  4. Poverty and food insecurity
  5. Ignorance about nutrition and child feeding
  6. Large family size with poor food distribution

B. Secondary Causes (Underlying Disease)

  1. Recurrent infections - diarrhea, measles, respiratory infections increase requirements and reduce intake
  2. Malabsorption - celiac disease, chronic diarrhea, parasitic infestations
  3. Chronic illness - tuberculosis, HIV/AIDS, congenital heart disease
  4. Prematurity and low birth weight
  5. Wrong feeding practices - diluted formula feeds, "rice milk" diets

C. Social/Environmental Causes

  • Low socioeconomic status
  • Maternal malnutrition and anaemia
  • Inadequate antenatal and postnatal care
  • Cultural taboos regarding certain foods
  • Lack of maternal education

SECTION 3: PATHOPHYSIOLOGY

Marasmus Pathophysiology

When calorie intake is severely deficient:
  1. Body mobilizes fat stores first → loss of subcutaneous fat
  2. Then mobilizes muscle protein (gluconeogenesis) → muscle wasting
  3. Cortisol and growth hormone increase → catabolic state
  4. Body weight falls to < 60% of expected weight
  5. Albumin relatively maintained (protein-sparing adaptation) → NO oedema
  6. Immune function severely impaired → recurrent infections

Kwashiorkor Pathophysiology

  1. Adequate calories but protein severely deficient
  2. Serum albumin falls markedly (< 2.5 g/dL) → reduced oncotic pressure → oedema
  3. Superimposed acute illness/infection triggers stress response - blocks protein-sparing mechanisms
  4. Free radical damage worsens tissue injury
  5. Gut microbiome disruption (decreased anti-inflammatory taxa, increased inflammatory bacteria)
  6. Fatty liver develops - protein deficiency impairs VLDL synthesis, fat cannot be exported from liver → hepatomegaly with fatty infiltration
  7. Hair changes - hair becomes thin, sparse, discoloured (flag sign - alternating dark/light bands)
(Dermatology 2-Volume Set 5e, p. 974-975)

SECTION 4: CLINICAL FEATURES - DETAILED COMPARISON

MARASMUS

SystemFeatures
GeneralExtreme wasting; "old man" or "monkey face" appearance; weight < 60% of expected
FaceDrawn, wizened, sunken cheeks (buccal fat pad lost); loose skin around mouth
EyesSunken eyes; alert and hungry-looking (unlike kwashiorkor child who is apathetic)
SkinLoose, baggy skin hanging in folds especially over buttocks and thighs ("baggy pants" sign); dry, wrinkled; no oedema
Subcutaneous fatSeverely depleted or absent
MusclesSeverely wasted; prominent ribs, scapulae, iliac crests
HairMay be sparse but usually retains colour
OedemaABSENT
LiverUsually normal size
MoodIrritable, alert, hungry, crying
Weight< 60% of expected (Grade III-IV Gomez)
Key feature: "Baggy pants sign" + Alert, hungry child + Severe wasting without oedema

KWASHIORKOR

SystemFeatures
GeneralWeight 60-80% of expected; oedema may mask wasting
Face"Moon face" due to oedema
SkinClassic "flaky paint" or "enamel paint" dermatitis - areas of hyperpigmentation and desquamation; later erosions; peeling in sheets; depigmented patches
Hair"Flag sign" (Bandeira sign) - alternating light and dark bands; hair becomes reddish-brown, silky, sparse, easily pluckable; flag sign pathognomonic of PEM
OedemaPRESENT - bilateral pitting; starts in feet, progresses upward; may become generalized (anasarca)
LiverHepatomegaly with fatty infiltration (due to lack of apoprotein for VLDL); parotid glands may enlarge
MoodApathetic, miserable, irritable when touched, not hungry; sits/lies quietly
EyesAngular stomatitis; corneal changes if Vit A also deficient
GI tractDiarrhea, vomiting; potbelly (distended abdomen) due to oedema and gas
MuscleWasting present but masked by oedema
AnaemiaSevere anaemia
Weight60-80% expected (body weight deceptively higher due to oedema)
Key feature: Oedema + Moon face + Flaky paint skin + Flag sign in hair + Apathetic child + Hepatomegaly
(Dermatology 2-Volume Set 5e, p. 975)

MARASMIC KWASHIORKOR

  • Features of BOTH conditions present
  • Severe wasting + bilateral oedema
  • Worst prognosis of the three
  • May occur when a marasmic child develops acute illness (infection)

SECTION 5: COMPARISON TABLE - KWASHIORKOR vs MARASMUS (Highest Exam Value)

FeatureKwashiorkorMarasmus
CauseProtein deficiency (adequate calories)Total calorie + protein deficiency
Age1-3 years (after weaning)Infants < 1 year (also older)
OnsetAcute/subacuteChronic, gradual
Body weight60-80% of expected< 60% of expected
OedemaPresent (hallmark)Absent
WastingPresent but masked by oedemaSevere and obvious
Subcutaneous fatPresentAbsent/depleted
SkinFlaky paint dermatitis; pigmentation changesDry, loose, baggy
HairFlag sign, reddish-brown, sparse, easily pluckableMay be sparse; colour may be retained
FaceMoon face (oedema)Monkey/old man face (wasting)
MoodApathetic, miserableAlert, hungry, irritable
LiverHepatomegaly (fatty)Usually normal
Serum albuminVery low (< 2.5 g/dL)May be low but less severely
Serum proteinsVery lowLow
AnaemiaSevereModerate
ImmunitySeverely impairedSeverely impaired
PotbellyPresent (oedema + ascites)Present (gas/worm load)
PrognosisPoorerBetter with treatment

SECTION 6: GRADING / CLASSIFICATION OF MALNUTRITION

A. Gomez Classification (Weight-for-Age)

GradeWeight as % of expected (50th percentile)Severity
Normal90-100%Normal
Grade I75-89%Mild
Grade II60-74%Moderate
Grade III< 60%Severe (SAM)

B. Waterlow Classification (Weight-for-Height AND Height-for-Age)

NormalStunted (low ht-for-age)
Not wasted (normal wt-for-ht)NormalStunted (chronic past malnutrition)
Wasted (low wt-for-ht)Acute malnutrition (wasting)Wasted + Stunted (chronic + acute)
  • Wasting = low weight-for-height = acute/current malnutrition
  • Stunting = low height-for-age = chronic/past malnutrition
  • Underweight = low weight-for-age = acute + chronic combined

C. IAP Classification (Weight-for-Age)

Grade% of StandardOedema
Grade I71-80%No
Grade II61-70%No
Grade III50-60%No
Grade IV< 50% OR any oedema±

D. WHO SAM Criteria (Used in IMNCI/Clinical Practice)

CriteriaThreshold
Weight-for-height< -3 SD (< 70% of median)
MUAC (Mid-Upper Arm Circumference)< 115 mm (< 11.5 cm)
Bilateral pitting oedemaAny grade = SAM

SECTION 7: INVESTIGATIONS

InvestigationFinding in PEM
Serum albuminVery low in Kwashiorkor (< 2.5 g/dL; normal 3.5-5.5); less reduced in Marasmus
Total proteinLow
HaemoglobinLow (anaemia)
Blood glucoseLow (hypoglycaemia - emergency)
Serum electrolytesLow sodium, potassium, magnesium
Serum phosphorusLow (risk of refeeding syndrome if replaced too fast)
Liver enzymes (SGOT, SGPT)Elevated in Kwashiorkor (fatty liver)
Stool examinationWorm ova, occult blood
UrineSpecific gravity low; ketones possible
X-rayOsteoporosis; delayed bone age
Skin test (tuberculin)May be negative (anergy) due to immune suppression

SECTION 8: WHO 10-STEP MANAGEMENT PROTOCOL FOR SAM

WHO has a standardized 10-step approach divided into two phases:

PHASE 1: STABILIZATION (Days 1-7) - Treat the child, NOT the malnutrition aggressively yet

Step 1: Treat/Prevent Hypoglycaemia
  • Blood glucose < 54 mg/dL = hypoglycaemia
  • Give 10% glucose or 10% sucrose orally (50 ml) or IV if unconscious
  • Start feeding 2-hourly (day and night) to prevent recurrence
  • Monitor blood glucose
Step 2: Treat/Prevent Hypothermia
  • Axillary temperature < 35°C = hypothermia
  • Warm with clothes, blanket, skin-to-skin contact
  • Kangaroo care for young infants
  • Warm room (25-30°C); avoid wet clothes
Step 3: Treat/Prevent Dehydration
  • Do NOT use standard ORS in SAM - electrolyte imbalance already present
  • Use ReSoMal (Rehydration Solution for Malnutrition) - lower sodium, higher potassium and magnesium
  • ReSoMal: 5-10 ml/kg/hr for first 2 hours; then 5-10 ml/kg alternating with F-75 formula for next 4-10 hours
  • Avoid IV fluids unless shock - very dangerous in SAM (risk of fluid overload and heart failure)
Step 4: Correct Electrolyte Imbalance
  • Give extra potassium (3-4 mmol/kg/day)
  • Give extra magnesium (0.4-0.6 mmol/kg/day)
  • Reduce sodium (do NOT give salty food/saline)
Step 5: Treat/Prevent Infection
  • All SAM children assumed to have infection even without obvious signs
  • Give broad-spectrum antibiotics: Amoxicillin oral OR Ampicillin + Gentamicin IV for 7 days
  • Add Metronidazole if suspected gut infection
  • Treat malaria, TB if present
Step 6: Correct Micronutrient Deficiencies
  • Vitamin A: Single high-dose (age-specific) on Day 1 unless given in last month
    • < 6 months: 50,000 IU
    • 6-12 months: 100,000 IU
    • 12 months: 200,000 IU
  • Folic acid: 5 mg on Day 1; then 1 mg/day
  • Zinc: 2 mg/kg/day for 2 weeks
  • Copper: 0.3 mg/kg/day
  • Iron: Do NOT give iron in Phase 1 (worsens infection by providing substrate for bacteria)
  • Multivitamin supplement daily
Step 7: Start cautious feeding (F-75 Formula)
  • F-75: 75 kcal/100 ml; starter formula
  • Feed 2-3 hourly (8-12 feeds/day); small amounts
  • Total: 100 ml/kg/day initially
  • Monitor for signs of heart failure (respiratory distress, increasing oedema)
  • If child refuses to eat → nasogastric tube feeding
Step 8: Achieve Catch-Up Growth (Transition to F-100)
  • Begins when: appetite returns, oedema reducing, no infection
  • F-100: 100 kcal/100 ml; higher protein and energy
  • Transition gradually over 2-3 days to avoid refeeding syndrome
  • Increase volume by 10 ml/feed every 2 feeds until 150-220 ml/kg/day
  • Target catch-up: 10-15 g/kg/day weight gain
Step 9: Sensory Stimulation and Emotional Support
  • Tender loving care (TLC)
  • Stimulating environment with toys, play
  • Structured play therapy
  • Maternal involvement and education
Step 10: Prepare for Follow-Up After Recovery
  • Discharge when weight-for-height > -2 SD AND no oedema AND eating well
  • RUTF (Ready-to-Use Therapeutic Food): Peanut-based paste; 500 kcal/sachet; 150 kcal/kg/day for 4-6 weeks in community
  • Monthly follow-up for 6 months
  • Immunization catch-up
  • Feeding counseling

SECTION 9: NUTRITIONAL REHABILITATION CENTRE (NRC)

  • Government-run facilities at district/sub-district hospitals
  • For SAM children aged 6 months to 5 years without medical complications
  • Free residential care for 14 days: medical treatment + therapeutic feeding
  • Mother stays with child - learns feeding techniques
  • RUTF provided on discharge
  • Monthly follow-up for 3 months
Admission criteria to NRC:
  • SAM (MUAC < 11.5 cm or WFH < -3 SD or bilateral pitting oedema)
  • Medical complications (present → stabilization ward first)

SECTION 10: ASSOCIATED NUTRITIONAL DEFICIENCIES

A. Vitamin A Deficiency

  • Night blindness (Nyctalopia): Earliest sign - impaired dark adaptation
  • Conjunctival xerosis (X1A): Dry, dull conjunctiva
  • Bitot's spots (X1B): Foamy, triangular, white deposits on conjunctiva
  • Corneal xerosis (X2): Dry, hazy cornea
  • Corneal ulceration/keratomalacia (X3): Softening, destruction of cornea → blindness
  • Xerophthalmia: All eye manifestations of Vitamin A deficiency
  • Systemic effects: Squamous metaplasia of respiratory and urinary tract epithelium → recurrent infections; follicular dermatosis (phrynoderma)
  • Treatment: Oral Vitamin A (WHO schedule)
  • Prevention: Vitamin A supplementation program (NIS); promoting green leafy vegetables, fruits, egg, dairy
(Robbins & Kumar Basic Pathology, p. 293)

B. Vitamin D Deficiency - Rickets

  • Cause: Inadequate sun exposure + dietary deficiency
  • Pathology: Defective bone mineralization at growth plates
  • Clinical features:
    • Craniotabes: Thinning of skull bones; ping-pong ball feeling on pressing skull
    • Frontal bossing: Prominent forehead
    • Rachitic rosary: Enlargement of costochondral junctions (beading of ribs)
    • Harrison's groove (sulcus): Horizontal depression along diaphragm attachment
    • Pigeon chest (Pectus carinatum)
    • Bowlegs (Genu varum) or Knock knees (Genu valgum)
    • Delayed dentition, delayed closure of fontanelles
    • Hypocalcemic tetany: Carpopedal spasm, Trousseau's sign, Chvostek's sign
  • Investigations: Low serum calcium, low phosphorus, elevated ALP, elevated PTH; X-ray: widened, frayed, cupped metaphysis (especially at wrist)
  • Treatment: Vitamin D 1000-2000 IU/day + calcium supplementation

C. Iron Deficiency Anaemia

  • Most common nutritional deficiency globally
  • Pallor (conjunctival, palmar, nail bed)
  • Irritability, fatigue, poor concentration, pica (eating dirt/clay)
  • Koilonychia (spoon-shaped nails) in severe cases
  • Treatment: Iron 3-6 mg/kg/day elemental iron; continue 3 months after Hb normalizes

D. Iodine Deficiency Disorders (IDD)

  • Goitre: Enlargement of thyroid gland
  • Cretinism: Congenital hypothyroidism - mental retardation, deaf-mutism, short stature, spasticity
  • Prevention: Iodized salt

SECTION 11: BREASTFEEDING AND COMPLEMENTARY FEEDING

Breastfeeding (Highest Priority in Prevention of PEM)

Initiation: Within 1 hour of birth (early initiation)
  • Colostrum - first yellowish milk; rich in IgA, lactoferrin, protein, Vitamin A; acts as "first vaccine"
  • Exclusive breastfeeding for 6 months
  • Continue breastfeeding up to 2 years and beyond
Advantages of Breastfeeding:
  • Provides ideal nutrition (protein, fat, carbohydrate, vitamins, minerals in right proportions)
  • Rich in immunoglobulins (IgA) - prevents infections
  • Contains lysozyme, lactoferrin - anti-infective
  • Promotes bonding and psychological security
  • Protects against diarrhoea, respiratory infections, otitis media
  • Reduces risk of SIDS
  • Easily digestible; rarely causes allergy
  • Cost-effective; always available at right temperature
  • Benefits mother: reduces postpartum hemorrhage, delays ovulation, reduces breast/ovarian cancer risk
Signs of adequate breastfeeding:
  • 6-8 wet diapers/day
  • Baby satisfied after feeds
  • Adequate weight gain (20 g/day in first 3 months)
  • Stool pattern normal

Complementary Feeding

  • Introduce at 6 months (not before 4 months, not after 6 months)
  • Timely, adequate, safe, appropriate
  • Start with semi-solid mashed foods (dal, rice, banana, suji)
  • Frequency:
    • 6-8 months: 2-3 meals/day
    • 9-12 months: 3-4 meals/day
    • 12-24 months: 4-5 meals/day
  • Continue breastfeeding with every meal
  • Gradually increase texture, variety, frequency
  • Avoid tea, juices, sugary/salty foods in early complementary feeding

SECTION 12: NURSING MANAGEMENT OF A CHILD WITH PEM

Nursing Assessment

  1. Anthropometric measurements: weight, height, MUAC, skin fold thickness
  2. Clinical signs: oedema, skin changes, hair changes, hepatomegaly, anaemia
  3. Dietary history: feeding practices, quantity, quality, frequency
  4. Infection history: recurrent diarrhea, respiratory infections
  5. Developmental assessment
  6. Psychosocial assessment: family support, mother's knowledge

Nursing Diagnoses

Nursing DiagnosisGoal
Imbalanced nutrition: less than body requirements r/t inadequate intakeAdequate weight gain 10-15 g/kg/day
Risk for fluid volume deficit/excess r/t oedema and refeedingBalanced fluid status; oedema reduction
Risk for infection r/t immune suppressionNo new infections; infection-free
Hypothermia r/t decreased subcutaneous fatTemperature 36.5-37.5°C
Risk for hypoglycaemia r/t depleted glycogen storesBlood glucose ≥ 54 mg/dL
Delayed growth and development r/t malnutritionAge-appropriate development
Knowledge deficit (mother) r/t feeding practicesMother demonstrates correct feeding

Nursing Interventions

  1. Feeding: Implement WHO 10-step protocol; administer F-75 (Phase 1) → F-100 (Phase 2); tube feed if refusing
  2. Monitor: Weight daily; fluid intake-output; blood glucose every 3-6 hours; vital signs; oedema grading
  3. Infection control: Strict hand hygiene; isolate from infectious patients; administer prescribed antibiotics
  4. Warmth: Maintain neutral thermal environment; avoid cold stress
  5. Stimulation: Play activities; sensory stimulation; talk and interact
  6. Mother education: Teach correct breastfeeding, complementary feeding, hygiene, immunization, danger signs
  7. Vitamin/mineral supplementation: Administer as prescribed (Vitamin A, folic acid, zinc, copper)
  8. Records: Document weight, intake-output, medications, condition daily

Health Education for Mother/Caregiver

  • Exclusive breastfeeding for 6 months
  • Timely introduction of complementary foods
  • Food to give: high-protein foods (pulses, eggs, fish, meat, milk), green leafy vegetables, fruits
  • Food hygiene and safe water
  • Regular growth monitoring
  • Complete immunization
  • Seek care early for infections
  • Importance of regular deworming

SECTION 13: PREVENTION OF PEM

Primary Prevention

  1. Promote exclusive breastfeeding for 6 months
  2. Timely, appropriate complementary feeding from 6 months
  3. Nutrition education and counseling in antenatal and postnatal care
  4. Poverty alleviation and food security programs
  5. ICDS (Integrated Child Development Services): Supplementary nutrition, immunization, health check-up, health education for children 0-6 years and pregnant/lactating mothers
  6. Mid-Day Meal Programme (PM POSHAN): Free cooked meals in schools
  7. Complete immunization (prevents infections that precipitate PEM)
  8. Vitamin A supplementation program
  9. Iron and folic acid supplementation for children and mothers

Secondary Prevention (Early Detection)

  • Growth monitoring at every visit using WHO growth charts
  • MUAC screening in community
  • IMNCI assessment
  • NRC referral when SAM detected

Tertiary Prevention

  • WHO 10-step management
  • RUTF supplementation
  • Rehabilitation and follow-up
  • Prevention of relapse through counseling

CONCLUSION

Protein Energy Malnutrition in its two major clinical forms - Kwashiorkor (protein deficiency with oedema) and Marasmus (total calorie and protein deficiency with severe wasting) - represents a serious but largely preventable public health emergency in India. The nurse occupies a central role in the prevention, early detection, and comprehensive management of PEM. Through skilled assessment, meticulous implementation of the WHO 10-step protocol, sustained feeding support, micronutrient supplementation, infection control, and sustained maternal education, nurses can dramatically reduce mortality and facilitate full nutritional recovery in affected children.

Exam tip for 50 marks: Mandatory sections: Introduction + Definitions + Causes + Pathophysiology of both + Full clinical features table comparing Kwashiorkor and Marasmus (this table alone can fetch 15 marks) + Grading (Gomez + Waterlow) + Investigations + WHO 10-step management with F-75/F-100 details + Nursing care plan + Associated deficiencies (Vit A, Rickets) + Breastfeeding + Prevention (ICDS/NRC). Write the comparison table neatly as it is the highest-scoring single component.

Say "Next" for Topic 6: Nephrotic Syndrome.

Next

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Excellent, rich textbook content. Delivering the complete 50-mark answer now:

NEPHROTIC SYNDROME IN CHILDREN

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Nephrotic Syndrome (NS) is a clinical complex characterized by four cardinal features resulting from increased glomerular permeability to plasma proteins. It is one of the most common renal disorders in children, with an incidence of 1-5 cases per 100,000 children per year. The peak age of onset in children is 2-6 years, and it is more common in boys (ratio 2:1).
The four hallmarks of nephrotic syndrome form a logical chain:
Massive Proteinuria → Hypoalbuminemia → Generalized Oedema + Hyperlipidemia/Lipiduria
In children, Minimal Change Disease (MCD) is the most common cause, accounting for 80-85% of cases, and it typically responds well to steroids with an excellent prognosis.
(Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 844; Tietz Textbook of Laboratory Medicine, p. 1883)

SECTION 1: DEFINITION

Nephrotic Syndrome is defined by the presence of:
  1. Massive (heavy) proteinuria: > 3.5 g/day in adults; > 40 mg/m²/hour or > 3+ protein on urine dipstick in children
  2. Hypoalbuminemia: Serum albumin < 3 g/dL (< 2.5 g/dL is severe)
  3. Generalised oedema (anasarca)
  4. Hyperlipidaemia and lipiduria
The diagnosis requires at least proteinuria + hypoalbuminemia (the other two follow as consequences).

SECTION 2: CLASSIFICATION / CAUSES

A. Primary (Idiopathic) - Most Common in Children

TypeAge GroupFrequencyResponse to Steroids
Minimal Change Disease (MCD/MCNS)2-6 years80-85% of childhood NS90-95% respond
Focal Segmental Glomerulosclerosis (FSGS)Older children/adolescents~10%Poor
Membranous NephropathyOlder childrenRareVariable
Membranoproliferative GN (MPGN)School ageRarePoor

B. Secondary Causes

CauseExamples
InfectionsMalaria (quartan), Hepatitis B, Hepatitis C, HIV, Syphilis
Systemic diseasesLupus nephritis (SLE), Henoch-Schonlein Purpura (HSP), Diabetes mellitus
Drugs/ToxinsGold, mercury, penicillamine, NSAIDs
MalignanciesLymphomas, leukaemia
HereditaryCongenital nephrotic syndrome (Finnish type)

SECTION 3: PATHOPHYSIOLOGY (Step-by-Step Chain)

Step 1: Glomerular Basement Membrane (GBM) Injury

  • The GBM normally acts as a size and charge barrier
  • In MCD: Loss of polyanion (negative charge) on GBM → allows negatively charged albumin to pass through
  • In other causes: structural damage + podocyte injury → increased permeability

Step 2: Massive Proteinuria

  • Proteins (mainly albumin - smallest, most abundant) leak into Bowman's space
  • 3.5 g/day in adults; > 40 mg/m²/hr in children
  • Selective proteinuria (MCD): mainly albumin lost (selectivity index < 0.1)
  • Non-selective proteinuria (FSGS, MPGN): large proteins (IgG, globulins) also lost

Step 3: Hypoalbuminemia

  • Urinary albumin loss exceeds liver's compensatory synthetic capacity
  • Increased renal catabolism of filtered albumin
  • Serum albumin falls < 3 g/dL → < 2.5 g/dL in severe cases

Step 4: Oedema Formation (Underfill + Overfill theories)

Classical (Underfill) theory:
  • Low serum albumin → ↓ plasma oncotic pressure → fluid leaks into interstitium → ↓ intravascular volume → activates RAAS → aldosterone → Na and water retention → worsens oedema
Overfill theory:
  • Primary sodium retention by diseased kidney → plasma expansion → oedema
Combined effect:
  • Oedema is characteristically soft, pitting, periorbital (most prominent in morning), dependent (legs/feet in daytime)
  • Severe: ascites, pleural effusion, scrotal/vulval oedema, anasarca
(Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 844)

Step 5: Hyperlipidaemia

  • Hypoalbuminemia signals liver to increase lipoprotein synthesis
  • Decreased catabolism of lipids
  • Results in elevated total cholesterol, LDL, VLDL, triglycerides
  • Lipiduria: Free fat, oval fat bodies, fatty casts in urine
  • Maltese cross pattern on polarized light microscopy of urine

Step 6: Other Metabolic Consequences

  • Loss of immunoglobulins (IgG) → susceptibility to infections
  • Loss of clotting factors (antithrombin III, protein C and S) + increase in procoagulant factors → thrombosis
  • Loss of thyroid binding globulin → altered thyroid function tests
  • Loss of Vitamin D binding protein → hypocalcaemia
  • Loss of transferrin → iron deficiency
  • Loss of zinc

SECTION 4: CLINICAL FEATURES

Onset

  • Often insidious; may follow upper respiratory tract infection
  • First noticed as periorbital puffiness (morning), which parents may mistake for allergy
  • Parents note swollen eyes, swelling of feet/legs, decreased urine output

History

  • Periorbital oedema (earliest and most noticed sign)
  • Generalized swelling (face, legs, abdomen)
  • Decreased or frothy urine output (frothy urine = proteinuria)
  • Decreased appetite
  • Diarrhea (gut wall oedema)
  • History of recent infection (URTI, skin infection)

Physical Examination Findings

SignDescription
Periorbital oedemaSoft, pitting; most prominent in morning; reduces with activity
Pitting oedemaBilateral lower limbs; ankles, feet; dependent
AscitesDistended, tense, shifting dullness; fluid thrill
Scrotal/Vulval oedemaGross oedema of genitalia
Pleural effusionDullness at bases; reduced breath sounds
PallorDilutional + actual anaemia
Blood pressureUsually normal or LOW (underfill) in MCD; may be elevated in secondary causes
UrineFrothy, reduced output, may be dark
MalnutritionWasting under the oedema; low serum proteins
XanthomasRarely, in long-standing hyperlipidaemia
Note: Blood pressure is typically normal in MCD (unlike nephritic syndrome). Hypertension suggests secondary cause or FSGS.

SECTION 5: INVESTIGATIONS

Urine Examination

TestFinding
Urine dipstick3+ or 4+ protein (massive proteinuria)
24-hour urine protein> 3.5 g/day (adults); > 40 mg/m²/hr (children)
Urine microscopyOval fat bodies, lipid droplets, fatty casts; Maltese cross on polarized light; NO RBCs or RBC casts (unlike nephritic)
Urine protein:creatinine ratio> 200 mg/mmol (> 2 mg/mg) = nephrotic range
Urine specific gravityHigh (concentrated)

Blood Tests

TestFinding
Serum albumin< 3 g/dL (< 2.5 g/dL = severe)
Total proteinLow
Serum cholesterolElevated (> 200 mg/dL)
TriglyceridesElevated
LDLElevated
Blood urea nitrogen, CreatinineUsually normal in MCD
Serum electrolytesMay show hyponatremia (dilutional)
Serum calciumLow (loss of Vit D binding protein)
CBCAnaemia; raised ESR
Serum complement (C3, C4)Normal in MCD; low in MPGN, lupus
ANA, Anti-dsDNAIf lupus nephritis suspected
ASO titreIf post-streptococcal cause

Renal Biopsy

  • NOT required for first presentation in children 1-12 years (assumed MCD; treat with steroids first)
  • Indicated when:
    • Age < 1 year or > 12 years
    • Steroid resistant (no remission after 4 weeks of full-dose steroids)
    • Steroid dependent or frequently relapsing
    • Persistent haematuria, hypertension, or low complement
    • Secondary cause suspected
Renal biopsy findings in MCD:
  • Light microscopy: Normal glomeruli ("minimal change")
  • Immunofluorescence: Negative (no deposits)
  • Electron microscopy: Effacement (fusion) of podocyte foot processes - hallmark

SECTION 6: MANAGEMENT

A. General Measures

1. Diet:
  • Normal protein intake (1-2 g/kg/day) - high protein diets worsen proteinuria
  • Low sodium diet (< 2 g/day) - to reduce oedema
  • Low saturated fat diet (for hyperlipidaemia)
  • Adequate calories; normal fluid intake unless severe oedema
2. Rest:
  • Restrict activity during acute oedematous phase
  • Bed rest in Fowler's/semi-recumbent position
  • Elevate lower limbs to reduce dependent oedema
3. Fluid management:
  • Restrict fluids only if severe hyponatraemia (serum Na < 125 mEq/L) or severe oedema with respiratory distress
  • Otherwise, no fluid restriction necessary

B. Medical Management

1. STEROIDS (First-line, Most Important Treatment)

First episode:
  • Prednisolone: 2 mg/kg/day (max 60 mg/day) orally in single morning dose for 4 weeks (full dose)
  • Then 1.5 mg/kg alternate days for 4 weeks (tapering)
  • Total: 12 weeks of steroid therapy (longer = lower relapse rate)
Response definitions:
TermDefinition
RemissionUrine protein nil or trace (< 4 mg/m²/hr) for 3 consecutive days
RelapseUrine protein ≥ 3+ (> 40 mg/m²/hr) for 3 consecutive days after remission
Frequent relapser≥ 2 relapses in 6 months OR ≥ 4 relapses in 12 months
Steroid-dependentRelapse during steroid tapering OR within 14 days of stopping
Steroid-resistantNo remission after 4 weeks of full-dose prednisolone
90% of MCD responds to steroids within 2-4 weeks.
(Tietz Textbook of Laboratory Medicine / Comprehensive Clinical Nephrology, p. 1883)

2. DIURETICS (for severe oedema)

  • Furosemide (Lasix): 1-3 mg/kg/day; loop diuretic; promotes sodium and water excretion
  • Add spironolactone (potassium-sparing) to prevent hypokalemia
  • IV albumin (salt-poor albumin 20%): 1 g/kg over 4-6 hours → followed immediately by IV furosemide; used for severe symptomatic oedema, hypovolaemia, ascites, pleural effusion
  • Caution: Diuretics can worsen hypovolaemia and precipitate AKI in underfilled patients

3. ANTIBIOTICS

  • Prophylactic Phenoxymethylpenicillin (penicillin V) in children with frequent relapses (reduces infection-triggered relapses)
  • Treat infections promptly - most common precipitant of relapse is infection

4. SECOND-LINE AGENTS (for frequent relapsers, steroid-dependent, steroid-resistant)

DrugUse
CyclophosphamideFrequent relapsers; 2 mg/kg/day for 8-12 weeks; max 12 weeks (gonadal toxicity limit)
LevamisoleImmunomodulator; steroid-sparing; 2.5 mg/kg alternate days for 12 months
Cyclosporin ASteroid-dependent/resistant; calcineurin inhibitor; nephrotoxic
TacrolimusAlternative to cyclosporin; less nephrotoxic
Mycophenolate mofetil (MMF)Steroid-sparing in frequent relapsers
RituximabAnti-CD20; steroid-resistant MCD; biological agent

5. TREATMENT OF HYPERLIPIDAEMIA

  • Dietary fat restriction
  • Statins (HMG-CoA reductase inhibitors) if persistent or high risk

6. ANTICOAGULATION

  • Consider if serum albumin < 20 g/L or membranous nephropathy → high thrombosis risk
  • Aspirin or low molecular weight heparin

SECTION 7: COMPLICATIONS

A. Infections (Most Common and Dangerous Complication)

  • Spontaneous bacterial peritonitis (SBP): Most feared; Streptococcus pneumoniae most common organism; presents with fever, abdominal pain, tenderness; treat with IV cefotaxime/ceftriaxone
  • Cellulitis, urinary tract infections, septicaemia
  • Varicella: Severe, life-threatening if child is on steroids (reduce/stop steroids; give acyclovir; give VZIG prophylaxis to contacts)
  • Causes: Loss of immunoglobulins (IgG), complement proteins; steroid-induced immunosuppression; oedema (bacterial culture medium)

B. Thromboembolism

  • Deep vein thrombosis, renal vein thrombosis, pulmonary embolism
  • Cause: Loss of antithrombin III, protein C and S; increased platelet aggregability; haemoconcentration; immobility
  • Renal vein thrombosis: sudden worsening of haematuria and flank pain; confirmed by Doppler/CT angiography

C. Hypovolaemia (Shock)

  • Occurs when aggressive diuresis or diarrhoea/vomiting reduces intravascular volume
  • Signs: Tachycardia, cold extremities, abdominal pain, reduced urine output
  • Treatment: IV albumin + fluids

D. Acute Kidney Injury (AKI)

  • From hypovolaemia, sepsis, or interstitial nephritis (NSAIDs)

E. Steroid Side Effects (Long-term)

  • Cushing's syndrome (moon face, buffalo hump, striae)
  • Growth retardation
  • Osteoporosis → fractures
  • Hypertension
  • Diabetes mellitus (steroid-induced)
  • Cataracts, glaucoma
  • Susceptibility to infection

F. Nutritional Problems

  • Protein malnutrition due to urinary losses + dietary restriction
  • Vitamin D deficiency → rickets, hypocalcaemia, tetany
  • Iron deficiency anaemia

G. Psychosocial Impact

  • Altered body image (oedema, Cushingoid appearance)
  • School absenteeism
  • Family stress and anxiety

SECTION 8: NEPHROTIC vs NEPHRITIC SYNDROME (Comparison - High-Yield)

FeatureNephrotic SyndromeNephritic Syndrome
ProteinuriaMassive (> 3.5 g/day)Mild to moderate (subnephrotic)
HaematuriaAbsent/minimalPresent (hallmark)
OedemaSevere, generalisedMild to moderate
HypertensionUsually absent (MCD)Present
Serum albuminVery lowNormal/mildly low
Serum lipidsElevatedNormal
Urine castsFatty casts, oval fat bodiesRBC casts (hallmark)
GFR / CreatinineUsually normalReduced (azotaemia)
Urine outputReducedOliguria
Complement (C3)Normal (MCD)Low (APSGN, SLE, MPGN)
Typical cause in childrenMCDAPSGN (post-streptococcal)
MechanismIncreased GBM permeabilityGlomerular inflammation
(Robbins & Kumar Basic Pathology, p. 2015-2017)

SECTION 9: NURSING MANAGEMENT

Nursing Assessment

  1. Daily weight (most sensitive indicator of fluid status; > 0.5 kg/day = fluid retention)
  2. Abdominal girth measurement (for ascites monitoring)
  3. Blood pressure (4-hourly)
  4. Urine output (hourly in acute phase; target > 1 ml/kg/hr)
  5. Urinalysis daily: protein, specific gravity, albumin
  6. Skin assessment: Oedematous skin is fragile; check for pressure areas, breakdown, infection
  7. Signs of infection: Fever, abdominal pain (peritonitis), respiratory distress
  8. Signs of hypovolaemia: Tachycardia, cold extremities, abdominal pain, dizziness
  9. Electrolytes, albumin, CBC - review results daily
  10. Growth and development assessment

Nursing Diagnoses

Nursing DiagnosisRelated ToGoal
Fluid volume excessHypoalbuminemia, sodium retentionReduction in oedema; maintain fluid balance
Risk for infectionImmunosuppression, protein lossPrevent infection; early detection
Imbalanced nutrition: less than body requirementsProtein loss in urine, anorexiaMaintain adequate nutrition
Impaired skin integrityOedema, immobilityNo skin breakdown
Risk for injury / thrombosisHypercoagulable state, immobilityNo thrombotic events
Anxiety (child and parents)Chronic illness, body imageReduce anxiety; promote coping
Deficient knowledgeDisease process, medicationsParents demonstrate understanding of care

Nursing Interventions

1. Fluid and Oedema Management:
  • Daily weight at same time, same scale, same clothing
  • Strict intake-output chart (every 2-4 hours)
  • Low sodium, low fat diet as prescribed
  • Elevate lower limbs when in bed; elevate scrotum with support
  • Position change every 2 hours
  • Administer diuretics as prescribed; monitor response
  • Administer IV albumin infusion as prescribed (run slowly; monitor for overload)
2. Infection Prevention:
  • Strict hand hygiene before and after care
  • Isolate from infectious patients
  • Avoid live vaccines while on high-dose steroids
  • Monitor temperature 4-hourly; report fever immediately
  • Teach family to avoid crowds and infectious contacts
  • Administer prophylactic penicillin as prescribed
  • Ensure Pneumococcal vaccine (Pneumovax) before starting steroids if possible
3. Skin Care:
  • Keep skin clean and dry; gentle handling
  • Use soft absorbent clothing (cotton)
  • Apply moisturiser to dry, stretched, oedematous skin
  • Use pressure-relieving mattress
  • Do NOT use tight clothing or restricting dressings
  • Change position frequently; document skin condition
4. Nutrition:
  • Serve small, frequent, attractive meals
  • Normal protein, low salt, low saturated fat diet
  • Provide favourite foods within dietary restrictions
  • Calcium and Vitamin D supplements as prescribed
  • Weigh and record dietary intake; involve dietitian
5. Medication Administration and Education:
  • Administer prednisolone with food (reduces gastric irritation)
  • Give in morning (mimics cortisol diurnal rhythm; reduces sleep disturbance)
  • Teach parents NOT to stop steroids abruptly (risk of adrenal crisis)
  • Teach urine testing for protein (dipstick) at home - twice weekly
  • Teach to seek help immediately for: fever, abdominal pain, marked increase in swelling, blood in urine, decreased urine output
6. Activity and Play:
  • Restrict strenuous activity during acute oedematous phase
  • Encourage gentle play within bed; provide age-appropriate toys
  • Resume normal activity gradually as oedema resolves
  • Encourage school attendance during remission
7. Psychological Support:
  • Reassure child and family: MCD has good prognosis in children
  • Encourage parents to express fears and ask questions
  • Address body image concerns (oedema, cushingoid features on steroids)
  • Connect with support groups
  • Ensure continuity of education

SECTION 10: DISCHARGE PLANNING AND FOLLOW-UP

Discharge criteria:
  • Oedema resolved or significantly reduced
  • On oral prednisolone (stable dose)
  • Parents competent in urine dipstick testing
  • Child tolerating diet and medications well
Discharge teaching:
  1. Urine dipstick protein testing at home - twice weekly; report 2+ or more for 3 consecutive days
  2. Daily weight at home; report > 0.5 kg/day gain
  3. Medication: Do not miss steroid doses; do not stop abruptly
  4. Low sodium diet at home - avoid chips, pickles, processed foods
  5. Report fever, abdominal pain, or worsening swelling immediately
  6. Avoid contact with chickenpox cases (notify school)
  7. Follow-up appointments: Weekly initially, then monthly
  8. Immunization: Pneumococcal vaccine, influenza vaccine; avoid live vaccines while on high-dose steroids
  9. School: Can attend school during remission; inform teacher about condition

CONCLUSION

Nephrotic Syndrome is a chronic, relapsing condition that profoundly affects the child's physical, nutritional, and psychosocial well-being. The nurse's role spans the full continuum - from meticulous fluid monitoring and skin care to medication administration, infection prevention, and family education. Since 80-90% of children with MCD achieve remission with steroids and the majority have an excellent long-term prognosis, informed nursing support is fundamental in helping the child and family manage relapses confidently at home and maintain quality of life throughout the course of the disease.

Exam tip for 50 marks: Structure your answer as: Introduction + Definition (4 hallmarks with the chain) + Classification with causes + Pathophysiology (step-by-step chain) + Clinical features + Investigations table + Medical management (steroid protocol + response definitions are highest-yield) + Complications (peritonitis, thrombosis, hypovolaemia) + Nephrotic vs Nephritic comparison table + Full nursing care plan + Discharge teaching. The pathophysiology chain and the nephrotic vs nephritic table are the most frequently tested components.

Say "Next" for Topic 7: Tetralogy of Fallot (TOF).

Next

Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Excellent detailed textbook content. Delivering the full 50-mark answer now:

TETRALOGY OF FALLOT (TOF)

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease (CHD), accounting for approximately 5-10% of all CHD and occurring in 0.5 per 1000 live births. It was first described by Étienne-Louis Arthur Fallot in 1888, hence the name. The term "tetralogy" refers to the four anatomical defects that make up this condition.
TOF is a right-to-left shunt lesion - deoxygenated blood from the right ventricle passes directly into the systemic circulation (aorta), bypassing the lungs, causing cyanosis. Without surgical intervention, mortality is high; with timely surgery, over 90% of patients survive to adulthood.
(Harrison's Principles of Internal Medicine 22E, p. 2116; Sabiston Textbook of Surgery, p. 2573)

SECTION 1: THE FOUR DEFECTS (Tetralogy) - Most Important Section

The anatomical hallmark is anterior malalignment of the infundibular/conal septum, which produces all four defects:

1. Ventricular Septal Defect (VSD)

  • Large, perimembranous, pressure non-restrictive VSD
  • Located high in the interventricular septum (subaortic/malalignment type)
  • Allows mixing of oxygenated and deoxygenated blood between ventricles

2. Pulmonary Stenosis (Right Ventricular Outflow Tract Obstruction - RVOTO)

  • Most important defect - determines severity of cyanosis
  • Obstruction can be at multiple levels:
    • Infundibular (subvalvular): Most common; muscular obstruction below pulmonary valve
    • Valvular: Thickened, bicuspid pulmonary valve
    • Supravalvular/pulmonary artery: Hypoplastic main or branch pulmonary arteries
  • Spectrum: Mild pulmonary stenosis → Pulmonary atresia (TOF/PA) - most severe form

3. Overriding Aorta

  • The aortic root is enlarged and sits astride (overrides) the VSD
  • Positioned over both ventricles (not exclusively over LV as normal)
  • Degree of override varies (25-100%); if > 50% override → some classify as Double Outlet RV

4. Right Ventricular Hypertrophy (RVH)

  • Secondary consequence of pulmonary stenosis (increased RV afterload)
  • RV wall hypertrophies progressively
  • At birth, RV and LV pressures equalize; RV pressure = systemic pressure
  • RVH is progressive and worsens the obstruction over time
(Sabiston Textbook of Surgery, p. 2573; Harrison's Principles of Internal Medicine 22E, p. 2116)
Memory Aid: PROV
  • Pulmonary stenosis (RVOTO)
  • Right ventricular hypertrophy
  • Overriding aorta
  • VSD

SECTION 2: PATHOPHYSIOLOGY

Step-by-Step Haemodynamic Flow

Normal circulation: RV → Pulmonary artery → Lungs → Oxygenated blood
In TOF:
  1. Pulmonary stenosis creates resistance to pulmonary blood flow
  2. RV pressure rises to equal or exceed LV pressure
  3. Deoxygenated blood from RV finds the path of least resistance → through the VSD into the overriding aorta (right-to-left shunt)
  4. Deoxygenated (blue) blood mixes with oxygenated blood in aorta → systemic cyanosis
  5. The greater the RVOTO, the larger the R-to-L shunt → more cyanosis
  6. Less blood reaches the lungs → reduced pulmonary blood flow
  7. Chronic hypoxia → secondary polycythaemia (compensatory increase in RBC mass to carry more oxygen)
  8. Polycythaemia → increased blood viscosity → risk of thrombosis and stroke
"Pink Tet": If RVOTO is mild, shunt may be left-to-right initially → child is pink at birth; becomes cyanotic as RVOTO worsens over months (infundibular muscle hypertrophy progresses)
(Harrison's Principles of Internal Medicine 22E, p. 2116)

SECTION 3: CLINICAL FEATURES

A. CYANOSIS

  • Central cyanosis - present in lips, tongue, mucous membranes, nail beds
  • Appears at birth (if severe RVOTO) or during first weeks/months of life
  • Worsens with activity, crying, feeding
  • Progressive - worsens as infundibular stenosis increases with age

B. CLUBBING OF FINGERS AND TOES

  • Develops over months to years in response to chronic hypoxia
  • Early: Loss of angle between nail and nail bed (Lovibond angle)
  • Late: Drumstick/watch-glass nail; soft tissue swelling at finger tips
  • Also toes: "Drumstick toes"

C. HYPERCYANOTIC EPISODES ("TET SPELLS") - High-Priority Section

  • Sudden episodes of intense cyanosis with hyperpnoea
  • Age of peak occurrence: 2 months - 2 years
  • Time of occurrence: Most commonly in the morning after waking up; also after feeding, crying, defecation, or exercise
Mechanism of Tet Spell:
  1. Infundibular muscle spasm (triggered by sympathetic stimulation from crying, feeding, exertion)
  2. → Sudden increase in RVOTO → drastic fall in pulmonary blood flow
  3. → Massive increase in R-to-L shunt → profound drop in oxygen saturation
  4. → Hypoxia → ↑ respiratory rate (hyperpnoea) → falls in PaCO₂
  5. → Metabolic acidosis → further stimulation of respiratory center
  6. → More hyperpnoea → worsens the cycle
Clinical Signs of Tet Spell:
  • Sudden onset intense cyanosis
  • Deep, rapid breathing (hyperpnoea - NOT respiratory distress)
  • Loss of consciousness (if prolonged)
  • Convulsions (if severe hypoxia)
  • Disappearance or softening of the murmur during spell (less blood crossing the RVOT)

D. SQUATTING POSTURE (Pathognomonic of TOF)

  • Older children (toddlers and above) instinctively squat after exercise
  • Mechanism of squatting:
    • Squatting increases systemic vascular resistance (SVR) by kinking femoral arteries
    • Increased SVR → reduces R-to-L shunt (blood diverted to lungs)
    • Also traps deoxygenated blood in lower extremities
    • Net effect: Increased pulmonary blood flow → improved oxygenation

E. GROWTH AND DEVELOPMENT

  • Poor weight gain and growth retardation (chronic hypoxia, poor feeding, increased metabolic demands)
  • Fatigue on exertion; limits physical activity
  • Developmental delays in severe untreated cases

F. POLYCYTHAEMIA

  • Compensatory increase in RBC and haematocrit due to chronic hypoxia
  • Haematocrit may exceed 60-70% in severe untreated cases
  • Complications of polycythaemia:
    • Hyperviscosity → sluggish flow → thrombosis
    • Cerebral venous thrombosis (stroke-like episodes)
    • Brain abscess (R-to-L shunt bypasses pulmonary filter; bacteria enter systemic circulation)

G. MURMUR

  • Harsh systolic ejection murmur at left upper sternal border (pulmonary stenosis murmur - ejection type)
  • Not the VSD murmur (VSD is non-restrictive so no significant pressure gradient across it)
  • Louder murmur = less severe TOF (more blood crossing RVOT = more PS turbulence)
  • Softer murmur = more severe TOF (during tet spell, murmur may disappear)

H. OTHER SIGNS

  • Parasternal heave (RVH)
  • Single or loud S2 (diminished/absent pulmonary component)
  • No cardiac failure in childhood (R-to-L shunt unloads RV into aorta)
  • Absent congestive heart failure - distinguishes TOF from acyanotic CHD

SECTION 4: DIAGNOSIS / INVESTIGATIONS

A. Chest X-Ray (CXR)

  • "Boot-shaped heart" (Coeur en Sabot) - pathognomonic appearance
    • Upturned cardiac apex (RVH pushes apex upward and laterally)
    • Concave (absent) main pulmonary artery segment (hypoplastic PA)
    • Normal or small cardiac size (no cardiomegaly - unlike left-to-right shunts)
  • Decreased pulmonary vascular markings (oligaemic lung fields)
  • Right aortic arch in 25% of cases

B. ECG (Electrocardiogram)

  • Right axis deviation (RAD)
  • Right ventricular hypertrophy (RVH): Tall R in V1, deep S in V5-V6; R > S in V1
  • Right bundle branch block (RBBB) - often post-repair

C. Echocardiography (2D Echo + Doppler) - Gold Standard

  • Defines all four components of TOF
  • Anterior malalignment VSD + overriding aorta
  • Infundibular/valvular/supravalvular PS and its severity (peak gradient)
  • RV hypertrophy
  • Pulmonary artery anatomy (main + branches)
  • Coronary artery anatomy (critical pre-operative)
  • Colour flow Doppler: Right-to-left shunt through VSD

D. Blood Tests

  • CBC: Polycythaemia; elevated haematocrit (PCV > 55%); elevated haemoglobin
  • Coagulation: Impaired (polycythaemia causes relative factor deficiency)
  • ABG (Arterial Blood Gas): Low PaO₂; low oxygen saturation; may show metabolic acidosis during spells
  • Iron studies: Iron deficiency anaemia worsens cyanosis (even mildly anaemic polycythaemic child has less oxygen carrying capacity)

E. Cardiac Catheterization

  • Not routinely required (echo usually sufficient)
  • Used pre-operatively when PA anatomy complex, coronary anomaly suspected, or prior to redo surgery

F. CT/MRI Angiography

  • For complex pulmonary artery anatomy, aortopulmonary collaterals, and pre-operative planning

SECTION 5: MANAGEMENT

A. MEDICAL MANAGEMENT (Pre-surgical / Conservative)

1. Management of Tet Spell (Emergency - Most Important)

Steps in order:
Step 1: Calm the child
  • Pick up child; hold in knee-chest position (simulates squatting)
  • Reassure child and parents; reduce crying/agitation
Step 2: Knee-Chest Position
  • Flex knees to chest (foetal position)
  • Increases SVR → reduces R-to-L shunt → more blood to lungs
  • Can be done immediately by nurse/parent
Step 3: Oxygen
  • Give 100% oxygen by face mask
  • Reduces hypoxia; reduces pulmonary vascular resistance
  • Note: Oxygen alone rarely reverses a severe spell
Step 4: Morphine Sulphate
  • 0.1-0.2 mg/kg SC/IM/slow IV
  • Relaxes infundibular muscle spasm (relieves RVOTO)
  • Suppresses the hyperpnoeic response
  • Drug of choice for tet spell
Step 5: IV fluid bolus
  • Normal saline 10-20 ml/kg IV
  • Increases preload; increases pulmonary blood flow
  • Also helps if dehydrated (dehydration worsens spells)
Step 6: Sodium Bicarbonate
  • 1-2 mEq/kg IV for metabolic acidosis
  • Corrects acidosis that stimulates the respiratory center
Step 7: Propranolol (beta-blocker)
  • 0.1-0.2 mg/kg slow IV
  • Reduces HR; reduces infundibular muscle contractility (reduces RVOTO)
  • Slows the heart → allows more filling time → more blood to lungs
Step 8: Phenylephrine (alpha-agonist)
  • 0.02 mg/kg IV (or methoxamine)
  • Increases SVR rapidly → diverts blood to lungs
  • Used in refractory spells in ICU setting
If spell does not break → Emergency surgery

2. Propranolol - Long-term Prophylaxis

  • Oral propranolol 0.5-1.5 mg/kg/day in 3-4 divided doses
  • Prevents recurrent tet spells by:
    • Reducing infundibular muscle hyperreactivity
    • Slowing heart rate
  • Used as bridge to surgery if surgery delayed

3. Prevention of Complications

  • Iron supplementation: Prevent iron deficiency (worsens cyanosis and increases stroke risk)
  • Hydration: Avoid dehydration (increases blood viscosity, risk of stroke)
  • Dental hygiene + SBE prophylaxis: Amoxicillin before dental procedures (prevents bacterial endocarditis)
  • Phlebotomy (venesection): Rarely needed; only if haematocrit > 65% with symptoms (headache, visual changes) - remove 5-10 ml/kg blood and replace with saline

B. SURGICAL MANAGEMENT

1. Palliative Surgery (Temporary - Bridge to Complete Repair)

Blalock-Taussig-Thomas (BTT) Shunt - Most common palliative procedure
  • Creates an anastomosis between subclavian artery and pulmonary artery
  • Classic BTT (1944 - first cardiac surgery ever performed): Direct subclavian artery to PA
  • Modified BTT (MBTT) - now standard: Gore-Tex synthetic tube graft between subclavian artery and ipsilateral PA
  • Effect: Increases pulmonary blood flow → improves oxygenation → allows pulmonary arteries to grow
  • Indication: Very small pulmonary arteries, complex anatomy, very small baby (< 3-4 kg), or when complete repair carries high risk
Other historical palliative shunts (rarely done now):
  • Waterston shunt (ascending aorta to right PA)
  • Potts shunt (descending aorta to left PA)
  • Both largely abandoned due to complications

2. Complete (Total) Intracardiac Repair - Definitive Treatment

Timing: Currently preferred: Primary complete repair in infancy (3-6 months)
  • Trend toward earlier repair; some centers repair as early as neonatal period if severely symptomatic
  • Most do elective repair at 3-6 months before tet spells begin
Procedure (done on cardiopulmonary bypass):
  1. VSD closure with Dacron/pericardial patch
  2. Relief of RVOTO:
    • Resection of infundibular muscle
    • Pulmonary valvotomy (if valvular PS)
    • Transannular patch (TAP) - if pulmonary annulus too small; widened with patch → causes pulmonary regurgitation (long-term issue)
  3. Repair/reconstruction of main and branch pulmonary arteries if hypoplastic
  4. If anomalous coronary crosses RVOT → RV-to-PA conduit used instead of direct repair
Goal: Close VSD (stop mixing) + open RVOT (restore pulmonary blood flow)
(Sabiston Textbook of Surgery, p. 2573; Harrison's Principles of Internal Medicine 22E, p. 2116)
Post-repair sequelae (long-term issues):
  • Pulmonary regurgitation (PR): Most significant long-term problem after TAP repair; causes progressive RV dilatation and dysfunction → may require pulmonary valve replacement later
  • Residual RVOTO
  • Arrhythmias: RBBB (universal); ventricular tachycardia (risk of sudden death)
  • Residual VSD
  • Aortic root dilatation

SECTION 6: CLASSIFICATION OF CONGENITAL HEART DISEASE (Context for TOF)

Acyanotic CHD (Left-to-Right Shunts) - No cyanosis initially

DefectFeatures
VSD (most common CHD overall)Holosystolic murmur at LLSB; L-to-R shunt; pulmonary congestion
ASDFixed split S2; systolic ejection murmur; L-to-R shunt
PDAContinuous "machinery" murmur; L-to-R shunt; bounding pulses
Pulmonary stenosisEjection murmur at LUSB; no shunt
Aortic stenosisEjection murmur at RUSB; radiates to neck
Coarctation of aortaHypertension in arms, low BP in legs; rib notching on X-ray

Cyanotic CHD (Right-to-Left Shunts) - Cyanosis present

DefectFeatures
TOFMost common; boot-shaped heart; tet spells; squatting
TGA (Transposition of Great Arteries)Egg-on-string CXR; parallel circulation; prostaglandin E1; Rashkind procedure
Tricuspid atresiaNo tricuspid valve; requires shunt then Fontan procedure
Total anomalous pulmonary venous return (TAPVR)All pulmonary veins drain to RA/systemic; snowman CXR (supracardiac type)
Truncus arteriosusSingle great vessel from both ventricles
Hypoplastic left heart syndrome (HLHS)Tiny left side; most severe; requires Norwood/Fontan
5 T's of Cyanotic CHD:
  • TOF
  • TGA
  • Tricuspid atresia
  • TAPVR
  • Truncus arteriosus

SECTION 7: NURSING MANAGEMENT

Pre-operative Nursing Care

Assessment

  • Continuous cardiorespiratory monitoring (HR, RR, SpO₂)
  • Assess degree of cyanosis: lips, tongue, nail beds, mucous membranes
  • Monitor for tet spells (sudden increase in cyanosis, hyperpnoea, loss of consciousness)
  • Daily weight and growth monitoring
  • Assess feeding tolerance (cyanosis worsens during feeding)
  • Neurological assessment (risk of stroke from polycythaemia)
  • Observe for clubbing, squatting behavior

Nursing Diagnoses and Interventions

Nursing DiagnosisInterventions
Decreased cardiac output r/t structural defectMonitor HR, BP, SpO₂ continuously; position in knee-chest during spells; administer prescribed medications
Impaired gas exchange r/t R-to-L shuntMaintain SpO₂ as prescribed; administer supplemental O₂; position to maximize breathing
Activity intolerance r/t chronic hypoxiaCluster care; schedule rest periods; avoid unnecessary stimulation
Imbalanced nutrition: less than body requirements r/t fatigue during feedingSmall, frequent feeds; fortified formula; nasogastric feeding if required; daily weight
Risk for thrombosis r/t polycythaemiaMaintain adequate hydration; avoid dehydration; iron supplementation; mobilize when possible
Risk for infection (SBE) r/t abnormal blood flowOral hygiene; prophylactic antibiotics before procedures; avoid unnecessary IV access
Anxiety (parents) r/t complex illness and impending surgeryExplain disease and plan of care; involve parents in care; provide emotional support

Feeding the Child with TOF

  • Feed in upright or semi-upright position (reduces effort)
  • Small, frequent feeds (every 2-3 hours rather than large feeds)
  • Limit feeding time to 20-30 minutes (prolonged feeding is exhausting)
  • Gavage/nasogastric feeding if SpO₂ drops during oral feeding
  • High calorie formula or breast milk fortification if growth faltering
  • Burp frequently during feeds

Prevention of Tet Spells

  • Avoid prolonged crying (respond promptly; comfort child)
  • Avoid constipation (straining triggers spells); ensure adequate hydration and fiber
  • Maintain comfortable room temperature (cold stress triggers spells)
  • Handle gently; minimize painful procedures
  • Cluster care (group all interventions to allow rest periods)
  • Position: Avoid hip extension; flexed position preferred

Peri-operative Nursing Care

Pre-operative:
  • Complete pre-op assessment (cardiac catheterization review, echo review, blood group/crossmatch)
  • Insert IV access; pre-op medications
  • Educate parents about surgical procedure and ICU stay
  • Ensure preoperative antibiotics (SBE prophylaxis)
  • NPO (nil per os) as per surgical protocol
Post-operative (Cardiac ICU):
  • Continuous monitoring: HR, BP, CVP, left atrial pressure, SpO₂, temperature
  • Mechanical ventilation management (weaning according to protocol)
  • Pain management (morphine infusion initially; then oral paracetamol/NSAIDs)
  • Chest drain care: Monitor output, patency; record drainage
  • Watch for complications:
    • Low cardiac output (cool periphery, oliguria, hypotension)
    • Pulmonary regurgitation (if transannular patch used) - volume load on RV
    • Arrhythmias: RBBB (universal post-repair); heart block; VT
    • Pneumothorax, haemothorax
    • Junctional ectopic tachycardia (JET) - common in first 24-48 hours
    • Residual VSD or RVOTO
  • Fluid balance: Careful fluid management (cardiac surgery patients prone to fluid overload)
  • Gradual advancement of feeds when extubated

Discharge Teaching

  1. Explain medications: Digoxin (if prescribed), diuretics, prophylactic antibiotics
  2. Infective Endocarditis prophylaxis: Amoxicillin before dental/surgical procedures
  3. Wound care: Keep sternal wound clean and dry; signs of infection
  4. Activity: Gradual return to normal activity; no contact sports for 6 weeks
  5. Follow-up: Echo at 1 month, 6 months, then annually (monitor for PR, RVOTO)
  6. Signs of deterioration: Increased cyanosis, tet spells, squatting, poor weight gain → seek care immediately
  7. Iron supplementation (if prescribed)
  8. Dental hygiene importance (prevention of bacteraemia)
  9. School: Can attend school when recovered; inform teacher about condition

SECTION 8: PROGNOSIS

  • Without surgery: 50% die by age 3 years; 70% by 10 years (from tet spells, brain abscess, stroke, infective endocarditis)
  • With complete repair: > 90% long-term survival; most lead normal lives
  • Long-term issues: Pulmonary regurgitation (40-60% need pulmonary valve replacement later); arrhythmias; residual RVOTO
  • Survival into adulthood is standard with appropriate surgical management
(Sabiston Textbook of Surgery, p. 2588)

CONCLUSION

Tetralogy of Fallot is a complex but surgically correctable cyanotic heart disease. Its four anatomical components - VSD, pulmonary stenosis, overriding aorta, and RVH - collectively produce right-to-left shunting, cyanosis, and its characteristic clinical features including tet spells and squatting. The nurse's expertise in recognising and managing tet spells can be life-saving, while comprehensive pre- and post-operative nursing care ensures optimal surgical outcomes. With timely complete intracardiac repair, the vast majority of children with TOF achieve excellent long-term outcomes and normal quality of life.

Exam tip for 50 marks: Key sections the examiner expects: Introduction + 4 defects (PROV) with clear explanation + Pathophysiology (R-to-L shunt chain) + Clinical features (cyanosis, clubbing, tet spell mechanism, squatting mechanism - these two are highest scoring) + CXR findings (boot-shaped heart) + ECG + Echo + Management of tet spell step-by-step (this section alone can fetch 10-15 marks) + Surgical management (BTT shunt vs complete repair) + Full nursing care plan + Post-operative care. Diagrams of heart anatomy in the exam will earn bonus marks.

Say "Next" for Topic 8: Meningitis - Nursing Management.

Next

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Excellent textbook content from Harrison's and Harriet Lane. Delivering the complete 50-mark answer now:

MENINGITIS IN CHILDREN - NURSING MANAGEMENT

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Meningitis is defined as inflammation of the meninges (the three protective membranes - dura mater, arachnoid mater, and pia mater) that surround the brain and spinal cord, along with the subarachnoid space and cerebrospinal fluid (CSF). It is a neurological emergency that requires immediate diagnosis and treatment to prevent death or permanent neurological disability.
In children, bacterial meningitis carries a mortality rate of 5-10% even with treatment, and up to 30% of survivors develop permanent sequelae including hearing loss, intellectual disability, and cerebral palsy. Viral (aseptic) meningitis, while more common, has a much better prognosis.

SECTION 1: CLASSIFICATION / TYPES

By Causative Agent:

TypeCommon OrganismsFeatures
Bacterial (Purulent)Most dangerousAcute onset, high mortality
Viral (Aseptic)Enteroviruses (most common), HSV, MumpsUsually self-limiting
Tuberculous (TB)Mycobacterium tuberculosisSubacute; very serious
FungalCryptococcus neoformansMainly immunocompromised
ParasiticRareVery rare in children

By Age Group - Common Organisms:

Age GroupMost Common Organisms
Neonates (0-28 days)Group B Streptococcus (GBS), E. coli, Listeria monocytogenes
Infants 1-3 monthsGBS, E. coli, Listeria, S. pneumoniae, N. meningitidis
3 months - 6 yearsStreptococcus pneumoniae (most common), Neisseria meningitidis
Older children/adolescentsNeisseria meningitidis (meningococcus)
ImmunocompromisedCryptococcus, Listeria, gram-negatives

SECTION 2: AETIOLOGY AND RISK FACTORS

Risk Factors for Meningitis:

  1. Age < 5 years and especially < 1 year (immature blood-brain barrier, immature immunity)
  2. Unimmunized children (Hib vaccine, PCV, meningococcal vaccine)
  3. Overcrowded living conditions
  4. Close contacts of meningococcal cases
  5. Preceding URTI or otitis media (sinusitis, mastoiditis)
  6. Head trauma, neurosurgery (direct inoculation)
  7. CSF shunt, cochlear implant
  8. Immunocompromised state (HIV, malnutrition, sickle cell disease, asplenia)
  9. Complement deficiency (increased risk of meningococcal disease)

Routes of Infection:

  • Haematogenous (most common): Bacteria colonize nasopharynx → enter bloodstream → seed meninges
  • Direct spread: Otitis media, sinusitis, mastoiditis, orbital cellulitis
  • Direct inoculation: Head trauma, neurosurgery, lumbar puncture (rare)

SECTION 3: PATHOPHYSIOLOGY

Step-by-Step Mechanism:

  1. Pathogen enters subarachnoid space (via blood or direct spread)
  2. Bacteria multiply in CSF (poor immune defenses - low complement and immunoglobulins in CSF)
  3. Bacterial cell wall components (LPS, teichoic acid) trigger inflammatory cascade
  4. Release of cytokines: TNF-α, IL-1, IL-6, IL-8
  5. Increased blood-brain barrier (BBB) permeability → vasogenic oedema
  6. Neutrophil infiltration into CSF → CSF becomes turbid/purulent
  7. Cerebral oedema (vasogenic + cytotoxic + interstitial) → raised ICP
  8. → Impaired cerebral autoregulation → cerebral ischaemia
  9. → Vasculitis of cerebral blood vessels → thrombosis → infarction, seizures
  10. → Hydrocephalus (exudate obstructs CSF flow) → further raised ICP
  11. Herniation (if untreated) → death
(Harrison's Principles of Internal Medicine 22E, Fig. 143-1)

SECTION 4: CLINICAL FEATURES

A. Classical Triad (All Ages)

  1. Fever (high grade, sudden onset)
  2. Headache (severe, generalised, "worst headache of life")
  3. Neck stiffness (nuchal rigidity)

B. Meningeal Signs (Signs of Meningeal Irritation)

1. Nuchal Rigidity (Stiff Neck)
  • Resistance to passive forward flexion of the neck
  • Patient cannot touch chin to chest
  • Pathognomonic sign of meningeal irritation
  • May be absent in very young infants (< 3 months) and immunocompromised
2. Kernig's Sign
  • Patient lies supine; hip flexed to 90°
  • Attempt to passively extend the knee beyond 135° causes pain and resistance (hamstring spasm)
  • Positive = meningeal irritation
3. Brudzinski's Sign
  • Patient lies supine
  • Passive flexion of the neck causes spontaneous flexion of both hips and knees
  • Positive = meningeal irritation
  • Also: Brudzinski's contralateral leg sign - flexion of one hip and knee causes same movement in opposite leg
(Harrison's Principles of Internal Medicine 22E, p. 1163)

C. Age-Specific Features

Neonates and Young Infants (< 3 months):
  • Classical signs often absent (no neck stiffness, no Kernig's/Brudzinski's)
  • Non-specific signs:
    • Bulging fontanelle (raised ICP)
    • High-pitched cry (cerebral irritation)
    • Poor feeding/refusal to feed
    • Lethargy, irritability
    • Temperature instability (fever OR hypothermia)
    • Apnoea
    • Seizures
    • Jitteriness
Infants 3-18 months:
  • Fever + irritability + bulging fontanelle
  • Neck stiffness begins to appear
  • Seizures common
Children > 18 months:
  • Classical triad: Fever + Headache + Neck stiffness
  • Photophobia (sensitivity to light)
  • Phonophobia (sensitivity to sound)
  • Vomiting (projectile, from raised ICP)
  • Altered level of consciousness (drowsiness → stupor → coma)
  • Seizures (15-40% of cases)

D. Additional Features by Organism

Meningococcal Meningitis (N. meningitidis) - EMERGENCY:
  • Petechial rash - begins as maculopapular rash → rapidly becomes petechial/purpuric (non-blanching)
  • Found on trunk, lower extremities, mucous membranes, conjunctiva
  • Indicates meningococcaemia (septicaemia) - most dangerous form
  • Waterhouse-Friderichsen syndrome: Bilateral adrenal haemorrhage; DIC; septic shock; extremely high mortality
  • Glass test: Press glass on petechiae → they do NOT blanch (unlike viral rash)
Pneumococcal Meningitis:
  • Severe; may complicate otitis media, sinusitis, pneumonia
  • Higher risk of complications (hearing loss, cerebral abscess)
Tuberculous Meningitis:
  • Subacute onset over days to weeks
  • Low-grade fever, headache, vomiting, behavioural changes
  • Cranial nerve palsies (III, IV, VI, VII)
  • Choroidal tubercles on fundoscopy

E. Signs of Raised ICP

  • Deteriorating consciousness (Glasgow Coma Scale falling)
  • Papilloedema (on fundoscopy)
  • Dilated, poorly reactive pupils
  • Sixth nerve palsy (lateral rectus weakness → squint)
  • Decerebrate/decorticate posturing
  • Cushing's Triad: Bradycardia + hypertension + irregular respirations (late, pre-terminal sign)
  • Herniation: Uncal herniation → ipsilateral fixed dilated pupil; central herniation → brainstem compression → death

SECTION 5: DIAGNOSIS / INVESTIGATIONS

A. Lumbar Puncture (LP) - Gold Standard Diagnosis

When to do LP:
  • Do LP immediately if no contraindications
  • Do NOT delay antibiotics for LP if contraindications present - start antibiotics first, then LP when safe
Contraindications to LP (do CT head first):
  1. Papilloedema (raised ICP)
  2. Focal neurological signs (suggests focal lesion)
  3. GCS ≤ 8 or rapidly deteriorating consciousness
  4. Coagulopathy / thrombocytopenia
  5. Skin infection at LP site
  6. Haemodynamic instability

B. CSF Analysis - Most Important Table

ParameterNormalBacterial MeningitisViral MeningitisTB Meningitis
AppearanceClear, colourlessTurbid/Cloudy/PurulentClearTurbid/slightly cloudy
Opening pressure70-180 mm H₂OElevated (> 200 mm H₂O)Normal/mildly elevatedElevated
WBC (cells/mm³)< 10> 100; often 1000-10,00010-10010-400
Cell typeMononuclearPMN (neutrophils) 80-90%Mononuclear (lymphocytes)Lymphocytes
Protein (mg/dL)< 60> 100 (often 200-500)60-100100-500
Glucose (mg/dL)40-80< 40 (LOW)40-80 (Normal)Low (< 45)
CSF:Blood glucose> 0.6< 0.4> 0.6< 0.5
Gram stainNegativePositive in 60-90%NegativeNegative (AFB smear)
CultureSterilePositiveNegativePositive (LJ medium; 6-8 weeks)
(Harriet Lane Handbook 23rd ed., Table 17.8)

C. Blood Investigations

  • Blood culture (2 sets before antibiotics) - positive in 50-80% bacterial meningitis
  • CBC: Elevated WBC, neutrophilia (bacterial); lymphocytosis (viral)
  • CRP, Procalcitonin: Markedly elevated in bacterial; less in viral
  • Serum glucose: For CSF:blood glucose ratio
  • Electrolytes: Hyponatremia (SIADH common complication)
  • Serum sodium: Low (water retention → cerebral oedema worsens)
  • Coagulation profile: DIC screening (PT, APTT, platelet, fibrinogen)
  • Blood urea, creatinine

D. Other Investigations

  • CT Head: Before LP if signs of raised ICP; rule out space-occupying lesion
  • MRI Brain: For complications (infarction, abscess, subdural empyema)
  • Chest X-ray: For TB (hilar lymphadenopathy, miliary TB)
  • Mantoux test / IGRA: For TB meningitis
  • PCR on CSF: For viral (HSV, enteroviruses), meningococcus, pneumococcus - highly sensitive
  • Throat swab, nasopharyngeal culture: For meningococcus

SECTION 6: MANAGEMENT

A. EMERGENCY MANAGEMENT - Bacterial Meningitis (TIME-CRITICAL)

"TIME IS BRAIN" - The faster the treatment, the better the outcome
First 60 minutes (Emergency Protocol):
Step 1: ABC - Stabilize
  • Airway: Secure airway; intubate if GCS ≤ 8 or airway compromised
  • Breathing: Supplemental oxygen; mechanical ventilation if needed
  • Circulation: IV access × 2; fluid resuscitation for shock; blood cultures NOW
Step 2: Blood cultures + IV access
  • 2 blood cultures before antibiotics (does NOT delay by more than 5-10 minutes)
Step 3: IV Antibiotics within 60 minutes of presentation

B. ANTIBIOTIC TREATMENT

Empirical (Before Culture Results):
AgeFirst-line empiricalAlternative
Neonates 0-4 weeksAmpicillin + Gentamicin (or cefotaxime)Covers GBS, E. coli, Listeria
Infants 1-3 monthsAmpicillin + CefotaximeCovers neonatal + childhood pathogens
Children > 3 monthsCeftriaxone (100 mg/kg/day ÷ 1-2 doses) OR CefotaximeCovers Pneumococcus + Meningococcus
Penicillin-resistant PneumococcusCeftriaxone + Vancomycin
TB meningitisHRZE (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol) for 2 months; then HR for 10 months
Specific therapy based on organism:
  • N. meningitidis: Penicillin G (if sensitive) OR Ceftriaxone; 7 days
  • S. pneumoniae: Penicillin G (if sensitive); Ceftriaxone + Vancomycin (if resistant); 10-14 days
  • Hib: Ceftriaxone; 7-14 days
  • GBS/Listeria (neonates): Ampicillin + Gentamicin; 14-21 days
(Harrison's Principles of Internal Medicine 22E, Table 143-3)

C. DEXAMETHASONE (Adjunctive Corticosteroid)

  • Dose: 0.15 mg/kg IV every 6 hours for 4 days
  • Timing: Give 20 minutes BEFORE (or at least concurrent with) first antibiotic dose
  • Mechanism: Reduces inflammatory cytokine cascade → decreases cerebral oedema, vasculitis, BBB damage
  • Proven benefit: Reduces hearing loss and neurological sequelae in Hib meningitis and pneumococcal meningitis
  • Not beneficial if given after antibiotics started
(Harrison's Principles of Internal Medicine 22E; Bradley and Daroff's Neurology, p. 418)

D. MANAGEMENT OF RAISED ICP

  1. Head elevation: 30° head-up position (reduces venous congestion; improves cerebral venous drainage)
  2. Avoid neck flexion: Maintain head in neutral position
  3. IV Mannitol: 0.25-1 g/kg as osmotic diuretic; reduces cerebral oedema; given over 30-60 minutes
  4. Hypertonic saline (3%): Alternative to mannitol; 3-5 ml/kg bolus; raises serum osmolarity
  5. Restrict fluids: Once SIADH confirmed; restrict to 2/3 maintenance
  6. Intubation + hyperventilation: To lower PaCO₂ to 30-35 mmHg → vasoconstriction → reduces ICP (temporary measure)
  7. Avoid hypotension: Maintains cerebral perfusion pressure

E. MANAGEMENT OF SEIZURES

  • IV Phenobarbitone (first-line in neonates): 20 mg/kg IV loading dose
  • IV Diazepam or Lorazepam (acute seizures): 0.1-0.2 mg/kg IV
  • IV Phenytoin (second-line): 15-20 mg/kg IV loading
  • Continuous seizure monitoring; EEG if subclinical seizures suspected

F. MANAGEMENT OF SIADH (Syndrome of Inappropriate ADH)

  • Complicates 30-50% of bacterial meningitis
  • Hyponatraemia (serum Na < 135 mEq/L)
  • Risk: Worsens cerebral oedema (water moves into brain cells)
  • Management:
    • Fluid restriction: 2/3 maintenance (60-70 ml/kg/day)
    • Hypertonic saline (3%) if severe hyponatraemia (Na < 120 or symptomatic)
    • Monitor serum sodium every 6-12 hours; correct slowly (not faster than 0.5 mEq/L/hr to avoid central pontine myelinolysis)

G. CHEMOPROPHYLAXIS FOR CONTACTS

Meningococcal disease:
  • All close contacts (household members, those with contact with oral secretions)
  • Rifampicin: 10 mg/kg (max 600 mg) every 12 hours for 2 days (oral)
  • Alternative single-dose: Ceftriaxone 125 mg IM (children < 15 years) OR Ciprofloxacin 500 mg oral (adults)
  • Azithromycin 500 mg single dose in pregnancy
Hib meningitis:
  • Rifampicin 20 mg/kg (max 600 mg) once daily for 4 days
  • For household contacts with unimmunized children < 4 years

SECTION 7: COMPLICATIONS

A. Acute Complications

ComplicationDescription
Cerebral herniationFatal; from raised ICP unchecked
Septic shockEspecially meningococcaemia; DIC
Disseminated Intravascular Coagulation (DIC)From endotoxaemia; petechiae, bleeding, organ failure
Waterhouse-Friderichsen syndromeBilateral adrenal haemorrhage; extreme cardiovascular collapse
Seizures15-40% cases; can lead to status epilepticus
SIADHHyponatraemia; worsens cerebral oedema
Subdural effusionFluid collection between dura and arachnoid; presents with persistent fever, bulging fontanelle, focal signs
Cerebral abscessExtension of infection
Cranial nerve palsyIII, VI, VII most common; from inflammation or raised ICP

B. Long-term Sequelae (30% of survivors)

ComplicationFrequency
Sensorineural hearing lossMost common sequela; 15-25% of bacterial meningitis; worse in Pneumococcal and Hib
Intellectual disabilityCognitive impairment, learning difficulties
Cerebral palsyMotor deficits from vascular infarction
HydrocephalusFrom CSF flow obstruction by inflammatory exudate
EpilepsyPost-meningitic epilepsy
Behaviour problemsAttention deficit, hyperactivity
Visual impairmentCortical blindness, optic nerve damage
Limb loss (meningococcaemia)Skin/tissue necrosis from DIC and infarction

SECTION 8: NURSING MANAGEMENT

Nursing Assessment

  1. Vital signs: Temperature, pulse, BP, respiratory rate every 1-2 hours (watch for Cushing's triad)
  2. Neurological monitoring: GCS every 1-2 hours; pupil size, equality, and reactivity
  3. Fontanelle assessment (infants): Bulging = raised ICP; sunken = dehydration
  4. Seizure observation: Document type, duration, frequency; post-ictal state
  5. Neck stiffness and meningeal signs: Reassess regularly
  6. Rash monitoring: Check skin for petechiae or purpura; mark edges with pen and recheck hourly
  7. Intake-output chart: Monitor for oliguria (septic shock) or excess output
  8. Pain assessment: Headache severity using age-appropriate scale
  9. Hearing assessment: Audiometry at discharge (especially pneumococcal/Hib)

Nursing Diagnoses and Interventions

Nursing DiagnosisInterventions
Risk for injury (brain herniation) r/t raised ICPHOB 30°; neutral head position; avoid neck compression; monitor neuro signs hourly; osmotherapy as prescribed; report deteriorating GCS immediately
Hyperthermia r/t infection and inflammationMonitor temperature 4-hourly; tepid sponging; antipyretics (paracetamol 15 mg/kg 4-6 hourly); remove excess clothing
Acute pain (headache) r/t meningeal irritationDarkened quiet room (reduce photophobia/phonophobia); analgesics as prescribed; comfortable positioning; gentle, minimal handling
Risk for seizures r/t cerebral irritationPadded side rails; airway management equipment at bedside; O₂ and suction ready; anticonvulsants as prescribed; document and time all seizures
Fluid volume imbalance r/t SIADH or dehydrationStrict intake-output; daily weight; fluid restriction if SIADH (2/3 maintenance); serum electrolytes monitoring; IV fluids as prescribed
Risk for infection spread r/t transmissible organismDroplet precautions for meningococcal meningitis (for first 24 hours of antibiotics); single room; mask when within 1 metre; hand hygiene
Imbalanced nutrition r/t reduced consciousness, vomitingNasogastric tube feeding; aspiration precautions; advance diet as tolerated
Anxiety (family) r/t sudden serious illnessUpdate parents frequently; involve in care; explain procedures; emotional support; chaplain/counselor if needed

Isolation Precautions

TypeDurationPrecaution
Meningococcal meningitisFirst 24 hours of antibioticsDroplet precautions (surgical mask; single room; gloves)
Bacterial meningitis (other)Standard precautionsNo special isolation required
TB meningitisUntil non-infectiousAirborne precautions (N95 mask; negative pressure room)

Positioning and Environment

  1. Head of bed elevated 30° (reduces ICP by improving venous drainage)
  2. Head in neutral alignment (avoid neck flexion or rotation - impairs jugular venous return)
  3. Quiet, dimly lit room (reduces sensory stimulation; helps photophobia and headache)
  4. Avoid clustering of painful procedures
  5. Minimal disturbance during ICP monitoring
  6. No tight clothing around neck

Medication Administration

  1. Administer antibiotics on time (delays worsen outcome; "time is brain")
  2. Give dexamethasone 20 minutes before antibiotics (if prescribed)
  3. Ensure IV access remains patent (antibiotics must be given IV for meningitis)
  4. Monitor for antibiotic reactions
  5. Mannitol: Give rapidly over 30-60 min; monitor urine output
  6. Phenobarbitone/Phenytoin: IV administration; monitor for respiratory depression, hypotension

Family/Parent Education

  1. Explain meningitis and its treatment plan
  2. Notify family about chemoprophylaxis (rifampicin for household contacts)
  3. Teach warning signs of relapse
  4. Arrange audiological testing at discharge and follow-up
  5. Developmental follow-up after discharge
  6. Immunization: Ensure PCV, Hib, Meningococcal vaccines are up to date
  7. Report contacts to public health authority (meningococcal disease is notifiable)

SECTION 9: COMPARISON - BACTERIAL vs VIRAL vs TB MENINGITIS

FeatureBacterialViral (Aseptic)TB
OnsetAcute (hours)Acute (hours-days)Subacute (days-weeks)
FeverHigh gradeModerateLow grade
SeveritySevere, rapidly worseningMild-moderateProgressive
CSF appearanceTurbid/purulentClearSlightly cloudy
CSF cellsPMN > 100-10,000Lymphocytes 10-100Lymphocytes 10-400
CSF glucoseVery lowNormalLow
CSF proteinVery high (> 100)Mildly elevatedHigh (100-500)
Gram stainPositiveNegativeNegative (AFB ±)
TreatmentIV antibiotics + dexamethasoneSupportive (antiviral for HSV)HRZE × 2 months + HR × 10 months
PrognosisSerious; 5-10% mortalityExcellent; self-limitingSerious; risk of disability

SECTION 10: PREVENTION

  1. Immunization:
    • Hib vaccine (in Pentavalent): Dramatically reduced Hib meningitis
    • PCV (Pneumococcal Conjugate Vaccine): Reduces Pneumococcal meningitis
    • Meningococcal vaccine: For high-risk groups, travellers to endemic areas
    • BCG vaccine: Protects against TB meningitis in children
    • MMR vaccine: Prevents mumps meningitis
  2. Chemoprophylaxis: Rifampicin for contacts of meningococcal/Hib cases
  3. Environmental measures:
    • Reduce overcrowding
    • Adequate ventilation
    • Good nutrition and general immunity
  4. Notification: Bacterial meningitis (especially meningococcal) is a notifiable disease in India - must be reported to public health authorities within 24 hours

CONCLUSION

Bacterial meningitis is one of the most feared neurological emergencies in paediatric practice. Every hour of delay in treatment increases mortality and sequelae. The nurse's role begins with recognising the classic triad of fever, headache, and neck stiffness; identifying the alarm sign of petechial rash (meningococcaemia); and triggering immediate emergency response. Skilled nursing management - including rigorous neurological monitoring, timely antibiotic administration, ICP management, seizure control, and family support - forms the bedrock of care that determines whether a child survives without disability. Early audiological assessment and long-term developmental surveillance complete the nurse's responsibilities in this condition.

Exam tip for 50 marks: Must include: Introduction + Classification by organism and age + Pathophysiology chain + Classical triad + Age-specific features (infant vs older child) + Meningeal signs (Kernig's + Brudzinski's + nuchal rigidity - draw a diagram if possible) + Petechial rash (meningococcal) + CSF analysis comparison table (biggest marks here) + Emergency management with timing + Antibiotic table (age-based empirical) + Dexamethasone (before antibiotics) + Complications (hearing loss) + Full nursing care plan + Isolation + Prevention. The CSF table and nursing care plan together can account for 25-30 marks.

Say "Next" for Topic 9: Thalassemia.

Next

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Excellent content from the textbooks. Delivering the complete 50-mark answer now:

THALASSEMIA

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Thalassemia is a group of inherited autosomal recessive haemoglobin disorders characterised by defective synthesis of one or more of the globin chains of haemoglobin, resulting in chronic haemolytic anaemia of varying severity. The name comes from the Greek word "thalassa" (sea) because it was first described in populations around the Mediterranean Sea.
Thalassemia is one of the most common genetic disorders globally. India has an estimated carrier (trait) prevalence of 3-4%, with approximately 10,000-12,000 babies with thalassemia major born every year. It is most prevalent in communities from Gujarat, Punjab, Sindh, Bengal, and parts of South India.
Understanding thalassemia is critical for nurses because it requires lifelong, intensive management including regular blood transfusions, iron chelation, and comprehensive family support.

SECTION 1: NORMAL HAEMOGLOBIN STRUCTURE

To understand thalassemia, one must understand normal haemoglobin:
Haemoglobin TypeGlobin ChainsWhen Present
HbAα₂β₂Adult (>95% of adult Hb)
HbA₂α₂δ₂Adult (2-3.5%)
HbF (Fetal Hb)α₂γ₂Fetus + neonate; replaced by HbA after birth
Hb Bart'sγ₄Found in alpha thalassemia (abnormal)
HbHβ₄Found in HbH disease (abnormal)
  • The α-globin genes are located on chromosome 16 (4 copies: 2 per chromosome)
  • The β-globin gene is located on chromosome 11 (2 copies: 1 per chromosome)

SECTION 2: CLASSIFICATION OF THALASSEMIA

A. BETA (β) THALASSEMIA

Caused by: Mutations in β-globin gene on chromosome 11 → reduced or absent β-chain synthesis
Types:
TypeGeneticsβ-chain ProductionClinical Severity
β-Thalassemia Minor (Trait)Heterozygous (one mutant gene)Reduced (β+)Asymptomatic carrier; mild microcytic anaemia
β-Thalassemia IntermediaCompound heterozygous or mild homozygousModerately reducedModerate anaemia (Hb 7-10 g/dL); variable transfusions
β-Thalassemia Major (Cooley's Anaemia)Homozygous (both genes mutant)Severely reduced or absent (β⁰)Severe; transfusion-dependent
Mutation types:
  • β⁺: Reduced (but not absent) β-chain production
  • β⁰: Complete absence of β-chain production

B. ALPHA (α) THALASSEMIA

Caused by: Deletion (mainly) of α-globin genes on chromosome 16
4 genes → 4 possible levels of deletion:
Genes DeletedNameClinical Features
1 gene (-α/αα)Silent carrierNo symptoms; normal CBC
2 genes (α-/α- or --/αα)α-Thalassemia TraitMild microcytosis; borderline low Hb; no symptoms
3 genes (--/-α)HbH DiseaseModerate haemolytic anaemia; splenomegaly; intermittent transfusions
4 genes (--/--)Hb Bart's Hydrops FetalisIncompatible with life; severe intrauterine hydrops; stillbirth or neonatal death
(Thompson & Thompson Genetics and Genomics in Medicine, 9th ed.)

C. OTHER TYPES

  • HbE-Thalassemia: HbE gene + β-thalassemia gene; highly prevalent in Northeast India, Bangladesh; half are as severe as thalassemia major
  • HbS-Thalassemia (Sickle-Thal): HbS gene + β-thalassemia gene; variable severity

SECTION 3: GENETICS AND INHERITANCE

  • Autosomal recessive inheritance
  • Carrier (Trait): Heterozygous - one normal + one mutant gene
  • Major: Homozygous - both genes mutant

Punnett Square for β-Thalassemia:

When both parents are carriers (Trait × Trait):
β (normal)β^t (mutant)
β (normal)Normal (25%)Carrier/Trait (25%)
β^t (mutant)Carrier/Trait (25%)Thalassemia Major (25%)
  • 25% chance: Normal child
  • 50% chance: Carrier (thalassemia trait)
  • 25% chance: Thalassemia major

SECTION 4: PATHOPHYSIOLOGY OF β-THALASSEMIA MAJOR

Step-by-Step Mechanism:

1. Deficient β-chain synthesis
  • Mutations in β-globin gene → reduced or absent β-chain production
  • Imbalance: excess free α-chains accumulate
2. Precipitation of free α-chains
  • Free α-chains are unstable and toxic
  • They precipitate inside RBC precursors in bone marrow
  • Ineffective erythropoiesis (destruction of RBCs before they reach blood)
  • Premature haemolysis of circulating RBCs (shortened RBC lifespan)
3. Severe Anaemia
  • Profound haemolytic anaemia
  • HbF (α₂γ₂) is produced as compensation but insufficient
4. Compensatory Bone Marrow Expansion
  • Chronic hypoxia from anaemia → erythropoietin (EPO) ↑ → bone marrow hyperplasia
  • Marrow expands into cortical bone and extramedullary sites
  • Skeletal deformities (frontal bossing, prominent malar eminences, depressed nasal bridge → "thalassaemic facies")
  • → Hepatosplenomegaly (extramedullary haematopoiesis)
  • → Osteoporosis, pathological fractures
  • → Growth retardation
5. Hepatosplenomegaly
  • Spleen becomes a site of extramedullary haematopoiesis AND traps and destroys damaged RBCs
  • Progressive massive splenomegaly → hypersplenism → worsens anaemia, thrombocytopenia, leucopenia
6. Iron Overload (Haemosiderosis)
  • Each unit of packed RBCs contains 200-250 mg of iron
  • Regular transfusions + increased GI iron absorption → transfusion haemosiderosis
  • Excess iron deposits in organs:
    • Heart: Cardiomyopathy → heart failure → most common cause of death
    • Liver: Cirrhosis, hepatic failure
    • Endocrine glands: Diabetes mellitus, hypogonadism (delayed puberty), hypothyroidism, hypoparathyroidism, growth hormone deficiency
    • Skin: Bronze skin discolouration
(Tintinalli's Emergency Medicine, p. 1518)

SECTION 5: CLINICAL FEATURES

A. β-Thalassemia Minor (Trait)

  • Asymptomatic - discovered incidentally
  • Mild anaemia (Hb 10-13 g/dL)
  • Microcytic, hypochromic RBCs on peripheral smear
  • HbA₂ elevated (4-7%) on Hb electrophoresis - hallmark diagnostic finding
  • Normal iron studies (unlike iron deficiency anaemia)
  • Mild splenomegaly occasionally
  • No regular treatment required - important for genetic counseling

B. β-Thalassemia Major (Cooley's Anaemia) - Most Important

Onset:
  • Normal at birth (HbF predominant)
  • Symptoms emerge at 6 months - 2 years when HbA is expected to replace HbF but cannot (no β-chains)
Symptom progression:
SystemClinical Features
GeneralPallor (severe), fatigue, weakness, failure to thrive, growth retardation
Face"Thalassaemic facies" - prominent frontal bossing, prominent cheekbones (malar eminences), depressed nasal bridge, protruding upper jaw (maxillary hypertrophy), wide-set eyes; due to marrow expansion
Skull X-ray"Hair-on-end" / "Sun-ray" pattern - radiating bony trabeculae due to marrow expansion
LiverHepatomegaly (extramedullary haematopoiesis + haemosiderin deposition)
SpleenMassive splenomegaly (one of the largest spleens in clinical medicine); hypersplenism
AbdomenProtuberant due to hepatosplenomegaly
SkinJaundice (mild), progressive bronze/dark pigmentation (haemosiderosis)
HeartLater: cardiomegaly, heart failure, arrhythmias (from iron overload)
EndocrineDelayed puberty, diabetes mellitus, short stature, hypothyroidism (iron deposition)
BonesOsteoporosis, pathological fractures; premature fusion of epiphyses → short stature
UrineDark (haemoglobinuria), jaundice causes dark urine
Age of First presentation: Severe anaemia + failure to thrive at 6-18 months

SECTION 6: INVESTIGATIONS

InvestigationFindings in β-Thalassemia Major
CBC (Complete Blood Count)Severe anaemia: Hb 2-7 g/dL; microcytic (low MCV), hypochromic (low MCH); elevated reticulocyte count; elevated WBC, reduced platelets (hypersplenism)
Peripheral Blood SmearMicrocytes, hypochromic cells, target cells, teardrop cells, fragmented cells (schistocytes), nucleated RBCs (normoblasts), basophilic stippling, Howell-Jolly bodies
Haemoglobin ElectrophoresisHbF markedly elevated (> 90% in untransfused), HbA absent or reduced; HbA₂ elevated in trait; confirmatory test
Serum BilirubinElevated indirect bilirubin (haemolysis)
Serum Iron, FerritinIron: High; Ferritin: Very high (iron overload indicator - normal < 300 ng/mL; target in thalassemia < 1000 ng/mL)
TIBCLow (unlike iron deficiency where TIBC is high)
Liver Function TestsElevated transaminases (haemosiderosis)
Blood glucoseElevated (iron-induced diabetes)
Thyroid functionLow T3, T4 (iron deposition)
EchocardiogramCardiomegaly, reduced ejection fraction (iron overload)
X-ray skull"Hair-on-end" / "Crew cut" appearance - perpendicular bony trabeculae
X-ray long bonesWidened medullary cavity, thin cortex; osteoporosis
Abdominal USGHepatosplenomegaly; gallstones (chronic haemolysis → pigment stones)
MRI Liver/Heart (T2)*Gold standard for quantifying iron deposition in liver and heart

SECTION 7: MANAGEMENT

A. BLOOD TRANSFUSION - Cornerstone of Management

Goals:
  • Maintain pre-transfusion Hb > 9-10 g/dL
  • Suppress ineffective erythropoiesis (by maintaining adequate Hb)
  • Prevent skeletal deformities and extramedullary haematopoiesis
Frequency: Every 2-4 weeks (lifelong)
Type: Packed Red Blood Cells (PRBC) - leukodepleted (reduces febrile transfusion reactions and alloimmunization)
Dose: 10-15 ml/kg per transfusion over 3-4 hours
Target: Post-transfusion Hb 13-14 g/dL; pre-transfusion Hb > 9-10 g/dL
Complications of repeated transfusions:
  • Alloimmunization: Development of antibodies against donor RBC antigens → future crossmatch difficulties; give extended cross-match (Rh, Kell, Duffy, Kidd phenotype matching)
  • Iron overload / haemosiderosis (most serious long-term complication)
  • Transfusion reactions (febrile, allergic, haemolytic)
  • Infections: Hepatitis B, C, HIV (from blood-borne transmission; reduce with screening)
  • Volume overload (especially cardiac patients)

B. IRON CHELATION THERAPY - Second Most Important

Why: Each unit of blood adds 200-250 mg iron; body has no way to excrete iron When to start: When serum ferritin > 1000 ng/mL or after 10-15 transfusions (approximately age 2-3 years) Goal: Maintain serum ferritin < 1000 ng/mL; liver iron < 7 mg/g dry weight
Three chelating agents:
DrugRouteDoseKey Points
Desferrioxamine (Deferoxamine/DFO)SC infusion (8-12 hours overnight); IV20-60 mg/kg/dayGold standard; subcutaneous pump; painful, inconvenient; ophthalmologic and audiological monitoring required
Deferiprone (DFP / L1)Oral75-100 mg/kg/day ÷ 3 dosesOral; good cardiac iron chelation; agranulocytosis (1-2%) - weekly CBC mandatory; arthropathy
Deferasirox (DFX/Exjade)Oral (once daily)20-40 mg/kg/dayMost convenient; once daily; renal toxicity; GI side effects; Fanconi syndrome
Combination therapy: DFO + Deferiprone often used in patients with high cardiac iron loading

C. SPLENECTOMY

Indications:
  • Massive splenomegaly with hypersplenism
  • Transfusion requirements increase > 200-220 ml/kg/year (despite adequate iron chelation)
  • Symptomatic massive spleen (dragging, pain)
  • Progressive thrombocytopenia/leucopenia
Age: Preferably after age 5-6 years (before age 2 = very high risk of overwhelming post-splenectomy sepsis)
Pre-splenectomy vaccines (mandatory):
  • Pneumococcal vaccine (PCV + PPSV23)
  • Meningococcal vaccine
  • Hib vaccine
  • Influenza vaccine (annually)
Post-splenectomy:
  • Lifelong prophylactic penicillin (or amoxicillin) - daily oral dose to prevent overwhelming post-splenectomy infection (OPSI)
  • Advise to seek medical care urgently for any fever (risk of OPSI)
  • Avoid countries with endemic malaria

D. BONE MARROW TRANSPLANTATION (BMT) / HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

  • Only curative treatment for thalassemia major
  • Uses HLA-matched sibling donor (best results) or matched unrelated donor
  • Best outcomes in young children before significant iron overload and organ damage (Pesaro Class I)
  • Pesaro Classification:
    • Class I: Adequate chelation, no hepatomegaly, no portal fibrosis - best outcome (90% EFS)
    • Class II: One/two risk factors
    • Class III: All three risk factors present - worst outcome
  • Gene therapy: Emerging curative approach; Betibeglogene autotemncel (Zynteglo) approved by FDA; ex vivo gene correction of patient's own stem cells
  • Limitations: High cost; donor availability; risk of GVHD (graft vs host disease); not widely available in India

E. FOLIC ACID SUPPLEMENTATION

  • 5 mg/day oral folic acid
  • Haemolytic anaemia increases folate demand (increased cell turnover)
  • Prevents megaloblastic change superimposed on haemolytic anaemia

F. MANAGEMENT OF COMPLICATIONS

ComplicationManagement
Diabetes mellitusInsulin therapy; diabetic diet
HypothyroidismLevothyroxine replacement
Hypogonadism/delayed pubertySex hormone replacement (testosterone/estrogen)
Cardiac iron overloadIntensive chelation (IV DFO continuous); cardiac failure management
OsteoporosisCalcium + Vitamin D; bisphosphonates
Hepatitis C infectionAntiviral therapy (direct-acting antivirals)
GallstonesCholecystectomy if symptomatic

SECTION 8: NURSING MANAGEMENT

Nursing Assessment

  1. Assess anaemia: Pallor of conjunctiva, nail beds, palms; fatigue; tachycardia; heart murmur
  2. Vital signs: HR, RR, BP, SpO₂
  3. Growth parameters: Weight, height (growth retardation common)
  4. Abdominal assessment: Hepatosplenomegaly (measure spleen span)
  5. Facial features: Thalassaemic facies, frontal bossing
  6. Skin: Jaundice, bronze discolouration
  7. Developmental assessment: School performance, psychosocial status
  8. Transfusion history: Last transfusion date, pre-transfusion Hb, any reactions
  9. Current ferritin level and chelation compliance
  10. Immunization status

Nursing Diagnoses

Nursing DiagnosisRelated ToGoal
Activity intoleranceChronic anaemiaChild participates in age-appropriate activities
Imbalanced nutrition: less than body requirementsIncreased metabolic needs, poor appetiteAdequate calorie/protein intake; normal growth trajectory
Risk for infectionFrequent transfusions, splenectomy, immunosuppressionNo infections; early detection
Risk for iron overload injuryRepeated transfusions; excess iron absorptionFerritin < 1000 ng/mL; chelation adherence
Impaired body imageThalassaemic facies, growth retardation, chronic illnessChild verbalizes acceptance; positive self-image
Non-compliance r/t chelationPainful/inconvenient chelation (DFO pump)Child and family demonstrate compliance with chelation
Anxiety/Grief (family)Chronic, lifelong, inherited diseaseFamily copes effectively; uses support resources
Deficient knowledgeDisease, management, genetic riskFamily demonstrates understanding

Nursing Interventions

1. Blood Transfusion Care:
  • Obtain pre-transfusion Hb (document for trend analysis)
  • Verify blood: patient ID, blood group, expiry, crossmatch report
  • Use leukodepleted, irradiated PRBC as prescribed
  • Filter blood through 170-micron filter
  • Administer at prescribed rate (10-15 ml/kg over 3-4 hours; slower if cardiac compromise)
  • Pre-medicate if history of febrile reactions: Paracetamol ± Diphenhydramine 30 min before
  • Monitor during transfusion: Temperature, pulse, BP, SpO₂, rash every 15 min
  • Stop transfusion immediately if reaction (haemolytic: flank pain, dark urine, fever, rigors; anaphylaxis)
  • Document: Type of reaction, time, management, outcome
2. Chelation Therapy Support:
  • Teach family how to set up DFO infusion pump (subcutaneous)
  • Rotate infusion sites to prevent skin induration
  • Encourage oral chelation compliance: Take with meals to reduce GI side effects (Deferasirox)
  • Monitor ferritin monthly; MRI T2* annually
  • Screen for chelation side effects:
    • DFO: Annual ophthalmology (retinal toxicity) and audiology (high-frequency hearing loss)
    • Deferiprone: Weekly CBC (agranulocytosis risk)
    • Deferasirox: Monthly serum creatinine, urine protein
3. Infection Prevention:
  • Strict hand hygiene; aseptic technique
  • Ensure pre-splenectomy vaccinations complete
  • Post-splenectomy: Daily prophylactic penicillin; educate about fever urgency
  • Monitor temperature; report fever > 38°C immediately (risk of OPSI)
  • Hepatitis B vaccination if not already immune; screen HBsAg, anti-HCV regularly
4. Nutritional Support:
  • High-calorie, high-protein diet
  • Avoid iron-rich foods and iron supplements (already iron overloaded)
  • Vitamin C supplementation enhances DFO chelation (give 100-200 mg with DFO only - not alone, as it increases iron absorption)
  • Calcium and Vitamin D supplements (for bone health)
  • Folic acid 5 mg/day
5. Activity and Rest:
  • Balance activity with rest (compensate for anaemia)
  • Encourage age-appropriate play and school attendance during stable periods
  • Avoid contact sports after splenectomy (risk of splenic rupture if any residual spleen tissue; also risk of injury)
  • Physiotherapy for bone and joint complications
6. Psychosocial Support:
  • Acknowledge the impact of living with a chronic, incurable disease
  • Address body image concerns (thalassaemic facies, short stature)
  • Encourage peer interaction and school involvement
  • Refer for psychological counseling if depression or anxiety present
  • Support family with grief counseling (parents carry guilt about genetic cause)
  • Connect with Thalassemia India and other support groups

SECTION 9: GENETIC COUNSELING AND PREVENTION

Screening

  • All couples planning pregnancy should be screened for thalassemia trait (CBC + HbA₂)
  • If BOTH parents are carriers → 25% risk of thalassemia major in each pregnancy
  • Antenatal screening of all pregnant women at first visit

Prenatal Diagnosis

If both parents are carriers:
  • Chorionic Villus Sampling (CVS): 10-12 weeks gestation; fetal DNA analysis by molecular testing
  • Amniocentesis: 15-18 weeks; fetal cells from amniotic fluid
  • Confirmation: DNA analysis for specific β-globin mutation

Carrier Detection

  • CBC: MCV < 76 fl; MCH < 27 pg; HbA₂ > 3.5%
  • Hb electrophoresis: HbA₂ 4-7% (confirms β-thalassemia trait)
  • DNA analysis: Gold standard for carrier detection and mutation identification

Prevention Strategies (India's National Programme)

  • Pre-marital thalassemia screening
  • Premarital counseling: Carrier × Carrier couples advised against marriage OR offered prenatal diagnosis
  • Newborn screening programs
  • National Thalassemia Control Programme: Government-run free blood transfusion and chelation centers

SECTION 10: THALASSEMIA vs IRON DEFICIENCY ANAEMIA (Comparison)

Featureβ-Thalassemia TraitIron Deficiency Anaemia
MCVLowLow
MCHLowLow
Serum IronNormal or HighLow
Serum FerritinNormal or HighLow
TIBCNormal/LowHigh
HbA₂> 3.5% (elevated)Normal
Response to iron therapyNo responseResponds
Family historyPositive (may be)Usually negative
Target cellsPresentRare
This distinction is critical: A child with thalassemia trait misdiagnosed as IDA and given iron will NOT improve and may worsen iron overload.

CONCLUSION

Thalassemia is a lifelong haemoglobinopathy that demands comprehensive, multidisciplinary care from birth. While β-thalassemia major currently requires regular blood transfusions and iron chelation for survival, advances in BMT and gene therapy offer real prospects of cure. Nurses are central to the management of thalassemia - administering safe blood transfusions, teaching and monitoring chelation therapy, preventing and detecting complications, providing psychosocial support to children and families, and educating communities about genetic screening and prevention. Ultimately, national thalassemia prevention programs - through screening, carrier detection, and genetic counseling - are the most powerful tools to reduce the burden of this disease in India.

Exam tip for 50 marks: Structure: Introduction + Normal Hb structure + Classification (alpha + beta types clearly tabulated) + Genetics (Punnett square!) + Pathophysiology step-by-step chain + Clinical features of β-thal major with thalassaemic facies + Investigations (Hb electrophoresis is diagnostic) + Management (Blood transfusion protocol + Iron chelation with 3 drugs = most marks) + Splenectomy indications + BMT (curative) + Full nursing care plan + Thalassemia vs IDA comparison + Prevention/genetic counseling. The pathophysiology chain and chelation therapy section carry the most examiner marks.

Say "Next" for the final Topic 10: Neonatal Jaundice / Hyperbilirubinemia.

Next

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Excellent detailed content from Tietz, Creasy & Resnik, and Robbins. Delivering the final complete 50-mark answer now:

NEONATAL JAUNDICE / HYPERBILIRUBINEMIA

Complete 50-Mark Answer | Child Health Nursing (INC Pattern)


INTRODUCTION

Neonatal jaundice (Neonatal Hyperbilirubinemia) is the yellow discolouration of the skin, sclera, and mucous membranes of a newborn caused by elevated levels of bilirubin in the blood. It is the most common condition requiring medical attention in the neonatal period, affecting approximately 60% of term and 80% of preterm neonates in the first week of life.
While most neonatal jaundice is benign and self-limiting (physiological jaundice), severe unconjugated hyperbilirubinemia can result in bilirubin neurotoxicity and kernicterus - a devastating, irreversible brain injury that is largely preventable with timely recognition and treatment.
Jaundice becomes visible when serum bilirubin exceeds 5-7 mg/dL (85-120 µmol/L) in term neonates.
(Tietz Textbook of Laboratory Medicine, 7th ed., p. 867)

SECTION 1: BILIRUBIN METABOLISM

Normal Bilirubin Metabolism:

Old/Damaged RBCs → broken down by Reticuloendothelial System (RES)
        ↓
Haemoglobin → Haem + Globin
        ↓
Haem → Biliverdin → UNCONJUGATED BILIRUBIN (UCB)
                   (Indirect bilirubin - fat-soluble, bound to albumin)
        ↓
Transported to LIVER (bound to albumin)
        ↓
Taken up by hepatocytes → conjugated with glucuronic acid
(enzyme: UDP-glucuronyl transferase = UGT1A1)
        ↓
CONJUGATED BILIRUBIN (Direct bilirubin - water-soluble)
        ↓
Excreted into bile → intestine → urobilinogen → stercobilin (in stool - makes stool brown)
Some urobilinogen reabsorbed → enterohepatic circulation

Why Neonates Are Prone to Jaundice:

  1. High RBC mass at birth - higher rate of haemoglobin breakdown
  2. Shorter RBC lifespan - fetal RBCs survive only 70-90 days (adult RBCs: 120 days)
  3. Immature liver conjugation - UGT1A1 enzyme is deficient at birth; matures over first 2 weeks
  4. Increased enterohepatic circulation - neonatal gut has high beta-glucuronidase activity which deconjugates bilirubin back to UCB for reabsorption
  5. Reduced intestinal motility and delayed passage of meconium - increases reabsorption of bilirubin from gut
  6. Low plasma albumin (especially preterm) - less binding capacity for UCB

SECTION 2: TYPES OF NEONATAL JAUNDICE

A. PHYSIOLOGICAL JAUNDICE (Normal, Benign)

Definition: Jaundice occurring due to normal neonatal physiology without underlying disease
Characteristics (all must be present to call physiological):
  • Appears after 24 hours of life (never in first 24 hours)
  • Peaks at 3-5 days (term); 5-7 days (preterm)
  • Resolves by 10-14 days in term; up to 21 days in preterm
  • Serum bilirubin: < 12 mg/dL (term); < 15 mg/dL (preterm) - at most centres
  • Conjugated (direct) bilirubin < 2 mg/dL (< 20% of total)
  • No haemolysis; no other disease
  • Baby feeds well; no other abnormality
Mechanism:
  • High bilirubin load + immature liver conjugation + increased enterohepatic circulation
  • Self-limiting as liver enzymes mature

B. PATHOLOGICAL JAUNDICE

Definition: Jaundice that exceeds the physiological limits or has an identifiable underlying cause
Features suggesting pathological jaundice (ANY ONE = pathological):
  1. Appears within first 24 hours of life
  2. Serum bilirubin rises by > 5 mg/dL/day (rapidly rising)
  3. Total serum bilirubin > 12 mg/dL (term) or > 15 mg/dL (preterm)
  4. Jaundice persists beyond 14 days (term) or 21 days (preterm)
  5. Conjugated (direct) bilirubin > 2 mg/dL or > 20% of total (cholestatic jaundice)
  6. Associated pallor, hepatosplenomegaly, signs of sepsis

SECTION 3: CAUSES OF NEONATAL JAUNDICE

A. CAUSES OF UNCONJUGATED HYPERBILIRUBINEMIA

1. Increased Bilirubin Production (Haemolytic)

CauseMechanism
Rh incompatibilityRh-negative mother, Rh-positive baby; IgG anti-D crosses placenta → haemolysis
ABO incompatibilityMother group O, baby group A or B; naturally occurring IgG anti-A or anti-B causes haemolysis
G6PD deficiencyMost common hereditary enzyme deficiency; oxidative stress → haemolysis
Hereditary spherocytosisAbnormal RBC membrane → RBC trapped and destroyed in spleen
Sepsis/InfectionHaemolysis + impaired liver function
PolycythaemiaHigh Hct > 65% → more RBC breakdown; seen in SGA babies, twin-twin transfusion
CephalhaematomaExtravascular blood → reabsorption → increased bilirubin load
Swallowed maternal bloodAfter birth; reabsorbed from gut

2. Decreased Conjugation (Liver)

CauseMechanism
PhysiologicalImmature UGT1A1 enzyme
Breast milk jaundiceSubstances in breast milk inhibit UGT1A1; late-onset (after day 4-7); benign
Breastfeeding jaundiceInadequate breastfeeding → dehydration + increased enterohepatic circulation (early, first 3-5 days)
HypothyroidismCongenital hypothyroidism delays bilirubin conjugation
Crigler-Najjar syndromeRare; complete (Type I) or partial (Type II) UGT1A1 deficiency
Gilbert syndromeMild reduced UGT1A1; benign; usually presents in adolescence

3. Increased Enterohepatic Circulation

  • Bowel obstruction, meconium ileus, pyloric stenosis
  • Delayed passage of meconium (e.g., Hirschsprung disease)
  • Inadequate feeds

B. CAUSES OF CONJUGATED HYPERBILIRUBINEMIA

(Direct bilirubin > 2 mg/dL = always PATHOLOGICAL)
CategoryExamples
Biliary obstructionBiliary atresia (most important), choledochal cyst
HepatocellularNeonatal hepatitis (idiopathic or TORCH infections), metabolic liver disease
MetabolicGalactosaemia, tyrosinaemia, alpha-1 antitrypsin deficiency
Total Parenteral Nutrition (TPN)Cholestasis from prolonged TPN
SepsisGram-negative sepsis; direct hepatocellular toxicity
Biliary Atresia: Absence/obliteration of extrahepatic bile ducts; presents with prolonged jaundice, pale/acholic stools, dark urine; requires urgent Kasai procedure (portoenterostomy) before 60 days of age.

SECTION 4: SPECIAL TYPES OF JAUNDICE

A. BREAST MILK JAUNDICE

  • Occurs in fully breastfed babies
  • Onset: After day 4-7; peaks at 2 weeks
  • Mechanism: Substances in breast milk (beta-glucuronidase, certain fatty acids, pregnanediol) → inhibit UGT1A1 → reduced conjugation
  • Bilirubin may reach 15-25 mg/dL but child is otherwise well
  • Do NOT stop breastfeeding (major error); continue; resolves spontaneously
  • If bilirubin very high → temporary interruption for 24-48 hours causes rapid drop (confirms diagnosis)
  • Benign; no kernicterus risk in otherwise term, healthy baby

B. BREASTFEEDING JAUNDICE (Early-onset)

  • Different from breast milk jaundice
  • Caused by insufficient breastfeeding in first 3-5 days
  • Inadequate milk intake → poor stool output → increased enterohepatic circulation → more bilirubin reabsorbed
  • Also: relative dehydration → concentrated bilirubin
  • Treatment: Improve breastfeeding technique; more frequent feeds; ensure adequate latch

C. HAEMOLYTIC DISEASE OF THE NEWBORN (HDN)

  • Rh incompatibility: Rh-negative mother sensitized by Rh-positive baby (in first pregnancy) → IgG anti-D antibodies cross placenta in subsequent pregnancies → coat fetal RBCs → haemolysis → jaundice within first 24 hours
  • ABO incompatibility: Mother O, baby A or B; naturally occurring IgG anti-A or anti-B → milder than Rh
  • Direct Coombs Test (DCT/DAT): Positive if RBCs coated with maternal IgG; confirms HDN
  • Prevention of Rh HDN: Anti-D immunoglobulin (Rho-GAM) given to Rh-negative mother at 28-32 weeks AND within 72 hours of delivery
(Robbins & Kumar Basic Pathology, p. 142)

SECTION 5: CLINICAL ASSESSMENT - KRAMER'S RULE

Kramer's scale: Jaundice progresses in a predictable head-to-toe direction
Kramer ZoneArea InvolvedApproximate Bilirubin Level
Zone 1Face, forehead5-7 mg/dL
Zone 2Upper trunk (above umbilicus)7-10 mg/dL
Zone 3Lower trunk + abdomen (to umbilicus)10-12 mg/dL
Zone 4Legs and arms12-15 mg/dL
Zone 5Palms and soles> 15 mg/dL
Important: Kramer's rule is a bedside screening tool only - not accurate enough to guide treatment decisions. Always confirm with serum bilirubin or transcutaneous bilirubinometer (TcB).

SECTION 6: INVESTIGATIONS

InvestigationPurposeFindings
Total serum bilirubin (TSB)Diagnosis and monitoringElevated; interpret using hour-specific nomogram (Bhutani nomogram)
Direct (conjugated) bilirubinDistinguish unconjugated vs conjugated< 2 mg/dL (normal); > 2 mg/dL = cholestasis
Blood group and Rh type (mother + baby)Detect ABO/Rh incompatibilityCompare mother and baby blood groups
Direct Coombs Test (DCT)Detect maternal antibodies on baby's RBCsPositive = HDN
CBC + Peripheral smearDetect haemolysis, polycythaemiaLow Hb, elevated reticulocytes, microspherocytes (ABO), normoblasts
Blood cultureRule out sepsisPositive in septic jaundice
Serum albuminBinding capacity for bilirubinLow albumin = higher risk of bilirubin neurotoxicity
Thyroid function (T3, T4, TSH)Rule out hypothyroidismLow T4, high TSH = hypothyroidism
G6PD assayDetect G6PD deficiencyReduced enzyme activity
Urine and stool colourConjugated jaundice assessmentDark urine + pale/acholic stools = biliary atresia
Liver function testsHepatocellular diseaseElevated transaminases
Abdominal USGBiliary atresia, choledochal cystAbsent or hypoplastic gall bladder
TcB (Transcutaneous bilirubinometer)Non-invasive screeningCorrelation with TSB; used for initial screening
Bhutani Nomogram (Hour-specific bilirubin risk assessment):
  • Pre-discharge TSB plotted against age in hours
  • Classifies into: Low risk, Low-intermediate risk, High-intermediate risk, High risk zones
  • Guides need for follow-up and treatment

SECTION 7: KERNICTERUS (Bilirubin Encephalopathy) - Critical Section

Definition

Kernicterus is a form of brain damage caused by deposition of unconjugated bilirubin in the basal ganglia and brainstem nuclei (globus pallidus most commonly affected), giving the parenchyma a characteristic yellow hue.
Threshold for concern:
  • Term healthy infant: TSB > 20-25 mg/dL - significant risk
  • Preterm/sick neonates: Much lower thresholds (> 10-15 mg/dL)
  • Kernicterus has been reported at levels > 30 mg/dL in otherwise healthy term breastfed newborns
(Creasy & Resnik's Maternal-Fetal Medicine, p. 1792)

Risk Factors for Kernicterus

  • Preterm birth (more permeable blood-brain barrier)
  • Haemolysis (rapid rise in bilirubin)
  • Sepsis or acidosis (disrupts blood-brain barrier)
  • Hypoxia, hypothermia, hypoglycaemia
  • Low serum albumin
  • Certain drugs (displace bilirubin from albumin)

Phases of Bilirubin Encephalopathy

PhaseClinical Features
Phase 1 (Acute - Early)Poor feeding, lethargy, hypotonia, high-pitched cry, temperature instability
Phase 2 (Acute - Intermediate)Hypertonia → retrocollis (backward arching of neck), opisthotonos (severe backward arching of whole body), irritability, fever, seizures
Phase 3 (Acute - Advanced)Stupor, coma, apnoea, death (70% mortality untreated)
Chronic (Survivors)Cerebral palsy (especially athetoid/dystonic type), high-frequency sensorineural hearing loss, gaze palsy (upward gaze paralysis), dental enamel dysplasia, intellectual disability
(Tietz Textbook of Laboratory Medicine, p. 869)

SECTION 8: MANAGEMENT

A. GENERAL MEASURES

  1. Ensure adequate hydration and feeding (reduces jaundice by increasing gut motility and decreasing enterohepatic circulation)
  2. Encourage frequent breastfeeding (8-12 times per 24 hours)
  3. DO NOT give extra water to breastfed babies (ineffective and reduces breast milk intake)
  4. Supplement with formula only if significantly dehydrated or if bilirubin approaching exchange transfusion threshold

B. PHOTOTHERAPY - First-line Treatment

Mechanism of Phototherapy

Phototherapy works through three mechanisms:
  1. Photo-isomerization (primary mechanism): Light converts bilirubin to water-soluble photo-isomers (4Z,15E-bilirubin) → excreted in bile without conjugation
  2. Structural isomerization: Converts bilirubin to lumirubin → excreted in bile and urine
  3. Photo-oxidation (minor): Oxidizes bilirubin to colourless polar products → excreted in urine
Optimal wavelength: 430-490 nm (blue-green light spectrum); Special blue (BB) tubes most effective

Types of Phototherapy Devices

TypeDescription
Conventional phototherapy (CPT)Standard blue fluorescent tubes; baby under tubes
Intensive/Double phototherapyLights above + fibreoptic mat below; increases light exposure surface area
Fibreoptic (biliblanket)Fibreoptic pad placed under/around baby; can be used with mother
LED phototherapyLight-emitting diode; energy efficient; modern standard
Intensive phototherapy: Used when bilirubin is near exchange transfusion threshold; exposes maximum body surface area

Indications for Phototherapy

Vary with gestational age, age in hours, and presence of risk factors (haemolysis, sepsis, asphyxia, prematurity):
  • Term infant (≥ 38 weeks), low risk: Start phototherapy at TSB ≥ 15 mg/dL at 24h; ≥ 18 mg/dL at 48h; ≥ 20 mg/dL at 72h+
  • Preterm (35-37 weeks): Lower thresholds
  • Presence of haemolysis or other risk factors: Start 2-3 mg/dL lower than standard thresholds

Phototherapy Nursing Protocol (Step-by-Step)

Before starting:
  1. Obtain baseline TSB; document time and weight
  2. Explain procedure to parents (some distress seeing baby under lights)
  3. Check equipment: Working lights; measure irradiance (optimal ≥ 30 µW/cm²/nm for intensive)
Setting up: 4. Place baby undressed (maximum surface area exposed); diaper only 5. Cover eyes with phototherapy goggles/eye shield - protect from retinal damage; check every 2-4 hours for correct placement and no pressure on eyes 6. Cover genitals (male scrotum) with small diaper only 7. Distance of lights: 25-45 cm from skin (check manufacturer instructions) 8. Ensure cot/incubator sides uncovered if side lighting used
During phototherapy: 9. Remove from lights for feeds (continue breastfeeding; skin-to-skin with mother) 10. Change baby's position every 2-3 hours (supine, prone, lateral) to expose different body surfaces 11. Monitor temperature: Every 3-4 hours (lights can cause overheating OR phototherapy under radiant warmer can overheat) 12. Strict intake-output (insensible water loss increased by 10-20% under phototherapy - increase feeds) 13. Repeat TSB: Every 6-12 hours (6 hours if near exchange transfusion threshold; 12-24 hours if responding well) 14. Watch for "bronze baby syndrome": Dark greyish-bronze discolouration of skin when phototherapy used in cholestatic (conjugated) jaundice - NOT harmful but indicates conjugated component; phototherapy NOT recommended for conjugated jaundice
Stopping phototherapy:
  • Stop when TSB falls to safe level (> 3-4 mg/dL below threshold)
  • Repeat TSB 12-24 hours after stopping (rebound jaundice)
  • If rebound significant, restart phototherapy

C. EXCHANGE TRANSFUSION (ET) - Emergency Treatment

Definition: Removal of baby's blood in aliquots and replacement with compatible donor blood; removes bilirubin-laden blood and maternal antibodies; replaces anaemic RBCs
Indication:
  • TSB approaching or exceeding exchange transfusion line on Bhutani nomogram (varies with gestational age and risk)
  • Term baby: Generally TSB ≥ 20-25 mg/dL depending on age in hours and risk factors
  • Preterm/sick baby: Lower thresholds
  • Acute bilirubin encephalopathy (any stage)
  • Haemolytic disease with rapid rise despite phototherapy
Procedure:
  • Double volume exchange transfusion (DVET): 160-200 ml/kg body weight (removes ~85-90% of circulating RBCs)
  • Blood used: O-negative, CMV-negative, irradiated, leukodepleted, crossmatched against mother's blood; reconstituted whole blood (PRBC + FFP)
  • Route: Umbilical venous catheter (UVC) - most common; or umbilical arterial catheter (UAC)
  • Technique: Alternating aliquots of 5-20 ml (depending on baby weight) withdrawn then infused
  • Done in NICU with continuous cardiorespiratory monitoring
Complications of exchange transfusion:
ComplicationDetails
Necrotising enterocolitis (NEC)Most serious; from ischaemia via UVC
Air embolismIf not careful during procedure
ThromboembolismCatheter-related clot
Electrolyte imbalanceHypocalcaemia (citrate in blood binds calcium); hyperkalaemia
ThrombocytopeniaDilutional
HypoglycaemiaFrom donor blood
InfectionSepsis
Cardiac arrhythmiasFrom rapid ion shifts
HypothermiaCold blood infusion
Pre-exchange: Check blood glucose; warm blood to 37°C; ensure IV calcium gluconate available

D. PHARMACOLOGICAL MANAGEMENT

DrugMechanismUse
Intravenous Immunoglobulin (IVIG)Blocks Fc receptors on RES macrophages → reduces haemolysisUsed in Rh or ABO HDN; 0.5-1 g/kg over 2-4 hours; reduces need for exchange transfusion
PhenobarbitoneInduces UGT1A1 enzyme → increases conjugationAntenatal (mother) for anticipated jaundice; less commonly used postnatally

SECTION 9: COMPARISON - PHYSIOLOGICAL vs PATHOLOGICAL JAUNDICE

FeaturePhysiologicalPathological
OnsetAfter 24 hoursWithin 24 hours
DurationResolves by 10-14 daysMay persist > 14-21 days
Peak bilirubin< 12 mg/dL (term)> 12 mg/dL
Rate of rise< 5 mg/dL/day> 5 mg/dL/day
Direct bilirubin< 2 mg/dLMay be > 2 mg/dL
CauseNormal neonatal physiologyUnderlying disease
General conditionWell babyMay be unwell
TreatmentUsually none / breastfeedingPhototherapy / ET

SECTION 10: NURSING MANAGEMENT

Nursing Assessment

  1. Inspect sclera, skin, mucous membranes for jaundice (in daylight/bright light - best assessment)
  2. Use Kramer's zones for bedside assessment (screening only)
  3. Monitor feeding: Frequency, duration, latch, weight gain
  4. Monitor urine output (wet diapers) and stool colour (pale stool = cholestasis)
  5. Vital signs (especially temperature during phototherapy)
  6. Neurological assessment: Alertness, cry quality, muscle tone, feeding behaviour
  7. Assess for signs of acute bilirubin encephalopathy: Lethargy, poor feeding, high-pitched cry, opisthotonos

Nursing Diagnoses

Nursing DiagnosisRelated ToGoal
Risk for injury (kernicterus)Elevated unconjugated bilirubinBilirubin decreases to safe level; no signs of encephalopathy
Impaired skin integrityPhototherapy exposure; rashSkin remains intact; no burns
Risk for injury (eye damage)Phototherapy lightsEyes protected; no corneal damage
Imbalanced nutrition: less than body requirementsPhototherapy separation; poor breastfeedingAdequate intake; weight gain resumes
Fluid volume deficitIncreased insensible losses under phototherapyAdequate hydration; urine output ≥ 1-2 ml/kg/hr
Anxiety (parents)Baby in incubator under lights; separationParents verbalize understanding; participate in care
Deficient knowledge (parents)Disease process and treatmentParents demonstrate understanding of jaundice and home monitoring

Nursing Interventions

1. Phototherapy Care (Most Important):
  • Eye shields correctly positioned; recheck every 2-4 hours; remove for feeds and parent contact
  • Undress baby; diaper only; position changes every 2-3 hours
  • Increase feeds by 10-20% (replace increased insensible losses)
  • Monitor temperature; avoid overheating
  • Repeat TSB as ordered
  • Document each TSB with time and age in hours for nomogram plotting
2. Feeding Support:
  • Encourage breastfeeding every 2-3 hours (8-12 feeds/day)
  • Bring baby out of phototherapy for feeds
  • Teach correct latch and positioning
  • Assess adequacy of breastfeeding (wet diapers, weight trend)
  • Do NOT supplement with water
3. Parent Education:
  • Explain why baby is under lights; what phototherapy does
  • Allow parents to remove baby for feeds and skin-to-skin contact
  • Teach parents to identify jaundice at home (look in good light; check sclera, face, chest, palms)
  • Teach danger signs: Extreme yellowing, difficulty waking for feeds, poor feeding, high-pitched cry → seek immediate care
  • Teach Kramer's rule (simple version)
  • Explain follow-up TSB check after discharge
4. Exchange Transfusion Nursing Care:
  • Pre-procedure: NPO (nil by mouth) for 3-4 hours if possible; blood glucose check; patent IV access; pre-warm blood; oxygen and resuscitation equipment ready
  • During procedure: Continuous cardiorespiratory monitoring; check temperature; document each aliquot withdrawn and infused; monitor blood glucose every 30 minutes; check calcium gluconate available
  • Post-procedure: Close monitoring for complications (NEC signs: abdominal distension, bile-stained aspirate, bloody stools; hypocalcaemia: jitteriness, tetany; hypoglycaemia; bleeding from UVC site); restart feeds when stable (gradually)
5. Prevention:
  • Ensure Rh-negative mothers receive anti-D immunoglobulin (Rho-GAM) at 28 weeks and within 72 hours of delivery
  • Promote early, exclusive breastfeeding to reduce breastfeeding jaundice
  • Ensure adequate breastfeeding support and education to all new mothers
  • Systematic pre-discharge bilirubin screening of all neonates (TSB or TcB)
  • Follow-up at 24-72 hours after discharge (especially if discharged early < 72 hours)
  • Ensure newborn metabolic screening includes hypothyroidism (prevents prolonged jaundice)

SECTION 11: PREVENTION OF Rh HDN

InterventionDetails
Anti-D immunoglobulin (Rho-GAM)Give to ALL Rh-negative mothers at 28-32 weeks gestation (antenatal)
Post-delivery Rho-GAMIf baby is Rh-positive, give to mother within 72 hours of delivery
Other indicationsAfter any sensitizing event: miscarriage, amniocentesis, CVS, external cephalic version, antepartum hemorrhage
Dose300 µg IM single dose covers up to 15 ml fetal blood in maternal circulation
EffectPassive immunity destroys fetal Rh-positive RBCs before mother can mount an immune response → prevents sensitization → protects future pregnancies

CONCLUSION

Neonatal jaundice is one of the most common and clinically significant conditions encountered in newborn care. A thorough understanding of bilirubin metabolism, the distinction between physiological and pathological jaundice, the principles of phototherapy, and the critical danger of kernicterus equips the nurse to make life-saving clinical decisions. The nurse's role - from hour-specific bilirubin assessment and efficient phototherapy management to breastfeeding support, parent education, and pre-discharge screening - directly prevents the tragedy of kernicterus. With universal screening, prompt treatment, and adequate breastfeeding support, virtually all cases of bilirubin neurotoxicity are preventable.

Exam tip for 50 marks: Structure: Introduction + Bilirubin metabolism (step-by-step diagram) + Causes (unconjugated vs conjugated clearly separated) + Physiological vs Pathological comparison table (very high marks) + Kramer's zones table + Kernicterus (phases table - 10-15 marks here) + Investigations + Phototherapy management in detail (mechanism + nursing protocol step-by-step = most marks) + Exchange transfusion (indications + complications) + IVIG + Full nursing care plan + Prevention (anti-D immunoglobulin). The phototherapy nursing protocol and kernicterus phases are consistently the highest-scoring parts of this question.

COMPLETE SERIES SUMMARY

You have now completed all 10 most important INC exam topics in Child Health Nursing at 50-mark depth:
#TopicKey Exam Focus
1Growth & DevelopmentMilestones table, theories (Erikson/Piaget), DDST
2National Immunization ScheduleNIS table, cold chain equipment, AEFI
3Preterm/LBW BabyThermoregulation, KMC, NRP, complications
4IMNCIDanger signs, colour-coded classification, ORS plans
5PEM (Kwashiorkor & Marasmus)Comparison table, WHO 10 steps, chelation
6Nephrotic SyndromePathophysiology chain, steroid protocol, nursing care
7Tetralogy of Fallot4 defects, tet spell management, surgical repair
8MeningitisCSF table, antibiotics, dexamethasone, nursing care
9ThalassemiaBlood transfusion, iron chelation, BMT, genetics
10Neonatal JaundicePhototherapy protocol, kernicterus phases, exchange transfusion

Next

We've completed all 10 topics from the original list! Before I continue, let me check what you'd like next.
Asking for Preferences

All 10 top topics are done! What would you like to do next?

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.